rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAAGGGACTAGCGCGGAGACCCAGTACTTCGGGCCA	CASSVEGTSAETQYF	In	VDJ	3	106	0.0016459882917436606	0.002295067769453947	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	0	6	5	2	2	23	39	51	41	53			01,02			01,02							Vb 1	CASSVEGTSAETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGTGCGTCCAGGGTTTAATGAAAAACTGTTTTTTGGCAGT	CASSVRPGFNEKLFF	In	VDJ	1	43	6.677122315563906E-4	9.310180574199974E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	3	4	8	2	23	34	47	42	49			01,02										Vb 1	CASSVRPGFNEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCCGGGACAGGGGTATAGATACGCAGTATTTTGGCCCA	CASSARDRGIDTQYF	In	VDJ	1	40	6.211276572617588E-4	8.660633092279046E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	2	5	3	3	23	36	49	39	52			01,02										Vb 1	CASSARDRGIDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGGAACAGGGGTTTCACTGAAGCTTTCTTTGGACAA	CASRNRGFTEAFF	In	VDJ	1	20	3.105638286308794E-4	4.330316546139523E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	2	4	2	3	23	34	43	36	46			01,02										Vb 1	CASRNRGFTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGACAGGGGTGGACCGGGGAGCTGTTTTTTGGAGAA	CASSVGQGWTGELFF	In	VDJ	1	19	2.950356371993354E-4	4.1138007188325465E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	2	2	5	0	3	23	-1	47	39	50			01,02										Vb 1	CASSVGQGWTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCGCAGGGGGCGGCGGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	17	2.6397925433624744E-4		46	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	0	2	2	5	23	36	46	38	51			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCACTAAGGACAGGATCCGAGCAGTACTTCGGGCCG	CASSALRTGSEQYF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	4	6	6	3	23	36	49	42	52			01,02										Vb 1	CASSALRTGSEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAGTAGGGAACAACCAGGCAGACCCAGTATTTTGGCCCA	CASSE*GTTRQTQYF	Stop	VDJ	1	16	2.484510629047035E-4		45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	5	0	8	12	6	15	23	34	44	40	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSE*GTTRQTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCGGACAGTGGTCTAATTCACCCCTCCACTTTGGGAAC	CASSAGQWSNSPLHF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	1	5	6	2	5	23	36	44	38	49			01,02										Vb 1	CASSAGQWSNSPLHF+TCRBV09-01+TCRBJ01-06	TCRBV09-01	TCRBD01-01*01	TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGACTAGCGGGGGAGCTAGCAGATACGCAGTATTTTGGCCCA	CASSGLAGELADTQYF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	2	2	4	0	6	23	-1	48	36	54			01,02										Vb 1	CASSGLAGELADTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAGGCAGTGCGCTATGAGCAGTTCTTCGGGCCA	CASSVEAVRYEQFF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	42	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	0	4	5	8	3	6	23	39	45	42	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVEAVRYEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAACGAGGGGCCGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSERGAGGNQPQHF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	48	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-05	01	5	5	2	2	6	6	23	34	45	40	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSERGAGGNQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01		TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAAGGCGAGCAGGGGGCCCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	228	9254	0.14369788350750787		53	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	4	0	2	7	1	28	45	60	52	61													Vb 16	X+TCRBV14-01+TCRBJ02-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATTTTCAGGTCTACTATGGCTACACCTTCGGTTCG		Out	VDJ	4	154	0.002391341480457771		43	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	4	3	4	3	29	44	52	48	55													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGGTGGCTACGAGCAGTACTTCGGGCCG	CASSQGGYEQYF	In	VDJ	3	141	0.0021894749918476993	0.0030528731650283636	36	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	3	0	9	3	0	3	29	-1	46	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQGGYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCACAGGGTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPQGATNEKLFF	In	VDJ	1	46	7.142968058510225E-4	9.959728056120902E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	3	0	1	2	29	42	49	43	51													Vb 16	CASSPQGATNEKLFF+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGCATGTAAATCTGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	44	6.832404229879346E-4		52	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	1	1	8	4	12	5	29	45	60	57	65				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGGGGGGGTGGCTACACCTTCGGTTCG		Out	VDJ	1	42	6.521840401248467E-4		38	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	9	0	7	1	0	29	46	-1	47	54													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD02-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTCCCGGGACTAGGTGTTTTTCGGGCCA		Out	VDJ	1	26	4.0373297722014315E-4		32	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02			6	0	8	19	4	6	29	40	52	44	58						01,02		TCRBJ02-01,TCRBJ02-05					Vb 16	X+TCRBV14-01+TCRBJ02-X	TCRBV14-01*01	TCRBD02-01	TCRBJ02	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATTGAACTATGGCTACACCTTCGGTTCG	CASSQLNYGYTF	In	VJ	1	26	4.0373297722014315E-4	5.62941150998138E-4	36	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	2	0	0	2	0	3	29	-1	44	-1	47													Vb 16	CASSQLNYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGTCGGCACAGATACGCAGTATTTTGGCCCA	CASSLVGTDTQYF	In	VDJ	15	616	0.009565365921831085	0.01333737496210973	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	8	1	1	3	24	36	40	37	43						01,02								CASSLVGTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGTTCCTCCTGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSWSSYNEQFF	In	VDJ	9	370	0.0057454308296712685	0.008011085610358118	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	10	10	2	0	9	0	24	31	-1	40	44														CASSSWSSYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCACCGGACGGTTTCCTACGAGCAGTACTTCGGGCCG	CASSHRTVSYEQYF	In	VDJ	5	210	0.0032609202006242334	0.004546832373446499	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-07	01	5	1	7	1	4	4	24	36	44	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHRTVSYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGAAAAAGGGAGGACAGGGGGAAGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	117	0.0018167983974906442		53	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	1	1	5	4	24	39	54	44	58														X+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCACCGAAGGCGCTAGCGGGTTTAAAGAGACCCAGTACTTCGGGCCA	CASTEGASGFKETQYF	In	VDJ	1	43	6.677122315563906E-4	9.310180574199974E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	10	4	4	3	12	4	24	31	51	43	55						01,02								CASTEGASGFKETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAAAGGGGCAGGCATCACAGATACRCAGTATTTTGGCCCA	CASKGAGITDTQYF	In	VDJ	1	40	6.211276572617588E-4	8.660633092279046E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	5	2	2	4	7	24	31	40	35	47														CASKGAGITDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGACGCAGGGGGCACAGGAAACACCATATATTTTGGAGAG	CASSVDAGGTGNTIYF	In	VDJ	1	34	5.279585086724949E-4	7.361538128437189E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	0	4	7	3	24	36	51	43	54														CASSVDAGGTGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCGGACGGAAAGGGCTATGGCTACACCTTCGGTTCG	CASSADGKGYGYTF	In	VDJ	1	30	4.6584574294631904E-4	6.495474819209284E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	5	1	7	4	2	8	24	36	42	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSADGKGYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCAGGACAGGGGGCGAGGCACTGAAGCTTTCTTTGGACAA	CASSQDRGRGTEAFF	In	VDJ	1	28	4.347893600832311E-4	6.062443164595332E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	0	4	3	4	24	35	49	38	53														CASSQDRGRGTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCTTCAGGACAGGGCCTACGAGCAGTACTTCGGGCCG	CASSLQDRAYEQYF	In	VDJ	1	28	4.347893600832311E-4	6.062443164595332E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	3	2	5	0	24	36	-1	41	49														CASSLQDRAYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAACCGCATTAGAGACAGCTGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	26	4.0373297722014315E-4		53	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	5	1	14	2	24	36	55	50	57														X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAACGTTCCCCCCATAGGGACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	23	3.5714840292551126E-4		50	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	3	0	8	2	13	0	24	38	-1	51	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTTTTTGGGGCGCACTACGAGCAGTACTTCGGGCCG	CASSFFGAHYEQYF	In	VDJ	1	22	3.416202114939673E-4	4.763348200753475E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	7	0	3	6	3	24	36	47	42	50														CASSFFGAHYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTAGGCCAGGGAGAGGTAGAACAGTTCTTCGGGCCA	CASSLGQGEVEQFF	In	VDJ	1	21	3.2609202006242334E-4	4.546832373446499E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-01	01	6	4	3	13	7	10	24	35	47	42	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGQGEVEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCTCGGTTTTAGTCCGCTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	2.795074457677914E-4		44	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	10	5	8	0	9	6	24	31	43	40	49						01,02								X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAATCAGACAGGGCTTTTTGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	2.795074457677914E-4		47	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	3	4	3	7	24	39	49	42	56														X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTATCGGTAGTCCGCACAGATACGCAGTATTTTGGCCCA	CASSLSVVRTDTQYF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	5	8	1	8	3	24	35	46	43	49						01,02								CASSLSVVRTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAGTGCGTCCGGCCCCCAGTCTCACTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	2.1739468004161556E-4		59	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	3	4	5	0	14	7	22	36	53	50	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCGACGGAGGTTTAATCACAGATACGCAGTATTTTGGCCCA	CASSDGGLITDTQYF	In	VDJ	1	54	8.385223373033743E-4	0.0011691854674576712	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	1	2	3	6	18	30	38	33	44														CASSDGGLITDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGCGGGGGGCCAATCGACCGGGGAGCTGTTTTTTGGAGAA	CASSLAGGQSTGELFF	In	VDJ	1	48	7.453531887141105E-4	0.0010392759710734854	48	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-02	01	0	6	0	5	1	6	18	35	42	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGGQSTGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01		TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCAAAACAGGTTCTCCCTACGAGCAGTACTTCGGGCCG	CASSKTGSPYEQYF	In	VDJ	1	30	4.6584574294631904E-4	6.495474819209284E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	4	2	3	5	18	30	38	33	43														CASSKTGSPYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGATCGGGACTAGCGGGGCCGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	21	3.2609202006242334E-4		46	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	0	3	4	3	3	18	29	45	32	48														X+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGGGCAGGGGTTTGACGAGCAGTACTTCGGGCCG	CASSLGQGFDEQYF	In	VDJ	1	19	2.950356371993354E-4	4.1138007188325465E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	5	4	4	18	32	42	36	46														CASSLGQGFDEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCCCCCAGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSSPRQGNTEAFF	In	VDJ	1	19	2.950356371993354E-4	4.1138007188325465E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	1	6	0	18	31	-1	37	44														CASSSPRQGNTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAAATGGGGGGTATGGAAACACCATATATTTTGGAGAG	CASSLNGGYGNTIYF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	2	9	1	3	3	2	18	33	42	36	44														CASSLNGGYGNTIYF+TCRBV07-06+TCRBJ01-03	TCRBV07-06*01	TCRBD02-01*01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCGACAGGGGTTCCAGGAGACCCAGTACTTCGGGCCA	CASSRQGFQETQYF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	2	5	1	6	18	30	39	31	45														CASSRQGFQETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGAGGGGGTGGGGACAGAGCACAGATATGCAGTATTTTGGCCCA	CASSLRGWGQSTDMQYF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	51	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	5	11	9	11	18	32	48	41	59														CASSLRGWGQSTDMQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGAATCTAGCTAACAATGAGCAGTTCTTCGGGCCA	CASSLNLANNEQFF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	7	5	4	2	18	32	41	36	43						01,02								CASSLNLANNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCTGGACAGTTCAATCAGCCCCAGCATTTTGGTGAT	CASSPGQFNQPQHF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	5	3	3	2	18	30	39	33	41														CASSPGQFNQPQHF+TCRBV07-06+TCRBJ01-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGTCAGCTGGGCAGATACGCAGTATTTTGGCCCA	CASSLVSWADTQYF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	42	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-03	01	3	0	9	4	8	0	18	32	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVSWADTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGTCACAGGTAGGTGTGTTAGTTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	69	0.001071445208776534		46	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	3	4	4	5	13	19	27	37	32	50														X+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGTATGACTGGAACACTGAAGCTTTCTTTGGACAA	CASSLYDWNTEAFF	In	VDJ	1	51	7.919377630087424E-4	0.0011042307192655784	42	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	2	10	1	4	1	19	33	41	37	42						01,02								CASSLYDWNTEAFF+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01	TCRBD02-01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCCATGGGGTAGCGGGGGTCACACCGGGGAGCTGTTTTTTGGAGAA	CASSPWGSGGHTGELFF	In	VDJ	1	23	3.5714840292551126E-4	4.979864028060451E-4	51	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	5	2	3	8	2	19	31	48	39	50														CASSPWGSGGHTGELFF+TCRBV07-05+TCRBJ02-02	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGTTTCGATAGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSFDSGGTDTQYF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	5	3	1	9	0	19	27	-1	36	44														CASSFDSGGTDTQYF+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCACGGGGGGCCGGGCAATGAGCAGTTCTTCGGGCCA	CASSHGGPGNEQFF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	42	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	1	6	2	5	19	31	40	33	45														CASSHGGPGNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGGATTTGACTAGCGGCACAGATACGCAGTATTTTGGCCCA	CASSLDLTSGTDTQYF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	2	6	1	6	0	19	33	-1	39	47						01,02								CASSLDLTSGTDTQYF+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCGATGTTTGTGACTCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	13	2.0186648861007157E-4		49	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	2	10	4	9	8	19	31	44	40	52						01,02								X+TCRBV07-05+TCRBJ01-02	TCRBV07-05*01	TCRBD02-01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTGGGAATAATAACAATGAGCAGTTCTTCGGGCCA	CASSFGNNNNEQFF	In	VDJ	3	119	0.0018478547803537323	0.002576538344953016	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-01	01	2	0	8	5	1	6	19	33	38	34	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSFGNNNNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGTCGAGGGACAACCGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRGTTATNEKLFF	In	VDJ	1	56	8.695787201664622E-4	0.0012124886329190664	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	0	6	0	4	4	19	27	37	31	41													Vb 5.1	CASRGTTATNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTGGGGCAGGGGGCTTAATCCATACGCAGTATTTTGGCCCA	CASSGAGGLIHTQYF	In	VDJ	1	56	8.695787201664622E-4	0.0012124886329190664	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	0	7	5	7	19	30	43	35	50													Vb 5.1	CASSGAGGLIHTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGGAGCAGAGCGCAAGAGCAGATACGCAGTATTTTGGCCCA	CASSPEQSARADTQYF	In	VDJ	1	41	6.366558486933027E-4	8.877148919586022E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	6	6	4	9	6	19	31	44	40	50						01,02							Vb 5.1	CASSPEQSARADTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAAGAGGACAGGGCTGGAAACACCATATATTTTGGAGAG	CASSQEDRAGNTIYF	In	VDJ	1	38	5.900712743986708E-4	8.227601437665093E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	1	3	2	5	0	19	31	-1	36	44													Vb 5.1	CASSQEDRAGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTATACCATAGCGGGAGCTCAAAGCACAGATACGCAGTATTTTGGCCCA	CASSYTIAGAQSTDTQYF	In	VDJ	1	37	5.745430829671268E-4	8.011085610358117E-4	54	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	5	2	0	6	5	19	32	47	38	52													Vb 5.1	CASSYTIAGAQSTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCAGGGACAGGGATTTGGAAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	30	4.6584574294631904E-4		50	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	3	1	1	7	19	31	41	32	48													Vb 5.1	X+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGGAAAAATGTGACCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	24	3.726765943570552E-4		44	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-01	01	5	2	7	2	9	1	19	30	42	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCACCAACCAAAGACACCCTCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	22	3.416202114939673E-4		50	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	6	0	9	4	19	29	42	38	46													Vb 5.1	X+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAAGTAGGTGGGGGTGAAAAACTGTTTTTTGGCAGT	CASSLEVGGGEKLFF	In	VDJ	1	21	3.2609202006242334E-4	4.546832373446499E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-04	01	0	6	1	7	8	0	19	35	-1	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLEVGGGEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01		TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAACAGCCCCGAGCAGGTAGCGAGGACAGATACGCAGTATTTTGGCCCA	CANSPEQVARTDTQYF	In	VDJ	1	21	3.2609202006242334E-4	4.546832373446499E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	5	6	3	10	3	19	31	46	41	49						01,02							Vb 5.1	CANSPEQVARTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCCTAACGGAGGGACAGATCTTCTCCGTCAATGAGCAGTTCTTCGGGCCA	CASSSLTEGQIFSVNEQFF	In	VDJ	1	20	3.105638286308794E-4	4.330316546139523E-4	57	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	5	6	10	11	19	32	49	42	60													Vb 5.1	CASSSLTEGQIFSVNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTGGGGGGCCTCACAGATACGCAGTATTTTGGCCCA	CASSLVGGLTDTQYF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-03	01	0	6	0	2	2	2	19	35	43	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLVGGLTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGCAGGGGTCGAACGAGCAGTACTTCGGGCCG	CASSLGQGSNEQYF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	2	5	2	4	19	35	43	37	47													Vb 5.1	CASSLGQGSNEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAGCAACTAGCGAGAACAGATACGCAGTATTTTGGCCCA	CASSLEQLARTDTQYF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	3	6	3	4	3	19	35	46	39	49						01,02							Vb 5.1	CASSLEQLARTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTACCTACGGGACTTTCAAAACGGCTATCTACGAACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	2.6397925433624744E-4		59	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	10	5	6	20	19	32	44	38	64						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGAGGGACAGTTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRGTVATNEKLFF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	5	0	1	3	19	30	38	31	41													Vb 5.1	CASRGTVATNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGGAACAGGGGGCGCGATCAAATGAGCAGTTCTTCGGGCCA	CASSPEQGARSNEQFF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	0	7	5	7	19	31	45	36	52													Vb 5.1	CASSPEQGARSNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTGGGACAGGGGGCTGGGCTATGGCTACACCTTCGGTTCG	CASSLWDRGLGYGYTF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	0	4	1	4	19	34	47	35	51													Vb 5.1	CASSLWDRGLGYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGCTAGCGGGGGGGCGACGGCAAGAGACCCAGTACTTCGGGCCA	CASSLGLAGGRRQETQYF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	54	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	4	0	2	2	6	19	35	49	37	55													Vb 5.1	CASSLGLAGGRRQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGTAGAACAGGGGGCGCGTAGCACTGAAGCTTTCTTTGGACAA	CASSVEQGARSTEAFF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	0	4	5	6	19	31	45	36	51													Vb 5.1	CASSVEQGARSTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGAAAGTTCTAGCGGGGAAATAGCACAGATACGCAGTATTTTGGCCCA	CASRKF*RGNSTDTQYF	Stop	VDJ	1	13	2.0186648861007157E-4		51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	3	0	6	4	19	30	45	36	49													Vb 5.1	CASRKF*RGNSTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTACAGGGRATGTCACAGATACGCAGTATTTTGGCCCA	CASSFTGXVTDTQYF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	3	2	2	1	4	19	33	41	34	45													Vb 5.1	CASSFTGXVTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTTGGGGAAATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	12	1.863382971785276E-4		43	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-06	01	1	0	8	5	3	1	19	34	41	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01		TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTCAGAACAAGGACAGGGATGAATCAGCCCCAGCATTTTGGTGAT	CASSLRTRTGMNQPQHF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	3	4	10	3	19	31	49	41	52													Vb 5.1	CASSLRTRTGMNQPQHF+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCGGGATGACTTTAGGTGGGAGCTATGGCTACACCTTCGGTTCG	CAGMTLGGSYGYTF	In	VDJ	3	112	0.0017391574403329245	0.002424977265838133	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	11	9	2	4	15	0	25	31	-1	46	51													Vb 3	CAGMTLGGSYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGGACAGGGCGGACACTGAAGCTTTCTTTGGACAA	CASSWDRADTEAFF	In	VDJ	2	61	9.472196773241821E-4	0.0013207465465725544	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	3	3	0	3	25	-1	47	38	50													Vb 3	CASSWDRADTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCACTGACTAGCACGTCCGGGGAGCTGTTTTTTGGAGAA	CASSALTSTSGELFF	In	VDJ	1	59	9.161632944610941E-4	0.0012774433811111592	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	2	7	6	5	4	25	37	49	42	53						01,02							Vb 3	CASSALTSTSGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTTTTGGGGGGAGGCTTTCGAGCAGTACTTCGGGCCG		Out	VDJ	1	55	8.540505287349182E-4		46	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	9	1	6	4	7	25	41	51	45	58						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTAACCAGCCCCCTACGATCGCAGTACTTCGGGCCG		Out	VDJ	1	48	7.453531887141105E-4		41	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	4	4	5	9	3	12	25	38	44	41	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAACCGGGGGGACATTTCTGCAGTATTTTGGCCCA	CASSLTGGTFLQYF	In	VDJ	1	45	6.987686144194785E-4	9.743212228813926E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	8	1	11	2	8	25	40	49	42	57													Vb 3	CASSLTGGTFLQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGGACGGGGGATTAAAACACCATATATTTTGGAGAG	CARTGD*NTIYF	Stop	VDJ	1	41	6.366558486933027E-4		36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	9	8	2	6	2	4	25	33	41	35	45													Vb 3	CARTGD*NTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCGTCCCCCCAGGGAACGTATGGCTACACCTTCGGTTCG	CASSPSPQGTYGYTF	In	VDJ	1	41	6.366558486933027E-4	8.877148919586022E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	5	9	4	25	37	51	46	55													Vb 3	CASSPSPQGTYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGCCCGGGGGAGCTCACACCGGGGAGCTGTTTTTTGGAGAA	CASSLPGGAHTGELFF	In	VDJ	1	38	5.900712743986708E-4	8.227601437665093E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	8	2	3	3	5	25	39	48	42	53													Vb 3	CASSLPGGAHTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCACCTCGAGGGACGGACAATCAGCCCCAGCATTTTGGTGAT	CASSPPRGTDNQPQHF	In	VDJ	1	37	5.745430829671268E-4	8.011085610358117E-4	48	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	5	0	7	3	9	3	25	37	51	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPPRGTDNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCGCCAGGGGAACACTGAAGCTTTCTTTGGACAA	CASRRQGNTEAFF	In	VDJ	1	37	5.745430829671268E-4	8.011085610358117E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	1	4	0	25	36	-1	40	45													Vb 3	CASRRQGNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCACCGGGGCTGGAAACACCATATATTTTGGAGAG	CASSFTGAGNTIYF	In	VDJ	1	36	5.590148915355828E-4	7.794569783051141E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	3	8	3	2	3	0	25	39	-1	42	47													Vb 3	CASSFTGAGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGTACAGCAGGGGGGGTAAGCCCCAGCATTTTGGTGAT	CASRYSRGGKPQHF	In	VDJ	1	33	5.12430317240951E-4	7.145022301130213E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	6	4	1	8	6	4	25	36	49	42	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRYSRGGKPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGAGGGGGCAGGTCAGCCCCAGCATTTTGGTGAT	CASREGAGQPQHF	In	VDJ	1	33	5.12430317240951E-4	7.145022301130213E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	5	0	6	2	3	25	36	45	38	48													Vb 3	CASREGAGQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATATGGGGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLYGGSNQPQHF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	1	6	1	0	2	0	25	41	-1	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLYGGSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGTGAACAGGGTTATAATTCACCCCTCCACTTTGGGAAC	CASSREQGYNSPLHF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	3	4	5	1	25	37	48	42	49													Vb 3	CASSREQGYNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGACGACTAGCGGGTCTTACGAGCAGTATTTCGGGCCG	CASSLTTSGSYEQYF	In	VDJ	1	29	4.503175515147751E-4	6.278958991902308E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	2	4	16	3	15	25	39	52	42	67						01,02							Vb 3	CASSLTTSGSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTGGGTGACGGGGTCCAGCAGCTCCTACGAGCAGTACTTCGGGCCG	CASSWVTGSSSSYEQYF	In	VDJ	1	29	4.503175515147751E-4	6.278958991902308E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	3	0	8	8	25	36	49	44	57													Vb 3	CASSWVTGSSSSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCGGACTCACCTACGAGCAGTACTTCGGGCCG	CASSPGLTYEQYF	In	VDJ	1	27	4.1926116865168716E-4	5.845927337288356E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	10	2	3	2	25	37	45	40	47						01,02							Vb 3	CASSPGLTYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATGATTACCGGGAGTCGGGAAAAACTGTTTTTTGGCAGT	CASMITGSREKLFF	In	VDJ	1	26	4.0373297722014315E-4	5.62941150998138E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	7	8	2	8	7	4	25	35	48	42	52													Vb 3	CASMITGSREKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGTAGCGGGCGGACCCAGTACTTCGGGCCA	CASSRSGRTQYF	In	VDJ	1	26	4.0373297722014315E-4	5.62941150998138E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	5	4	7	2	2	25	37	46	39	48						01,02							Vb 3	CASSRSGRTQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCCTGGTAGGGTGAACACTGAAGCTTTCTTTGGACAA	CASTPGRVNTEAFF	In	VDJ	1	26	4.0373297722014315E-4	5.62941150998138E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	7	5	3	0	8	0	25	35	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASTPGRVNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCGGAGTGGGGGGCGGACTACGAGCAGTACTTCGGGCCG	CASSPEWGADYEQYF	In	VDJ	1	25	3.882047857885992E-4	5.412895682674404E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	5	6	0	3	8	3	25	37	51	45	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPEWGADYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACGGACAGGGTCTACGAGCAGTACTTCGGGCCG	CASTDRVYEQYF	In	VDJ	1	25	3.882047857885992E-4	5.412895682674404E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	3	3	1	1	25	35	44	36	45													Vb 3	CASTDRVYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTACGAGGGACCGACACTGAAGCTTTCTTTGGACAA	CASSLRGTDTEAFF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	5	0	7	3	6	2	25	37	48	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLRGTDTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCTCACCGGGCTTCGAAACTGAAGCTTTCTTTGGACAA	CATSPGFETEAFF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	10	8	0	5	7	6	25	32	43	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CATSPGFETEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGAGGGGACACCGAATGCATGAGCAGTTCTTCGGGCCA	CASSLGRGHRMHEQFF	In	VDJ	1	23	3.5714840292551126E-4	4.979864028060451E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	9	0	8	0	12	25	-1	47	40	59													Vb 3	CASSLGRGHRMHEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCTTTACCCCGGAGCAGTTCTTCGGGCCA	CASSFFTPEQFF	In	VDJ	1	22	3.416202114939673E-4	4.763348200753475E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	3	3	7	10	4	4	25	39	45	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFFTPEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCGGGGGCGCTAGGCTATGGCTACACCTTCGGTTCG	CASSLSGALGYGYTF	In	VDJ	1	22	3.416202114939673E-4	4.763348200753475E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	1	6	0	4	1	6	25	41	48	42	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLSGALGYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCCCCTCGGGGGTGCTTCACCCCTCCACTTTGGGAAC	CASSSPLGGASPLHF	In	VDJ	1	22	3.416202114939673E-4	4.763348200753475E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	4	8	2	9	7	3	25	38	51	45	54													Vb 3	CASSSPLGGASPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGGGCGAGGGTTGCCACTGAAGCTTTCTTTGGACAA	CASSRARVATEAFF	In	VDJ	1	22	3.416202114939673E-4	4.763348200753475E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	11	0	4	6	4	25	36	47	42	51													Vb 3	CASSRARVATEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCCGACAGCGCTTATTGAAGAGACCCAGTACTTCGGGCCA	CASSFPTALIEETQYF	In	VDJ	1	21	3.2609202006242334E-4	4.546832373446499E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	5	3	3	9	25	39	47	42	56													Vb 3	CASSFPTALIEETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTCAGGGGCGACACTGAAGCTTTCTTTGGACAA	CASSLFRGDTEAFF	In	VDJ	1	21	3.2609202006242334E-4	4.546832373446499E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	2	3	1	2	25	41	48	42	50													Vb 3	CASSLFRGDTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATCAAGCACCCGAGCTTGCCTGGAAACACCATATATTTTGGAGAG	CASIKHPSLPGNTIYF	In	VDJ	1	20	3.105638286308794E-4	4.330316546139523E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	7	6	7	2	3	12	25	35	41	38	53						01,02							Vb 3	CASIKHPSLPGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCGGACAGTCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSFRTVYSNQPQHF	In	VDJ	1	20	3.105638286308794E-4	4.330316546139523E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	5	0	2	4	25	39	47	41	51													Vb 3	CASSFRTVYSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGGGACGTCGAGGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSGTSRGSYEQYF	In	VDJ	1	19	2.950356371993354E-4	4.1138007188325465E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	6	0	7	0	1	9	25	36	42	37	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSGTSRGSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCACCGCAAGGCGGGGGCGACTTGATACGCAGTATTTTGGCCCA	CASTTARRGRLDTQYF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	7	2	6	10	6	25	35	52	45	58													Vb 3	CASTTARRGRLDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCGGACAGCCGGAATGAACACTGAAGCTTTCTTTGGACAA	CASRTAGMNTEAFF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	1	5	0	1	6	25	34	41	35	47													Vb 3	CASRTAGMNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGGGTGCGGGACGAGCAGTACTTCGGGCCG	CASSLGVRDEQYF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	3	6	1	5	0	6	25	-1	44	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGVRDEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCGGCTTCAGGACTTAGGGATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	16	2.484510629047035E-4		49	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	1	10	6	9	5	25	38	52	47	57						01,02							Vb 3	X+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTGGACACCCGCACAGATACGCAGTATTTTGGCCCA	CASSLDTRTDTQYF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	6	1	2	3	25	37	44	39	47													Vb 3	CASSLDTRTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCCGGGGACTGAAGCTTTCTTTGGACAA	CASSPPGTEAFF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	3	5	4	0	25	37	-1	41	46													Vb 3	CASSPPGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCGGACAGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPDRANTGELFF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	3	0	2	0	25	37	-1	39	47													Vb 3	CASSPDRANTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTATTGACAGCTACAATGAGCAGTTCTTCGGGCCA	CASSIDSYNEQFF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	5	3	3	0	25	37	-1	40	45													Vb 3	CASSIDSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCGGGATGGGATTCAAGAGACCCAGTACTTCGGGCCA	CASRDGIQETQYF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	8	8	3	2	0	7	25	-1	39	34	46													Vb 3	CASRDGIQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACCTTGGGCTAAACAACACTTCACAGATACGCAGTATTTTGGCCCA	CASRPWAKQHFTDTQYF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	8	0	2	5	12	25	36	45	41	57													Vb 3	CASRPWAKQHFTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGAGGGGTGGCTACACCTTCGGTTCG	CASSLWRGGYTF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	0	5	2	7	1	0	25	42	-1	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLWRGGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGTTCTTCCAATGAGCAGTTCTTCGGGCCA	CASSLGSSNEQFF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	2	0	10	6	0	6	25	-1	42	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGSSNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGTTCGGGGGAGGCTATGGCTACACCTTCGGTTCG	CASSSFGGGYGYTF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	8	2	4	4	3	25	38	48	42	51						01,02							Vb 3	CASSSFGGGYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCATCGGACAGGGGGCCAAAAACATTCAGTACTTCGGCGCC	CASSIGQGAKNIQYF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	1	2	1	4	0	25	36	-1	40	49													Vb 3	CASSIGQGAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGGGGGAAGAAATCAGCCCCAGCATTTTGGTGAT	CASRLGGRNQPQHF	In	VDJ	3	129	0.002003136694669172	0.0027930541722599924	42	TCRBV12	TCRBV12-02	01				TCRBJ01	TCRBJ01-05	01	1	0	8	4	1	3	18	34	39	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLGGRNQPQHF+TCRBV12-02+TCRBJ01-05	TCRBV12-02*01		TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCACCGAAGAGCGGGGGACGGGAGATACGCAGTATTTTGGCCCA	CATEERGTGDTQYF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	42	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	6	2	5	8	5	18	23	39	31	44														CATEERGTGDTQYF+TCRBV12-02+TCRBJ02-03	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTCCCCGGGACGGAGGGAATATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	2.6397925433624744E-4		47	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	10	0	4	9	4	18	31	46	40	50														X+TCRBV12-02+TCRBJ02-07	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGGGAATAGCGGGGGACCGCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASRE*RGTAGTGELFF	Stop	VDJ	1	12	1.863382971785276E-4		51	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	5	2	4	4	8	18	29	42	33	50														CASRE*RGTAGTGELFF+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCACCAGTGATGGGGGGGACAGGACCACAGATACGCAGTATTTTGGCCCA	CATSDGGDRTTDTQYF	In	VDJ	1	35	5.434867001040389E-4	7.578053955744165E-4	48	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	4	2	7	2	23	35	50	42	52													Vb 14	CATSDGGDRTTDTQYF+TCRBV27-01+TCRBJ02-03	TCRBV27-01*01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTATACCTAGGGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSLYLGGYNEQFF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	45	TCRBV27	TCRBV27-01	01				TCRBJ02	TCRBJ02-01	01	1	5	1	4	4	1	23	39	49	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	CASSLYLGGYNEQFF+TCRBV27-01+TCRBJ02-01	TCRBV27-01*01		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCAGTCAAGGCTAGCATTTTCTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	6	239	0.0037112377521390082		49	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	7	4	9	7	25	35	49	44	56						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGCGTGGGGACAGGGGGCCTGTGGGCTGAAGCTTTCTTTGGACAA	CSGVGTGGLWAEAFF	In	VDJ	4	144	0.0022360595661423312	0.0031178279132204564	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	0	6	5	7	25	32	49	37	56													Vb 4	CSGVGTGGLWAEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGGACCCAGCTCTGGGGATACGCAGTATTTTGGCCCA	CSAGPSSGDTQYF	In	VDJ	3	109	0.0016925728660382926	0.00236002251764604	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	7	1	7	6	2	11	25	32	38	34	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSAGPSSGDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCCACCGGGACAGAAGGAAACATTCAGTACTTCGGCGCC	CSVSTGTEGNIQYF	In	VDJ	2	63	9.7827606018727E-4	0.0013640497120339496	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	0	5	6	6	4	25	34	47	40	51													Vb 4	CSVSTGTEGNIQYF+TCRBV29-01+TCRBJ02-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATGCGGGATTCTCCTCCGGGGAGCTGTTTTTTGGAGAA	CSVDAGFSSGELFF	In	VDJ	1	57	8.851069115980062E-4	0.001234140215649764	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	7	3	6	1	7	25	36	43	37	50													Vb 4	CSVDAGFSSGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTTCTTCAATCGGCCGGGGCCAACGTCCTGACTTTCGGGGCC	CSVVLQSAGANVLTF	In	VDJ	1	55	8.540505287349182E-4	0.0011908370501883688	45	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-06	01	4	9	0	4	10	1	25	35	48	45	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVLQSAGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01		TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCGGGGGGCCCAATGAGCAGTTCTTCGGGCCA	CSVAGGPNEQFF	In	VDJ	1	54	8.385223373033743E-4	0.0011691854674576712	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	1	6	1	2	25	35	43	36	45													Vb 4	CSVAGGPNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTACAACAGGGAACACTGAAGCTTTCTTTGGACAA	CSVTTGNTEAFF	In	VDJ	1	47	7.298249972825665E-4	0.0010176243883427878	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	4	1	3	0	25	34	-1	37	42													Vb 4	CSVTTGNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGCTAGCGGGACAGATACGCAGTATTTTGGCCCA	CSVEASGTDTQYF	In	VDJ	1	42	6.521840401248467E-4	9.093664746892998E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	4	3	2	0	25	36	-1	38	46						01,02							Vb 4	CSVEASGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGAGCTCGCATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	42	6.521840401248467E-4		34	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	6	7	4	1	5	25	32	36	33	41						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGGTTGTCACAGATACGCAGTATTTTGGCCCA	CSVEGVVTDTQYF	In	VDJ	1	36	5.590148915355828E-4	7.794569783051141E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	1	0	9	2	0	4	25	-1	41	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEGVVTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGAATAGCGGGGTGGGAGATACGCAGTATTTTGGCCCA	CSVNSGVGDTQYF	In	VDJ	1	32	4.96902125809407E-4	6.928506473823237E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	5	3	5	3	4	25	33	44	36	48													Vb 4	CSVNSGVGDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCCAGCCCTTTTATCGGAGACCCAGTACTTCGGGCCA	CSVEDPALLSETQYF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-05	01	0	4	5	5	2	11	25	39	44	41	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEDPALLSETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01		TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGAGGGCCCCTGGATGGCTACACCTTCGGTTCG	CSVGGPLDGYTF	In	VDJ	1	30	4.6584574294631904E-4	6.495474819209284E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	11	0	6	0	7	25	-1	40	35	47													Vb 4	CSVGGPLDGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTACCGCAGGGGGGTCTAAGTCTGAAGCTTTCTTTGGACAA	CSVTAGGSKSEAFF	In	VDJ	1	30	4.6584574294631904E-4	6.495474819209284E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	6	4	8	25	34	45	38	53													Vb 4	CSVTAGGSKSEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCGGCCAGGCGGTAATGAGCAGTTCTTCGGGCCA	CSARPGGNEQFF	In	VDJ	1	27	4.1926116865168716E-4	5.845927337288356E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	7	4	4	7	6	4	25	32	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSARPGGNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGTCACCCTCGGGGAGCTGTTTTTTGGAGAA	CSVEVTLGELFF	In	VDJ	1	22	3.416202114939673E-4	4.763348200753475E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	3	0	10	7	0	7	25	-1	38	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEVTLGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGCTCATGGGACAGGGAGGATCTGGGGAGCTGTTTTTTGGAGAA	CSVLMGQGGSGELFF	In	VDJ	1	22	3.416202114939673E-4	4.763348200753475E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	8	6	7	25	33	48	39	55													Vb 4	CSVLMGQGGSGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGGCGTTATCTTCGGGAGATACGCAGTATTTTGGCCCA	CSGALSSGDTQYF	In	VDJ	1	21	3.2609202006242334E-4	4.546832373446499E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	7	8	0	5	0	12	25	-1	36	32	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSGALSSGDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTGACCAACGGGGGGGCCTAGGTCGAGAGACCCAGTACTTCGGGCCA	CSADQRGGLGRETQYF	In	VDJ	1	21	3.2609202006242334E-4	4.546832373446499E-4	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	8	0	4	4	9	25	36	48	40	57													Vb 4	CSADQRGGLGRETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGTAGAGGGGGCCGCGAGCAGTACTTCGGGCCG	CSVGRGGREQYF	In	VDJ	1	19	2.950356371993354E-4	4.1138007188325465E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	5	0	6	4	2	25	35	46	39	48													Vb 4	CSVGRGGREQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAGGCCCCTTGGGACAGGGGTGAGGAAGATACGCAGTATTTTGGCCCA	CSVEEAPWDRGEEDTQYF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	54	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	0	2	5	8	6	25	39	57	47	63													Vb 4	CSVEEAPWDRGEEDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCAACAGGGGGCCCAATGAGCAGTTCTTCGGGCCA	CSANRGPNEQFF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	3	0	6	3	1	25	32	44	35	45													Vb 4	CSANRGPNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTGTTCTACGGGGGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	16	2.484510629047035E-4		44	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	8	2	2	7	0	25	38	-1	45	51													Vb 4	X+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCACCAACCAGACATCTGTGTATCTCTATGCCAGCAGTAGCCAGCGTCGACGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	YASSSQRRRQSRANVLTF	In	VDJ	2	77	0.0011956707402288856	0.0016671718702637162	54	TCRBV26	TCRBV26-01	01				TCRBJ02	TCRBJ02-06	01	5	2	6	5	13	5	27	39	56	52	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									YASSSQRRRQSRANVLTF+TCRBV26-01+TCRBJ02-06	TCRBV26-01*01		TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGCGATGCCAGGGGAGTGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	4	144	0.0022360595661423312		49	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	2	5	10	5	26	38	54	48	59		TCRBV06-01,TCRBV06-07												X+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGGGGACTYGGCYGTGTATCTCTGTGCTAGCAGCGCGTCAGGCACAGATACGCAGTATTTTGGCCCA	CASSASGTDTQYF	In	VDJ	2	68	0.0010559170173449898	0.0014723076256874378	39	TCRBV07	unresolved					TCRBJ02	TCRBJ02-03	01	5	4	5	1	4	0	18	30	-1	34	37		TCRBV07-01,TCRBV07-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSASGTDTQYF+TCRBV07-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGGSGACTYGGCTGTGTATCTCTGTGCCAGCAGCCTAGGTGGCTCAAGGCTTAATTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	55	8.540505287349182E-4		49	TCRBV07	unresolved		unresolved			TCRBJ01	TCRBJ01-04	01	5	4	8	7	0	17	22	-1	38	34	55		TCRBV07-01,TCRBV07-05		TCRBD01,TCRBD02										X+TCRBV07-X+TCRBJ01-04	unresolved	unresolved	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGRGGACTYSGCYGTGTATCTCTGTGCCAGCAGCTTAGAATCGGGCGGGGAGCTGTTTTTTGGAGAA	CASSLESGGELFF	In	VDJ	1	52	8.074659544402863E-4	0.001125882301996276	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	8	4	7	6	0	22	35	-1	41	45		TCRBV07-01,TCRBV07-08				01,02								CASSLESGGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGGGACACCTACGAGCAGTATTTCGGGCCG		Out	VDJ	1	49	7.608813801456545E-4		38	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	6	16	0	14	23	-1	44	39	58		TCRBV06-01,TCRBV06-07												X+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGGTCACACAGGGGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	45	6.987686144194785E-4		37	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	2	5	1	0	22	37	-1	38	45		TCRBV07-01,TCRBV07-04												X+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTACGGATTGTCGCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	43	6.677122315563906E-4		52	TCRBV10	unresolved					TCRBJ02	TCRBJ02-06	01	5	1	8	5	2	15	23	35	40	37	55		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ02-06	unresolved		TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTAGGACCGTTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSE*DRSSTDTQYF	Stop	VDJ	1	41	6.366558486933027E-4		48	TCRBV10	unresolved					TCRBJ02	TCRBJ02-03	01	1	1	7	0	1	6	23	39	44	40	50		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSE*DRSSTDTQYF+TCRBV10-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACCCCATGAACACTGAAGCTTTCTTTGGACAA	CASSYPMNTEAFF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	6	0	2	0	23	38	-1	40	42		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSYPMNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGCCCTCAAAAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPQKNTGELFF	In	VDJ	1	30	4.6584574294631904E-4	6.495474819209284E-4	42	TCRBV06	unresolved					TCRBJ02	TCRBJ02-02	01	6	4	6	1	4	3	23	34	40	38	43		TCRBV06-08,TCRBV06-09		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPQKNTGELFF+TCRBV06-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCTTTGGAACGGGGTCAGATACGCAGTATTTTGGCCCA	CASSFGTGSDTQYF	In	VDJ	1	29	4.503175515147751E-4	6.278958991902308E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	3	4	5	1	19	33	43	38	44		TCRBV07-06,TCRBV07-07												CASSFGTGSDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCGGTTGACCGGGGAGGCTTACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	29	4.503175515147751E-4		43	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	11	9	1	2	9	4	23	29	44	38	48		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCCCCGGGACCAACAATGAGCAGTTCTTCGGGCCA	CASSPGTNNEQFF	In	VDJ	1	28	4.347893600832311E-4	6.062443164595332E-4	39	TCRBV07	unresolved					TCRBJ02	TCRBJ02-01	01	5	0	7	5	3	2	22	34	42	37	44		TCRBV07-01,TCRBV07-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGTNNEQFF+TCRBV07-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CTCCCTCYCAGACWTCTGTWTACTTCTGTGCCAGCAGTGCTGACAGGGAGCATACCTACAATGAGCAGTTCTTCGGGCCA	CASSADREHTYNEQFF	In	VDJ	1	28	4.347893600832311E-4	6.062443164595332E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	3	2	3	6	26	38	48	41	54		TCRBV06-07,TCRBV06-09												CASSADREHTYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCACTAGGACAGGGAAAAACTACGAGCAGTACTTCGGGCCG	CASTRTGKNYEQYF	In	VDJ	1	26	4.0373297722014315E-4	5.62941150998138E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	3	3	3	5	26	36	47	39	52		TCRBV06-07,TCRBV06-08												CASTRTGKNYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGTAMSCTCYCAGACATCTGTGTACTTCTGTGCCAGCAGTTACGGGGGGCCCGATTACAATGAGCAGTTCTTCGGGCCA	CASSYGGPDYNEQFF	In	VDJ	1	25	3.882047857885992E-4	5.412895682674404E-4	45	TCRBV06	unresolved		unresolved			TCRBJ02	TCRBJ02-01	01	2	6	0	4	1	5	24	39	46	40	51		TCRBV06-04,TCRBV06-05,TCRBV06-06		TCRBD01,TCRBD02										CASSYGGPDYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	unresolved	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGGACTCMGCCRTGTATCKCTGTGCCAGCAGCCCCCTCGAGGGCTGGAATGAGCAGTTCTTCGGGCCA	CASSPLEGWNEQFF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	11	0	7	6	4	19	31	42	37	46		TCRBV07-07,TCRBV07-08												CASSPLEGWNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCCCTCGGCAGGATGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPRQDATNEKLFF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	4	0	7	3	26	37	48	44	51		TCRBV06-07,TCRBV06-08												CASSPRQDATNEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTAGATCGGTATAGTAGCGAAAAACTGTTTTTTGGCAGT	CASSLDRYSSEKLFF	In	VDJ	1	22	3.416202114939673E-4	4.763348200753475E-4	45	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	5	7	8	10	0	19	35	-1	45	49		TCRBV07-05,TCRBV07-07				01,02								CASSLDRYSSEKLFF+TCRBV07-X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTAGAATCTGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	22	3.416202114939673E-4		41	TCRBV06	unresolved					TCRBJ02	TCRBJ02-03	01	1	0	10	5	7	0	23	39	-1	46	48		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTACCCGCCGAATAGCCGTCCGAGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	18	2.795074457677914E-4		46	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	5	7	10	10	7	28	40	54	50	61		TCRBV06-04,TCRBV06-07				01,02								X+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCGGTACCGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSESVPGYNEQFF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	45	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	8	4	3	5	0	26	43	-1	48	52		TCRBV10-01,TCRBV10-02				01,02								CASSESVPGYNEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTTCACCCACTATGTCCGAAGCTTTCTTTGGACAA	CASSSPTMSEAFF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	3	9	8	5	5	23	36	45	41	50		TCRBV06-08,TCRBV06-09				01,02								CASSSPTMSEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGTACCCTCYCAGACATCTGTGTACTTCTGTGCCAGCAGTGAATTTCACCTGCCGGAAGCTTTCTTTGGACAA	CASSEFHLPEAFF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	39	TCRBV06	unresolved					TCRBJ01	TCRBJ01-01	01	3	3	7	8	5	6	28	42	49	47	55		TCRBV06-01,TCRBV06-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEFHLPEAFF+TCRBV06-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCGCCGGGGAGGGATGGTATGGCTACACCTTCGGTTCG	CASSAGEGWYGYTF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	9	0	5	5	4	26	37	49	42	53		TCRBV06-07,TCRBV06-08												CASSAGEGWYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ASGACTCGGCCCTGTATCTCTGTGCCAGCAGCTTCTAGCGARGTCCACCGGGGAACACTGAAGCTTTCTTTGGACAA	CASSF*RXPPGNTEAFF	Stop	VDJ	1	16	2.484510629047035E-4		51	TCRBV05	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	4	6	1	0	12	20	-1	40	34	52		TCRBV05-04,TCRBV05-08				01,02								CASSF*RXPPGNTEAFF+TCRBV05-X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCACGCGGACAGGGTGGGTCACTGAAGCTTTCTTTGGACAA	CASSTRTGWVTEAFF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	45	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	3	4	4	5	18	30	42	34	47		TCRBV11-01,TCRBV11-03												CASSTRTGWVTEAFF+TCRBV11-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTCGAACAGGGGCGGCTACACCTTCGGTTCG	CASSSNRGGYTF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	36	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	2	8	3	1	26	39	49	42	50		TCRBV06-07,TCRBV06-08												CASSSNRGGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGGGGACTCRGCYRTGTATCKCTGTGCTAGCAGATCGGGACTAGCGGGGGGTGAGGCCCAGTACTTCGGGCCA	CASRSGLAGGEAQYF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	45	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	0	1	9	3	5	22	33	51	36	56		TCRBV07-04,TCRBV07-06												CASRSGLAGGEAQYF+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACGGACAGGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSYGQGAGELFF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	1	6	0	0	24	-1	-1	39	49		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSYGQGAGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTTACTCCGGGGAGCTGTTTTTTGGAGAA	CASSYSGELFF	In	VJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	33	TCRBV06	unresolved					TCRBJ02	TCRBJ02-02	01	1	0	0	6	0	0	28	-1	-1	-1	44		TCRBV06-04,TCRBV06-07												CASSYSGELFF+TCRBV06-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTACAACAGGGGGCGCGGACTGAAGCTTTCTTTGGACAA	CASSLQQGARTEAFF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	45	TCRBV05	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	0	5	3	4	19	33	45	36	49		TCRBV05-05,TCRBV05-06,TCRBV05-07												CASSLQQGARTEAFF+TCRBV05-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTAGCAGACGACCCGGGTGGCTACACCTTCGGTTCG	CASSLADDPGGYTF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	8	4	7	8	0	19	36	-1	44	48		TCRBV07-05,TCRBV07-07				01,02								CASSLADDPGGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTGGGGCCCTGGCTATGGCTACACCTTCGGTTCG	CASSWGPGYGYTF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	7	0	4	0	5	23	-1	41	36	46		TCRBV06-04,TCRBV06-08												CASSWGPGYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGAGAAAACCCCGTAGGTGGGAAGGAGACCCAGTACTTCGGGCCA	CASRENPVGGKETQYF	In	VDJ	1	28	4.347893600832311E-4	6.062443164595332E-4	48	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-05	01	2	0	8	5	12	2	23	38	54	50	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASRENPVGGKETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01		TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAACGCTGCGGGGGGGCTTGGAGCCAACGTCCTGACTTTCGGGGCC	CASNAAGGLGANVLTF	In	VDJ	1	23	3.5714840292551126E-4	4.979864028060451E-4	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	7	7	0	7	5	6	23	33	47	38	53													Vb 22	CASNAAGGLGANVLTF+TCRBV02-01+TCRBJ02-06	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCGGTCTTCTAAGCTCCTACGAGCAGTACTTCGGGCCG	CASGLLSSYEQYF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	4	9	0	6	2	23	32	41	38	43						01,02							Vb 22	CASGLLSSYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGGGACAGGTTCGGGTGAGACCCAGTACTTCGGGCCA	CASSGTGSGETQYF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	4	5	1	7	23	34	43	35	50													Vb 22	CASSGTGSGETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTCCCTCTTGACAGGGGGCAAAAACATTCAGTACTTCGGCGCC	CASSSLLTGGKNIQYF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	48	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	2	1	3	8	0	23	35	-1	43	52													Vb 22	CASSSLLTGGKNIQYF+TCRBV02-01+TCRBJ02-04	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGACAGTAAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	42	6.521840401248467E-4		35	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	5	5	0	2	26	-1	41	37	43														X+TCRBV06-07+TCRBJ01-04	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCACTAGCGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	33	5.12430317240951E-4		34	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	4	5	4	0	0	26	-1	-1	36	43						01,02								X+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCCCCTCGGGGCGGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPLGAVSYNEQFF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	48	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-01	01	5	7	0	0	6	3	26	38	49	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLGAVSYNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAGGGCGGGACCAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	20	3.105638286308794E-4		46	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	7	3	2	5	4	26	38	49	43	53														X+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCACCGGAGACAGGGCCTACGAGCAGTACTTCGGGCCG	CASTGDRAYEQYF	In	VDJ	1	20	3.105638286308794E-4	4.330316546139523E-4	39	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	3	2	5	0	26	36	-1	41	48														CASTGDRAYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAGGGTGGACAGGGAACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	13	2.0186648861007157E-4		47	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	3	3	6	2	26	38	52	44	54														X+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTCTCGAACGGGCCCTACAATGAGCAGTTCTTCGGGCCA	CASSFSNGPYNEQFF	In	VDJ	1	26	4.0373297722014315E-4	5.62941150998138E-4	45	TCRBV07	TCRBV07-07	01				TCRBJ02	TCRBJ02-01	01	3	8	0	2	7	0	19	33	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSNGPYNEQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTGGACAGGGGGTGGATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	23	3.5714840292551126E-4		43	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	1	6	0	3	19	-1	42	32	45														X+TCRBV07-07+TCRBJ01-04	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTCGAGGGGGACGGGGTCTAGCGGGGAGCTGTTTTTTGGAGAA	CASSSRGTGSSGELFF	In	VDJ	1	22	3.416202114939673E-4	4.763348200753475E-4	48	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	5	1	7	2	11	19	32	40	34	51														CASSSRGTGSSGELFF+TCRBV07-07+TCRBJ02-02	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTGTGGGGGGCCGTAGATACGCAGTATTTTGGCCCA	CASSLWGAVDTQYF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	42	TCRBV07	TCRBV07-01	01				TCRBJ02	TCRBJ02-03	01	4	6	0	5	4	3	22	35	45	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLWGAVDTQYF+TCRBV07-01+TCRBJ02-03	TCRBV07-01*01		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGTCGTCAGGCGGAAGGAGACCCAGTACTTCGGGCCA	CASSLVVRRKETQYF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	45	TCRBV07	TCRBV07-01	01				TCRBJ02	TCRBJ02-05	01	4	4	4	5	7	6	22	35	46	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVVRRKETQYF+TCRBV07-01+TCRBJ02-05	TCRBV07-01*01		TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCCGTACTCATCTCCAGGACAACGAGCAGTTCTTCGGGCCA	CASRTHLQDNEQFF	In	VDJ	7	278	0.004316837217969223	0.006019139999133937	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	1	6	10	14	2	23	32	51	46	53													Vb 12	CASRTHLQDNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAAAGGGACAGCGTCGTCGGTGGCTACACCTTCGGTTCG		Out	VDJ	2	66	0.001024860634481902		41	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	5	7	2	9	23	33	42	35	51													Vb 12	X+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGTCGACCGGGACAGGGAGCAGATACGCAGTATTTTGGCCCA	CASRPGQGADTQYF	In	VDJ	2	62	9.62747868755726E-4	0.001342398129303252	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	9	0	3	4	6	2	23	31	46	37	48													Vb 12	CASRPGQGADTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTGGACAGGGTCAACCTACGAGCAGTACTTCGGGCCG	CASSWTGSTYEQYF	In	VDJ	1	52	8.074659544402863E-4	0.001125882301996276	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	3	2	1	4	23	35	44	36	48													Vb 12	CASSWTGSTYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGCGTGAGAACTCAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	48	7.453531887141105E-4		47	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	3	10	0	7	1	23	38	48	45	49						01,02							Vb 12	X+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGGAAAGTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	21	3.2609202006242334E-4		43	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-03	01	2	1	8	0	0	4	23	-1	41	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCCGGGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	18	2.795074457677914E-4		38	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	8	4	0	1	0	23	34	-1	35	39						01,02							Vb 12	X+TCRBV10-02+TCRBJ01-03	TCRBV10-02*01	TCRBD02-01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGCGGGGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSEAGGSYEQYF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	7	1	0	0	0	23	-1	-1	38	46													Vb 12	CASSEAGGSYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCCCTAGGGCAGCCCGCGGATGGCTACACCTTCGGTTCG	CASSESLGQPADGYTF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	48	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-02	01	0	5	3	6	3	10	23	40	47	43	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESLGQPADGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGCAACCGAACACTGAAGCTTTCTTTGGACAA	CASSEQPNTEAFF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	39	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-01	01	2	3	7	1	2	1	23	38	42	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEQPNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCCAGCGGGGGCCACTACAATGAGCAGTTCTTCGGGCCA	CAISESSGGHYNEQFF	In	VDJ	1	54	8.385223373033743E-4	0.0011691854674576712	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	2	3	1	3	23	40	49	41	52													Vb 12	CAISESSGGHYNEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGCCGGACTGGAACAGAGACCCAGTACTTCGGGCCA	CAISRTGTETQYF	In	VDJ	1	20	3.105638286308794E-4	4.330316546139523E-4	39	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	1	10	4	2	5	24	35	42	37	47						01,02							Vb 12	CAISRTGTETQYF+TCRBV10-03+TCRBJ02-05	TCRBV10-03*01	TCRBD02-01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAGACACTGAACACTGAAGCTTTCTTTGGACAA	CAISETLNTEAFF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	39	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	6	0	0	1	23	-1	41	38	42													Vb 12	CAISETLNTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCCCCCACGGGTACGTGAAGCTTTCTTTGGACAA		Out	VDJ	1	16	2.484510629047035E-4		35	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	10	8	4	7	7	4	24	31	42	38	46						01,02							Vb 12	X+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD02-01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCGGGACTAGCGGGGCCCAGTACTTCGGGCCA	CASSAGTSGAQYF	In	VDJ	20	806	0.012515722293824439	0.017451175680942278	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	0	3	9	3	0	27	39	-1	42	55			01,02										Vb 17	CASSAGTSGAQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCGGGACTAGCGGGGGCACCGTCTTCGGGCCA	CASSLGTSGGTVF	In	VDJ	13	518	0.008043603161539776	0.011215519854501364	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	17	3	5	27	39	56	42	61			01,02										Vb 17	CASSLGTSGGTVF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTTGGGACGAGCGGAGGCTACACCTTCGGTTCG	CASSFGTSGGYTF	In	VDJ	8	318	0.004937964875230982	0.006885203308361842	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	0	7	8	3	7	27	39	47	42	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSFGTSGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCGGGACAGCAATCAGCCCCAGCATTTTGGTGAT	CASSTRDSNQPQHF	In	VDJ	6	225	0.0034938430720973927	0.004871606114406963	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	4	0	7	1	3	0	27	40	-1	43	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTRDSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGTGCGATCTCCTACGAGCAGTACTTCGGGCCG	CASSSAISYEQYF	In	VDJ	5	222	0.0034472584978027607	0.00480665136621487	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	7	6	0	2	2	27	40	45	42	47			01,02			01,02							Vb 17	CASSSAISYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCAAAGCTTGCCGGGCACAGATACGCAGTATTTTGGCCCA	CATQSLPGTDTQYF	In	VDJ	5	205	0.0031832792434665132	0.004438574459793011	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	10	6	7	1	5	7	27	34	42	39	49			01,02			01,02							Vb 17	CATQSLPGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCCGCCAGGGGGCTCTAATGAAAAACTGTTTTTTGGCAGT	CASRPPGGSNEKLFF	In	VDJ	5	198	0.0030745819034457057	0.004287013380678127	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	0	3	5	1	27	38	51	43	52			01,02										Vb 17	CASRPPGGSNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGAGCCGCGCCCAGCCAAAAACATTCAGTACTTCGGCGCC	CASEPRPAKNIQYF	In	VDJ	5	194	0.0030124691377195296	0.004200407049755337	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	9	6	7	0	2	7	27	35	40	37	47			01,02			01,02							Vb 17	CASEPRPAKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01	TCRBJ02-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCTACCCGGAACAGATACGCAGTATTTTGGCCCA	CASSILPGTDTQYF	In	VDJ	4	178	0.0027640180748148262	0.003853981726064175	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	3	1	8	3	7	0	27	41	-1	48	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSILPGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCCGCCAGGGGGCTCTAATGAAAAATTGTTTTTTGGCAGT	CASRPPGGSNEKLFF	In	VDJ	3	135	0.002096305843258436	0.002922963668644178	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	0	15	5	13	27	38	51	43	64			01,02										Vb 17	CASRPPGGSNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTCGGCAGGGAGGCCCGGGGAGCTGTTTTTTGGAGAA	CASSISAGRPGELFF	In	VDJ	3	126	0.00195655212037454	0.002728099424067899	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	9	1	6	7	1	27	41	54	48	55			01,02										Vb 17	CASSISAGRPGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGTCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSIVYSNQPQHF	In	VDJ	3	113	0.0017546856317644684	0.0024466288485688304	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	4	9	0	3	0	27	41	-1	44	47			01,02			01,02							Vb 17	CASSIVYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCCGCCCGGGGGCTCTAATGAAAAACTGTTTTTTGGCAGT	CASRPPGGSNEKLFF	In	VDJ	3	111	0.0017236292489013804	0.002403325683107435	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	6	6	0	3	7	1	27	38	51	45	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRPPGGSNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGAGGGGGCGGGAAACACCATATATTTTGGAGAG		Out	VDJ	3	110	0.0017081010574698365		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	5	0	4	2	1	27	40	49	42	50			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGGGGACAGCAGGTGAGCAGTTCTTCGGGCCA	CASSTGTAGEQFF	In	VDJ	2	98	0.001521762760291309	0.002121855107608366	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	5	9	2	4	27	40	49	42	53			01,02										Vb 17	CASSTGTAGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGAACCTACCAGGGCCACGGAACATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	87	0.0013509526545443253		52	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	3	6	9	9	27	39	53	48	62			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGCACCTCAGGCGAGCAGTACTTCGGGCCG	CASSMGTSGEQYF	In	VDJ	2	79	0.0012267271230919734	0.0017104750357251116	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	4	6	8	0	27	41	-1	49	53			01,02										Vb 17	CASSMGTSGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTAGACAGGGGGCAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	72	0.0011180297830711656		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	0	3	3	1	27	41	54	44	55			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGGGAGGATGGCTACACCTTCGGTTCG	CASSMREDGYTF	In	VDJ	2	68	0.0010559170173449898	0.0014723076256874378	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	9	1	6	2	0	27	41	-1	43	49			01,02										Vb 17	CASSMREDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGGACAGGGGATGGGCAATCAGCCCCAGCATTTTGGTGAT	CASRGQGMGNQPQHF	In	VDJ	2	68	0.0010559170173449898	0.0014723076256874378	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	2	2	0	4	27	-1	48	38	52			01,02										Vb 17	CASRGQGMGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCATATGGACAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSIIWTSRANVLTF	In	VDJ	2	66	0.001024860634481902	0.0014290044602260426	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	1	6	5	5	4	27	41	51	46	55			01,02										Vb 17	CASSIIWTSRANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGGAGGCGATTAGTATGGACAGGGGATCACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	66	0.001024860634481902		55	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	1	2	3	16	3	26	36	61	52	64			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGGCAGGGTAGCACCGGGGAGCTGTTTTTTGGAGAA	CASGQGSTGELFF	In	VDJ	2	64	9.93804251618814E-4	0.0013857012947646474	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	4	3	4	3	3	27	36	44	39	47			01,02										Vb 17	CASGQGSTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCGTTAATGGGGGTCGACTATGGCTACACCTTCGGTTCG	CASSPLMGVDYGYTF	In	VDJ	2	62	9.62747868755726E-4	0.001342398129303252	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	6	6	1	3	9	3	27	38	52	47	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPLMGVDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACACAGACAGGTAGCGTTGGGAATGAGCAGTTCTTCGGGCCA	CATQTGSVGNEQFF	In	VDJ	1	58	9.006351030295502E-4	0.0012557917983804616	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	2	4	7	4	10	27	34	44	38	54			01,02										Vb 17	CATQTGSVGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGACATCCGGGGAGCTGTTTTTTGGAGAA	CASSIGTSGELFF	In	VDJ	1	56	8.695787201664622E-4	0.0012124886329190664	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	1	6	6	0	1	27	-1	48	43	49			01,02										Vb 17	CASSIGTSGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCACAGGGACCAAGTCGAACTATGGCTACACCTTCGGTTCG	CASTTGTKSNYGYTF	In	VDJ	1	56	8.695787201664622E-4	0.0012124886329190664	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	3	2	2	9	27	37	45	39	54			01,02										Vb 17	CASTTGTKSNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGAGCCGCGTCCAGCCAAAAACATTTAGTACTTCGGCGCC	CASEPRPAKNI*YF	Stop	VDJ	1	55	8.540505287349182E-4		42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-04	01	9	3	6	14	20	3	27	35	58	55	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASEPRPAKNI*YF+TCRBV19-01+TCRBJ02-04	TCRBV19-01		TCRBJ02-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTAGGGGACAGGGGAAAATCTATGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	55	8.540505287349182E-4		55	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	2	4	3	10	26	42	55	45	65			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAAACCCGGACAGGCCGAATCCCTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	53	8.229941458718303E-4		53	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	4	2	6	10	27	38	51	44	61			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGGGACCCAGCACAGATACGCAGTATTTTGGCCCA	CASSPGPSTDTQYF	In	VDJ	1	52	8.074659544402863E-4	0.001125882301996276	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	5	0	7	0	2	2	27	39	46	41	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPGPSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCGGAGATTGGAGCACTGAAGCTTTCTTTGGACAA	CASSTGDWSTEAFF	In	VDJ	1	49	7.608813801456545E-4	0.001060927553804183	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	2	4	2	7	27	40	46	42	53			01,02										Vb 17	CASSTGDWSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGACAGGGTCGGTACGAGCAGTACTTCGGGCCG	CASGQGRYEQYF	In	VDJ	1	48	7.453531887141105E-4	0.0010392759710734854	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	1	3	4	0	4	27	-1	44	36	48			01,02										Vb 17	CASGQGRYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGACAAGCGGGGAGCTGTTTTTTGGAGAA	CASSMGTSGELFF	In	VDJ	1	48	7.453531887141105E-4	0.0010392759710734854	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	6	7	1	2	27	41	48	42	50			01,02										Vb 17	CASSMGTSGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGGCTAGCGGTAACAATGAGCAGTTCTTCGGGCCA	CASSIGASGNNEQFF	In	VDJ	1	45	6.987686144194785E-4	9.743212228813926E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	5	5	5	2	27	41	53	46	55			01,02			01,02							Vb 17	CASSIGASGNNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTGGCTAGCGGGATCCAAGAGACCCAGTACTTCGGGCCA	CASSIVASGIQETQYF	In	VDJ	1	44	6.832404229879346E-4	9.52669640150695E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	4	3	1	3	1	27	43	55	46	56			01,02										Vb 17	CASSIVASGIQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCGCGGCTCGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	43	6.677122315563906E-4		43	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	7	5	1	3	4	27	39	46	42	50			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGCGGGGTTTCGGCTACACCTTCGGTTCG	CASSIGRGFGYTF	In	VDJ	1	42	6.521840401248467E-4	9.093664746892998E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	7	3	8	1	4	27	43	50	44	54			01,02										Vb 17	CASSIGRGFGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCAGTCAGCTCGAACACTGAAGCTTTCTTTGGACAA	CASSIAVSSNTEAFF	In	VDJ	1	41	6.366558486933027E-4	8.877148919586022E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	1	4	5	1	0	7	27	-1	46	43	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIAVSSNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCTAGTAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	39	6.055994658302147E-4		40	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	4	8	3	1	1	27	44	49	45	50			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGGAGGGGCGGTGAACACTGAAGCTTTCTTTGGACAA	CASRGGAVNTEAFF	In	VDJ	1	39	6.055994658302147E-4	8.444117264972069E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	0	0	0	4	27	-1	45	38	49			01,02										Vb 17	CASRGGAVNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCAAGAAACAGCTAGCAATCAGCCCCAGCATTTTGGTGAT	CATQETASNQPQHF	In	VDJ	1	39	6.055994658302147E-4	8.444117264972069E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	3	5	0	8	1	27	34	46	42	47			01,02										Vb 17	CATQETASNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCGTCAGGAGTCCTACGAGCAGTACTTCGGGCCG	CASSIRQESYEQYF	In	VDJ	1	38	5.900712743986708E-4	8.227601437665093E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	4	4	1	4	2	27	41	49	45	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIRQESYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTACGAGCGGGGGAGGAGACGCAGTATTTTGGCCCA	CASSLRAGEETQYF	In	VDJ	1	37	5.745430829671268E-4	8.011085610358117E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	6	2	9	6	5	27	38	52	44	57			01,02										Vb 17	CASSLRAGEETQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGGGGGCAGGGAGGTGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	37	5.745430829671268E-4		40	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	7	6	0	8	1	8	27	37	44	38	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGGGGGGGCAGCACAGATACGCAGTATTTTGGCCCA	CASSRGGSTDTQYF	In	VDJ	1	36	5.590148915355828E-4	7.794569783051141E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	0	0	0	1	27	-1	47	39	48			01,02										Vb 17	CASSRGGSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGCCGTGGGCGGGGGTGTCTGTCACAGATACGCAGTATTTTGGCCCA	CASSPPWAGVSVTDTQYF	In	VDJ	1	36	5.590148915355828E-4	7.794569783051141E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	2	2	9	7	27	39	55	48	62			01,02										Vb 17	CASSPPWAGVSVTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAGGGGGGTATTTCCTACGAGCAGTACTTCGGGCCG	CASSEGGISYEQYF	In	VDJ	1	35	5.434867001040389E-4	7.578053955744165E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	5	5	1	1	1	5	27	39	46	40	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSEGGISYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCCAGCAGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLQQVNTGELFF	In	VDJ	1	34	5.279585086724949E-4	7.361538128437189E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	4	1	6	1	27	39	49	45	50			01,02										Vb 17	CASSLQQVNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACGTGCGACAGGCCCTTAACCAGCCCCAGCATTTTGGTGAT	CASNVRQALNQPQHF	In	VDJ	1	34	5.279585086724949E-4	7.361538128437189E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	4	7	6	8	27	37	49	43	57			01,02										Vb 17	CASNVRQALNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCGGTTGCGAGTTCTAACTATGGCTACACCTTCGGTTCG	CASTPVASSNYGYTF	In	VDJ	1	32	4.96902125809407E-4	6.928506473823237E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	7	7	6	0	8	4	27	37	48	45	52			01,02			01,02							Vb 17	CASTPVASSNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCCGCAGTATCTAACTATGGCTACACCTTCGGTTCG	CASSIAAVSNYGYTF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	5	0	3	3	27	43	49	46	52			01,02										Vb 17	CASSIAAVSNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGACAGGGGCAACACTGAAGCTTTCTTTGGACAA	CASRDRGNTEAFF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	2	1	1	27	38	47	39	48			01,02										Vb 17	CASRDRGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACAAGAACAGGGTTCAATCAGCCCCAGCATTTTGGTGAT	CASTRTGFNQPQHF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	3	3	3	5	2	27	37	48	42	50			01,02										Vb 17	CASTRTGFNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCATAGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSFIGGNTEAFF	In	VDJ	1	27	4.1926116865168716E-4	5.845927337288356E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	1	1	5	0	27	39	-1	44	50			01,02										Vb 17	CASSFIGGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGGACAGGGGTACGTATTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	27	4.1926116865168716E-4		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	2	6	2	7	27	39	50	41	57			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGTGAGGGTGAACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	24	3.726765943570552E-4		34	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	11	0	5	2	3	27	36	43	38	46			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAGGGACCGAGTAATGGCTACACCTTCGGTTCG	CASSEGPSNGYTF	In	VDJ	1	23	3.5714840292551126E-4	4.979864028060451E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	0	7	6	2	6	27	39	46	41	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSEGPSNGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCATGTGAATCAAGAGACCCAGTACTTCGGGCCA	CASSIDHVNQETQYF	In	VDJ	1	20	3.105638286308794E-4	4.330316546139523E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	0	2	8	2	6	2	27	44	52	50	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDHVNQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACCGGCAGGGTAGGTACTTCGGGCCA		Out	VDJ	1	20	3.105638286308794E-4		34	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	3	13	4	3	27	42	51	46	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAAAGACAGGGATCCTCAGCCCCAGCATTTTGGTGAT	CASKDRDPQPQHF	In	VDJ	1	20	3.105638286308794E-4	4.330316546139523E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	2	3	6	4	4	27	35	46	39	50			01,02										Vb 17	CASKDRDPQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGACCGGGACATCGAGGGGGGAGCTGTTTTTTGGAGAA	CASRTGTSRGELFF	In	VDJ	1	19	2.950356371993354E-4	4.1138007188325465E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	6	8	4	6	27	38	48	42	54			01,02										Vb 17	CASRTGTSRGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGACTAGCGGAGCCTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	19	2.950356371993354E-4		38	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	5	9	1	4	27	38	48	39	52			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGTACCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVPGANVLTF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-06	01	6	3	7	2	3	0	27	38	-1	41	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSVPGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01		TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTTTGTCAGGGGCGGGTACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	16	2.484510629047035E-4		52	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	2	2	6	5	27	41	53	47	58			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAGCCGATCCGGGGGTTCCTCCTCCTACGAGCAGTACTTCGGGCCG	CASSSRSGGSSSYEQYF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	2	0	9	6	27	38	53	47	59			01,02										Vb 17	CASSSRSGGSSSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCACGGTCCCAGGGCTGGCTACACCTTCGGTTCG	CATHGPRAGYTF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	4	3	7	10	1	27	34	49	44	50			01,02										Vb 17	CATHGPRAGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTACTGACACCTATGGCTACACCTTCGGTTCG	CASSITDTYGYTF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	6	4	4	1	27	41	49	45	50			01,02										Vb 17	CASSITDTYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGTCTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSIVFSGANVLTF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	3	4	10	0	3	1	27	41	46	44	47			01,02			01,02							Vb 17	CASSIVFSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD02-01	TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCTAGTAGCCTACGAGCGGGGGAGGAGATGCAGTATTTTGGCCCA	CASSLRAGEEMQYF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	6	2	11	6	7	27	38	52	44	59			01,02										Vb 17	CASSLRAGEEMQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCAGAAAAGAACCGGGACAGGGTTTACCAGATACGCAGTATTTTGGCCCA	CATRKEPGQGLPDTQYF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	0	3	4	13	5	27	34	56	47	61			01,02										Vb 17	CATRKEPGQGLPDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTTAGTGATTAAAACTGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	48	7.453531887141105E-4		56	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	14	5	23	35	54	49	59													Vb 11	X+TCRBV25-01+TCRBJ02-06	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACCAGGACAGGGCGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSEPGQGATNEKLFF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	51	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	1	3	0	3	2	23	38	49	41	51													Vb 11	CASSEPGQGATNEKLFF+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACCCAGGGGGTCAGTCCTACGAGCAGTACTTCGGGCCG	CASSDPGGQSYEQYF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	1	1	2	4	23	37	46	39	50													Vb 11	CASSDPGGQSYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCGTCGGGACAGTCAACTATGATGGCTACACCTTCGGTTCG	CASSVGTVNYDGYTF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	6	4	9	23	34	45	38	54													Vb 11	CASSVGTVNYDGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCAGCAGTTTAGGAGGTAATGAAAAACTGTTTTTTGGCAGT	CASSLGGNEKLFF	In	VDJ	1	19	2.950356371993354E-4	4.1138007188325465E-4	39	TCRBV22	TCRBV22-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	13	10	1	4	12	0	25	28	-1	40	45														CASSLGGNEKLFF+TCRBV22-01+TCRBJ01-04	TCRBV22-01*01	TCRBD02-01*02	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGAAGGCCTTATCCCAGAAATAATGAAAAACTGTTTTTTGGCAGT	CASSQGRPYPRNNEKLFF	In	VDJ	2	76	0.0011801425487973417	0.0016455202875330186	54	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-04	01	1	4	5	4	13	3	23	39	55	52	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQGRPYPRNNEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01		TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAACTTCCAGCACTGAAGCTTTCTTTGGACAA	YASSQTSSTEAFF	In	VDJ	1	38	5.900712743986708E-4	8.227601437665093E-4	39	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-01	01	2	4	5	4	5	0	22	37	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	YASSQTSSTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGGTCTGGGGGGGGGAGAGACCCAGTACTTCGGGCCA	YASSQGLGGGETQYF	In	VDJ	1	35	5.434867001040389E-4	7.578053955744165E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	9	0	4	4	2	22	38	49	42	51													Vb 7.1	YASSQGLGGGETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGGATACAGGAATCGCCGCCTAAATCAGCCCCAGCATTTTGGTGAT	XASSQGYRNRRLNQPQHF	In	VDJ	1	23	3.5714840292551126E-4	4.979864028060451E-4	54	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	3	4	4	3	12	22	38	46	41	58													Vb 7.1	XASSQGYRNRRLNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGAAGGGGTCGGATGGGAGCTGTTTTTTGGAGAA	YASSQEGVGWELFF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	5	2	9	0	6	22	-1	44	39	50													Vb 7.1	YASSQEGVGWELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCTCCGGGACAGGGGTACCGACAGATACGCAGTATTTTGGCCCA	CASSSGTGVPTDTQYF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	2	3	3	5	23	35	48	38	53													Vb 7.1	CASSSGTGVPTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGTGGCCGGGGACAGTGAATGAAAAACTGTTTTTTGGCAGT	CASSQWPGTVNEKLFF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	5	5	7	2	23	37	51	44	53													Vb 7.1	CASSQWPGTVNEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGGGGGGATACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	12	1.863382971785276E-4		37	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	1	5	0	2	23	-1	43	37	45													Vb 7.1	X+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD02-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGTGTAGATTCCGGGCGCGGCTACACCTTCGGTTCG	CASSVDSGRGYTF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	39	TCRBV06	TCRBV06-09	01				TCRBJ01	TCRBJ01-02	01	5	8	0	8	9	2	26	38	51	47	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 13.1	CASSVDSGRGYTF+TCRBV06-09+TCRBJ01-02	TCRBV06-09*01		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCACCGGGACAAGTGGCTACACCTTCGGTTCG	CASTGTSGYTF	In	VDJ	1	19	2.950356371993354E-4	4.1138007188325465E-4	33	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	6	7	2	2	26	36	44	38	46			01,02										Vb 12	CASTGTSGYTF+TCRBV10-01+TCRBJ01-02	TCRBV10-01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGTGGCCCAGGGGGATCCTTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	16	2.484510629047035E-4		52	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	1	0	5	5	26	39	51	44	56			01,02										Vb 12	X+TCRBV10-01+TCRBJ01-05	TCRBV10-01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCCCCCGGGGGGGTATGGCTACACCTTCGGTTCG		Out	VDJ	1	34	5.279585086724949E-4		38	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	0	5	3	0	22	34	-1	37	45														X+TCRBV12-01+TCRBJ01-02	TCRBV12-01*01	TCRBD02-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGTCACATAACACAGACGAAGATTTACGAGCAGTACTTCGGGCCG	CASSHITQTKIYEQYF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	48	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	5	4	9	9	22	33	46	42	55														CASSHITQTKIYEQYF+TCRBV12-01+TCRBJ02-07	TCRBV12-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATAGCGGGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CSAIAGGSTDTQYF	In	VDJ	43	1750	0.027174335005201944	0.03789026977872082	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	5	0	0	0	0	26	-1	-1	36	47		TCRBV20-01,TCRBV20-or09_02												CSAIAGGSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCATTACGGGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CSAITGASTDTQYF	In	VDJ	18	735	0.011413220702184817	0.015913913307062745	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	6	0	0	6	1	26	34	46	40	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAITGASTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACAAGGGGATCCAATCAGCCCCAGCATTTTGGTGAT	CSATRGSNQPQHF	In	VDJ	13	512	0.007950434012950511	0.01108561035811718	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	5	2	3	2	3	26	36	43	38	46		TCRBV20-01,TCRBV20-or09_02												CSATRGSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGGAGGGAGACCCCCGGAAAACGAGCAGTACTTCGGGCCG		Out	VDJ	10	408	0.006335502104069939		49	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	10	0	5	3	13	26	39	48	42	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCGAGGAGGCGATACGCAGTATTTTGGCCCA	CASSRGGDTQYF	In	VDJ	10	400	0.006211276572617587	0.008660633092279046	36	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	1	6	3	1	26	38	46	41	47		TCRBV12-03,TCRBV12-04												CASSRGGDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGCATTGCGGGAGGGGATATACGAGCAGTACTTCGGGCCG	CASSALREGIYEQYF	In	VDJ	8	343	0.0053261696610195815	0.007426492876629282	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	0	4	5	4	26	38	52	43	56		TCRBV12-03,TCRBV12-04												CASSALREGIYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGAGAGGGACCAGGGAACACAGATACGCAGTATTTTGGCCCA	CSGEGPGNTDTQYF	In	VDJ	8	334	0.005186415938135685	0.007231628632053003	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	7	0	7	2	4	7	26	33	42	37	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSGEGPGNTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAATCTTGGGCCTTATGGCTACACCTTCGGTTCG		Out	VDJ	8	307	0.004767154769483998		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	8	0	5	8	2	23	34	46	42	48	TCRBV02,TCRBV09													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAAGTTTACCTAAATAGATATGGCTACACCTTCGGTTCG	CASSEVYLNRYGYTF	In	VDJ	7	301	0.004673985620894734	0.006517126401939982	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	4	9	5	9	6	22	34	46	43	52	TCRBV09,TCRBV12					01,02								CASSEVYLNRYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTGGAACGAACTAGCACAGATACGCAGTATTTTGGCCCA	CASSVERTSTDTQYF	In	VDJ	7	274	0.004254724452243047	0.005932533668211146	45	unresolved						TCRBJ02	TCRBJ02-03	01	5	1	8	0	2	7	24	36	41	38	48	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVERTSTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGACAGACTTTGGCCACTACGAGCAGTACTTCGGGCCG	CSAGTDFGHYEQYF	In	VDJ	6	254	0.0039441606236121675	0.0054995020135971935	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	3	0	10	26	-1	42	35	52		TCRBV20-01,TCRBV20-or09_02												CSAGTDFGHYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCTCCGGGGGGCCCACCTACGAGCAGTACTTCGGGCCG	CSAPSGGPTYEQYF	In	VDJ	6	234	0.0036335967949812885	0.005066470358983242	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	1	2	5	4	26	35	47	40	51		TCRBV20-01,TCRBV20-or09_02												CSAPSGGPTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGCTAGCGTCCCCGATACGCAGTATTTTGGCCCA	CASSLASVPDTQYF	In	VDJ	5	213	0.0033075047749188654	0.0046117871216385916	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	6	6	4	5	24	36	46	40	51		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLASVPDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCGGGGGGGGCCCTTGCTGAGCAGTTCTTCGGGCCA	CASSSGGALAEQFF	In	VDJ	4	163	0.002531095203341667	0.003529207985103711	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	0	9	1	8	24	36	45	37	53		TCRBV24-01,TCRBV24-or09_02												CASSSGGALAEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTTGGGTGGGACAGGGACTACAATGAGCAGTTCTTCGGGCCA	CASSFGWDRDYNEQFF	In	VDJ	4	148	0.0022981723318685073	0.0032044342441432468	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	3	5	1	18	32	46	37	47	TCRBV07,TCRBV11													CASSFGWDRDYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGAAATAGCGGGGGGGTACGAGCAGTACTTCGGGCCG	CASSQEIAGGYEQYF	In	VDJ	4	146	0.0022671159490054195	0.0031611310786818516	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	5	0	4	4	0	20	35	-1	39	50	TCRBV04,TCRBV23													CASSQEIAGGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGCCAGGGAGAGGTAGAGCAGTTCTTCGGGCCA	CASSLGQGEVEQFF	In	VDJ	3	134	0.0020807776518268917	0.0029013120859134804	42	TCRBV12						TCRBJ02	TCRBJ02-01	01	1	4	3	10	2	7	26	42	49	44	56		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGQGEVEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCTACGTCGGGTAGCGGGGCTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	132	0.002049721268963804		46	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	5	3	3	9	2	22	31	48	40	50	TCRBV07,TCRBV11													X+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCCTGGGGCGGAGGGGACCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	131	0.00203419307753226		46	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	10	0	6	9	3	24	35	50	44	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGAAAGGGGGTCTACCGGGGAGCTGTTTTTTGGAGAA	CASSQERGSTGELFF	In	VDJ	3	119	0.0018478547803537323	0.002576538344953016	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	5	1	5	1	3	23	40	47	41	50	TCRBV04,TCRBV23													CASSQERGSTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGACCTGACAGAGCTAAGAGAGATTGAAGCTTTCTTTGGACAA	CSARDLTELREIEAFF	In	VDJ	3	115	0.0017857420146275564	0.0024899320140302256	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	5	7	6	13	26	37	48	43	61		TCRBV20-01,TCRBV20-or09_02												CSARDLTELREIEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCCGGGCAGATACGCAGTATTTTGGCCCA	CASSSRADTQYF	In	VDJ	3	112	0.0017391574403329245	0.002424977265838133	36	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	8	4	4	2	0	26	39	-1	41	45		TCRBV12-03,TCRBV12-04				01,02								CASSSRADTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCGCCGCCAGGGAAAGGACAGATACGCAGTATTTTGGCCCA	CASAARERTDTQYF	In	VDJ	3	111	0.0017236292489013804	0.002403325683107435	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	4	3	3	7	5	24	31	43	38	48	TCRBV02,TCRBV21													CASAARERTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGCCCAGGGGACGGATTATGGCTACACCTTCGGTTCG	CASSLAQGTDYGYTF	In	VDJ	3	105	0.0016304601003121167	0.0022734161867232496	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	2	5	4	6	18	32	42	36	48	TCRBV07,TCRBV11													CASSLAQGTDYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTATCAGGAGGGGGCGGCTATGGCTACACCTTCGGTTCG	CASSLSGGGGYGYTF	In	VDJ	2	94	0.001459649994565133	0.0020352487766855756	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	5	0	4	5	2	18	33	45	38	47	TCRBV05,TCRBV11													CASSLSGGGGYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGRGACWCRGCMSTGTATCTCTRCGCCAGCAGCCTATGGGCCGGCGTTGAAGCTTTCTTTGGACAA	XASSLWAGVEAFF	In	VDJ	2	90	0.001397537228838957	0.0019486424457627852	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	8	0	7	5	6	20	31	40	36	46	TCRBV07,TCRBV17,TCRBV23													XASSLWAGVEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACCGAGGGAAAACCGGTTCTTCGGGCCA	CASSQPRENRFF	In	VDJ	2	87	0.0013509526545443253	0.0018836876975706924	36	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	11	0	15	2	7	26	41	48	43	55		TCRBV03-01,TCRBV03-02												CASSQPRENRFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTACCGGGACGGCACCAATCAGCCCCAGCATTTTGGTGAT	CSARDYRDGTNQPQHF	In	VDJ	2	86	0.0013354244631127812	0.0018620361148399948	48	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	0	7	3	5	5	26	40	50	45	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDYRDGTNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGACGGACAGCGACGCACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRRTATHSGANVLTF	In	VDJ	2	84	0.0013043680802496934	0.0018187329493785996	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	7	1	5	0	2	7	24	35	43	37	50	TCRBV24,TCRBV27													CASRRTATHSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCGACAAGGGGACTATCGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	84	0.0013043680802496934		44	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	9	3	8	3	26	36	51	44	54		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCACCGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASTGSGANVLTF	In	VDJ	2	81	0.0012577835059550614	0.0017537782011865068	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	12	8	4	1	6	0	26	31	-1	37	41	TCRBV12,TCRBV21					01,02								CASTGSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01	TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCTAACCCCGGGGACCCAGTACTTCGGGCCA	CASSQDLTPGTQYF	In	VDJ	2	79	0.0012267271230919734	0.0017104750357251116	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	8	4	7	8	0	23	40	-1	48	52	TCRBV01,TCRBV04					01,02								CASSQDLTPGTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGGGGAACACTGAAGCTTTCTTTGGACAA	CASSQVGNTEAFF	In	VDJ	2	75	0.0011646143573657976	0.001623868704802321	39	TCRBV03						TCRBJ01	TCRBJ01-01	01	1	0	9	1	1	0	26	42	-1	43	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVGNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGAGGGGACAGGGGGCTTTTATTCACCCCTCCACTTTGGGAAC	CSASEGTGGFYSPLHF	In	VDJ	2	73	0.0011335579745027097	0.0015805655393409258	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	0	0	8	4	4	26	37	53	41	57		TCRBV20-01,TCRBV20-or09_02												CSASEGTGGFYSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCAGGGGGCAGCTGCGAGCAGTACTTCGGGCCG		Out	VDJ	2	73	0.0011335579745027097		40	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	0	6	0	5	26	-1	48	40	53		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCTAGCGGGGGGCCCTATGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	71	0.0011025015916396217		44	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	4	1	5	1	6	26	37	49	38	55		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTCGACAGGGAGATTCAGACGAGCAGTACTTCGGGCCG	CSAPRQGDSDEQYF	In	VDJ	2	69	0.001071445208776534	0.0014939592084181354	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	5	4	8	26	35	46	39	54		TCRBV20-01,TCRBV20-or09_02												CSAPRQGDSDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCGGGACGTACCAAGAGACCCAGTACTTCGGGCCA	CASSPGTYQETQYF	In	VDJ	2	67	0.0010403888259134459	0.0014506560429567402	42	TCRBV03						TCRBJ02	TCRBJ02-05	01	4	0	7	0	2	2	26	39	46	41	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGTYQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGACAGGGGGGAACACTGAAGCTTTCTTTGGACAA	CSATGGNTEAFF	In	VDJ	2	65	0.0010093324430503578	0.001407352877495345	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	1	1	0	0	26	-1	-1	34	43		TCRBV20-01,TCRBV20-or09_02												CSATGGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACCAGGAGGCCACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	65	0.0010093324430503578		43	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	10	1	3	4	2	26	41	50	45	52		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTTGGGCAGGGTGGTCCGAGTGAGACCCAGTACTTCGGGCCA	CASSFGQGGPSETQYF	In	VDJ	2	64	9.93804251618814E-4	0.0013857012947646474	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	3	5	4	10	19	33	42	37	52	TCRBV05,TCRBV11													CASSFGQGGPSETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATGGGCGTCGTCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLWASSTNEKLFF	In	VDJ	2	62	9.62747868755726E-4	0.001342398129303252	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	8	0	0	4	5	24	36	44	40	49		TCRBV24-01,TCRBV24-or09_02												CASSLWASSTNEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAAGAAATACCCTTTCGAGCAGTACTTCGGGCCG	CASSQKKYPFEQYF	In	VDJ	2	62	9.62747868755726E-4	0.001342398129303252	42	TCRBV03						TCRBJ02	TCRBJ02-07	01	2	2	8	6	2	10	26	41	45	43	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQKKYPFEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCGAGGGGCCGGGTTTCAAGAGACCCAGTACTTCGGGCCA	XASSRGAGFQETQYF	In	VDJ	2	61	9.472196773241821E-4	0.0013207465465725544	45	unresolved						TCRBJ02	TCRBJ02-05	01	5	5	2	2	2	8	22	34	41	36	49	TCRBV04,TCRBV07,TCRBV17			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSRGAGFQETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCATCCCTACGAGGGAAAACTGTTTTTTGGCAGT		Out	VDJ	1	60	9.316914858926381E-4		41	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	2	11	0	10	11	0	26	38	-1	49	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*02	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATGTCGGGACTAGCCAAAAACATTCAGTACTTCGGCGCC	CSARDMSGLAKNIQYF	In	VDJ	1	60	9.316914858926381E-4	0.0012990949638418568	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	0	10	0	6	0	26	40	-1	46	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDMSGLAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01	TCRBJ02-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACGGCCGGGCCCCAGCATTTTGGTGAT		Out	VDJ	1	60	9.316914858926381E-4		37	TCRBV03						TCRBJ01	TCRBJ01-05	01	0	9	0	9	1	3	26	43	47	44	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGATCGGACGGCCTCCTACGAGCAGTACTTCGGGCCG	CSARDRTASYEQYF	In	VDJ	1	59	9.161632944610941E-4	0.0012774433811111592	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	1	7	0	5	3	26	37	46	42	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDRTASYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGCTAGTAGTGAAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRLVVKNTGELFF	In	VDJ	1	59	9.161632944610941E-4	0.0012774433811111592	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	4	8	1	1	7	26	37	42	38	49		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASRLVVKNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCGGAGGGGCAGATACGCAGTATTTTGGCCCA	CASSLGGADTQYF	In	VDJ	1	57	8.851069115980062E-4	0.001234140215649764	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	10	0	4	2	1	26	39	47	41	48		TCRBV03-01,TCRBV03-02												CASSLGGADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCACCCTTTTTGCCACAGATACGCAGTATTTTGGCCCA	CSASTLFATDTQYF	In	VDJ	1	56	8.695787201664622E-4	0.0012124886329190664	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	3	7	2	3	9	26	35	40	38	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASTLFATDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCCCGGGGCCCCGGAGACCCAGTACTTCGGGCCA	CSAPPGAPETQYF	In	VDJ	1	56	8.695787201664622E-4	0.0012124886329190664	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	5	7	0	5	6	4	26	35	46	41	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPPGAPETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGACCCGACAGGGAGACTATGGCTACACCTTCGGTTCG	CRTRQGDYGYTF	In	VDJ	1	56	8.695787201664622E-4	0.0012124886329190664	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	2	3	3	5	2	26	31	43	36	45		TCRBV20-01,TCRBV20-or09_02												CRTRQGDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCGGACAGGGAGGTAAATCGCTCGGCTACACCTTCGGTTCG	CASSLGQGGKSLGYTF	In	VDJ	1	56	8.695787201664622E-4	0.0012124886329190664	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	3	8	2	13	26	39	49	41	62		TCRBV03-01,TCRBV03-02												CASSLGQGGKSLGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATATTAGCGCCGGGACATATCACAGATACGCAGTATTTTGGCCCA	CSARILAPGHITDTQYF	In	VDJ	1	55	8.540505287349182E-4	0.0011908370501883688	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	6	2	11	3	26	38	55	49	58		TCRBV20-01,TCRBV20-or09_02												CSARILAPGHITDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTGGGTCGATTCTAATGAAAAACTGTTTTTTGGCAGT	CASSQDWVDSNEKLFF	In	VDJ	1	55	8.540505287349182E-4	0.0011908370501883688	48	TCRBV03						TCRBJ01	TCRBJ01-04	01	0	0	9	3	2	6	26	43	48	45	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDWVDSNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTAGTAGTACCACAGATACGCAGTATTTTGGCCCA	CASSFSSTTDTQYF	In	VDJ	1	54	8.385223373033743E-4	0.0011691854674576712	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	5	8	2	0	6	26	-1	43	40	49		TCRBV12-03,TCRBV12-04				01,02								CASSFSSTTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGTGGGACTAGCGGGAGAAGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	53	8.229941458718303E-4		47	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	0	2	3	4	3	26	34	52	38	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAATTGCTCGGGACGGTGACCTACGAGCAGTACTTCGGGCCG	CSAKLLGTVTYEQYF	In	VDJ	1	52	8.074659544402863E-4	0.001125882301996276	45	TCRBV20						TCRBJ02	TCRBJ02-07	01	4	0	7	2	8	5	26	36	49	44	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKLLGTVTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGACAGCTCCTACGAGCAGTACTTCGGGCCG	CSARGDSSYEQYF	In	VDJ	1	50	7.764095715771984E-4	0.0010825791365348808	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	5	0	0	0	26	-1	-1	39	46		TCRBV20-01,TCRBV20-or09_02												CSARGDSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACCCAGCCGCGGTGTCCCTTAATTCACCCCTCCACTTTGGGAAC	CASSQDPAAVSLNSPLHF	In	VDJ	1	50	7.764095715771984E-4	0.0010825791365348808	54	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	0	7	5	6	7	7	26	43	54	50	61		TCRBV03-01,TCRBV03-02				01,02								CASSQDPAAVSLNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD02-01	TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGTCTAGCGGACTCCAAGAGACCCAGTACTTCGGGCCA	CSARESSGLQETQYF	In	VDJ	1	49	7.608813801456545E-4	0.001060927553804183	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	4	5	1	2	3	26	40	49	42	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARESSGLQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCGGCGTTAATCGGGGCCCCGGGGAGCTGTTTTTTGGAGAA	CASGVNRGPGELFF	In	VDJ	1	48	7.453531887141105E-4	0.0010392759710734854	42	unresolved						TCRBJ02	TCRBJ02-02	01	10	7	0	6	12	1	24	31	48	43	49	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGVNRGPGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGTAGGTGGTAGCGGGCTGAATGAGCAGTTCTTCGGGCCA	CASSVGGSGLNEQFF	In	VDJ	1	48	7.453531887141105E-4	0.0010392759710734854	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	4	7	8	3	24	36	51	44	54	TCRBV12,TCRBV21					01,02								CASSVGGSGLNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAATATAAATACGCAGTATTTTGGCCCA	CSASNINTQYF	In	VDJ	1	48	7.453531887141105E-4	0.0010392759710734854	33	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	4	6	7	0	6	26	-1	39	37	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASNINTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGGGAACAGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSQEGNRATGELFF	In	VDJ	1	48	7.453531887141105E-4	0.0010392759710734854	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	3	3	4	5	1	26	43	54	48	55		TCRBV03-01,TCRBV03-02												CASSQEGNRATGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCCAAGGACAGGTGAACACTGAAGCTTTCTTTGGACAA	CASTQGQVNTEAFF	In	VDJ	1	48	7.453531887141105E-4	0.0010392759710734854	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	4	0	0	0	26	-1	-1	42	48		TCRBV03-01,TCRBV03-02												CASTQGQVNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGRGACWCRGCMSTGTATCTCTRCGCCAGCAGTCTTGGCGGCGACAACACAGATACGCAGTATTTTGGCCCA	XASSLGGDNTDTQYF	In	VDJ	1	47	7.298249972825665E-4	0.0010176243883427878	45	unresolved						TCRBJ02	TCRBJ02-03	01	4	2	6	2	8	1	20	33	45	41	46	TCRBV17,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSLGGDNTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGTCAAGCAAGAAGCCAAGAAAGCTCTGGAAACACCATATATTTTGGAGAG	CASSQARSQESSGNTIYF	In	VDJ	1	47	7.298249972825665E-4	0.0010176243883427878	54				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	6	7	0	3	15	18	29	35	32	50	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02				01,02								CASSQARSQESSGNTIYF+X+TCRBJ01-03		TCRBD02-01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAAGACAGGCGGGAGAACTATGGCTACACCTTCGGTTCG	CSAQDRRENYGYTF	In	VDJ	1	47	7.298249972825665E-4	0.0010176243883427878	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	7	2	2	8	0	26	35	-1	43	50		TCRBV20-01,TCRBV20-or09_02												CSAQDRRENYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACTAACACCGTACCAAGAGACCCAGTACTTCGGGCCA	CSALTPYQETQYF	In	VDJ	1	47	7.298249972825665E-4	0.0010176243883427878	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	3	9	0	0	7	26	-1	38	34	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSALTPYQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGAAGGACTAGGAGTTAGGAATGAGCAGTTCTTCGGGCCA	CSASEGLGVRNEQFF	In	VDJ	1	46	7.142968058510225E-4	9.959728056120902E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	8	7	4	8	26	37	48	41	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSASEGLGVRNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGGGCTGCCCGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSPGLPGTGELFF	In	VDJ	1	44	6.832404229879346E-4	9.52669640150695E-4	45	TCRBV03						TCRBJ02	TCRBJ02-02	01	4	7	0	5	1	8	26	39	45	40	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGLPGTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTAATGCAGAGACCCAGTACTTCGGGCCA	CSAINAETQYF	In	VDJ	1	43	6.677122315563906E-4	9.310180574199974E-4	33	TCRBV20						TCRBJ02	TCRBJ02-05	01	4	10	0	4	5	0	26	36	-1	41	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAINAETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAAATTACTACAGGGGGTCAGGTACGAGCAGTACTTCGGGCCG	CAKLLQGVRYEQYF	In	VDJ	1	43	6.677122315563906E-4	9.310180574199974E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	3	1	4	7	5	26	33	48	40	53		TCRBV03-01,TCRBV03-02												CAKLLQGVRYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTGGACTTCTGTCCAATTCACCCCTCCACTTTGGGAAC	CASSGLLSNSPLHF	In	VDJ	1	43	6.677122315563906E-4	9.310180574199974E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	5	1	10	7	0	7	26	-1	43	38	50	TCRBV09,TCRBV12					01,02								CASSGLLSNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01	TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCRGCCRTGTATSKCTGTGCCAGAAGCCTTGAGAAGTCGCGGCCCGCCGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	42	6.521840401248467E-4		49	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	7	5	6	11	7	18	30	45	41	52	TCRBV05,TCRBV07,TCRBV11					01,02								X+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCTCAGCCCGGGGGAGACCCAGTACTTCGGGCCA	CATSLSPGETQYF	In	VDJ	1	41	6.366558486933027E-4	8.877148919586022E-4	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	8	3	5	8	0	24	35	-1	43	48		TCRBV24-01,TCRBV24-or09_02												CATSLSPGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCGGGACGGGGGAAAACATTCAGTACTTCGGCGCC	CSARPGTGENIQYF	In	VDJ	1	41	6.366558486933027E-4	8.877148919586022E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	2	8	2	5	7	0	26	38	-1	45	51		TCRBV20-01,TCRBV20-or09_02												CSARPGTGENIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*01	TCRBJ02-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTGGTCGGTCGAACAGAGCGGGGGAAATGAGCAGTTCTTCGGGCCA	CASSQDWSVEQSGGNEQFF	In	VDJ	1	40	6.211276572617588E-4	8.660633092279046E-4	57	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	2	7	16	1	24	41	65	57	66		TCRBV03-01,TCRBV03-02												CASSQDWSVEQSGGNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCAAAACCGGGACAGCAACCTTTGAACACTGAAGCTTTCTTTGGACAA	CSAAKPGQQPLNTEAFF	In	VDJ	1	40	6.211276572617588E-4	8.660633092279046E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	0	8	7	26	35	50	43	57		TCRBV20-01,TCRBV20-or09_02												CSAAKPGQQPLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACAGGGAGGAGCTACACCTTCGGTTCG	CSARDTGRSYTF	In	VDJ	1	40	6.211276572617588E-4	8.660633092279046E-4	36	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	3	3	9	1	4	26	40	47	41	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDTGRSYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAACGTGTTTCCATTTCCATTCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	40	6.211276572617588E-4		52	TCRBV03						TCRBJ02	TCRBJ02-01	01	5	3	7	5	1	20	26	38	41	39	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCGCGGAATGACTATGGCTACACCTTCGGTTCG	CASSSRNDYGYTF	In	VDJ	1	40	6.211276572617588E-4	8.660633092279046E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	7	5	3	3	4	26	37	44	40	48		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSSRNDYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGGGGACTYRGCTKTGTATYTCTGTGCCAGCAGGGACAGGAGGAGTGAAAAACTGTTTTTTGGCAGT	CASRDRRSEKLFF	In	VDJ	1	39	6.055994658302147E-4	8.444117264972069E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	4	7	0	5	22	-1	40	33	45	TCRBV07,TCRBV09													CASRDRRSEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGGGGACAGGGCCCTCACACCGGGGAGCTGTTTTTTGGAGAA	CSGGQGPHTGELFF	In	VDJ	1	39	6.055994658302147E-4	8.444117264972069E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	0	3	3	1	5	26	33	43	34	48		TCRBV20-01,TCRBV20-or09_02												CSGGQGPHTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGCTCAGGGGGACTGAAGCTTTCTTTGGACAA	CASSQELRGTEAFF	In	VDJ	1	39	6.055994658302147E-4	8.444117264972069E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	1	5	3	0	26	43	-1	46	53		TCRBV03-01,TCRBV03-02												CASSQELRGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTAGACTCCGGGACAAACGAGCAGTACTTCGGGCCG	CASSLDSGTNEQYF	In	VDJ	1	38	5.900712743986708E-4	8.227601437665093E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	6	5	4	1	19	36	46	40	47	TCRBV05,TCRBV11													CASSLDSGTNEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCRGCCRTGTATCKCTGTGCCAGCAGCTTAGAGGCCGACGGCAATGAGCAGTTCTTCGGGCCA	CASSLEADGNEQFF	In	VDJ	1	38	5.900712743986708E-4	8.227601437665093E-4	42	unresolved						TCRBJ02	TCRBJ02-01	01	1	2	7	6	5	2	19	35	43	40	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEADGNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGACGGGGTCTCTGGAAACACCATATATTTTGGAGAG	XASSQDGVSGNTIYF	In	VDJ	1	38	5.900712743986708E-4	8.227601437665093E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	0	8	3	0	0	1	22	-1	44	39	45	TCRBV01,TCRBV04													XASSQDGVSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGGGACCCAATGAACACTGAAGCTTTCTTTGGACAA	CSAWDPMNTEAFF	In	VDJ	1	38	5.900712743986708E-4	8.227601437665093E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	0	7	0	1	4	26	35	41	36	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAWDPMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGCAGAAGGTAATTTCGGGCAGTACTTCGGGCCG	CSASAEGNFGQYF	In	VDJ	1	38	5.900712743986708E-4	8.227601437665093E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	4	5	9	2	13	26	37	42	39	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASAEGNFGQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GRGACWCGGCMCTKTATCTYTGCGCCAGCAGCTTGGCCGGGGGGGGCACTGAAGCTTTCTTTGGACAA	CASSLAGGGTEAFF	In	VDJ	1	37	5.745430829671268E-4	8.011085610358117E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	0	4	6	1	20	31	45	37	46	TCRBV05,TCRBV23													CASSLAGGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCACCCAAGACCCTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASTQDPATNEKLFF	In	VDJ	1	37	5.745430829671268E-4	8.011085610358117E-4	45	unresolved			unresolved			TCRBJ01	TCRBJ01-04	01	7	2	7	0	5	4	18	28	36	33	40	TCRBV03,TCRBV11			TCRBD01,TCRBD02										CASTQDPATNEKLFF+X+TCRBJ01-04	unresolved	unresolved	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCCCAGTACGGCTAACGAGCACAGATACGCAGTATTTTGGCCCA	CSARGPVRLTSTDTQYF	In	VDJ	1	37	5.745430829671268E-4	8.011085610358117E-4	51	TCRBV20						TCRBJ02	TCRBJ02-03	01	1	4	5	0	3	11	26	39	45	42	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGPVRLTSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATCCGAGCGGGGGCCACTCCTACGAGCAGTACTTCGGGCCG	CSANPSGGHSYEQYF	In	VDJ	1	37	5.745430829671268E-4	8.011085610358117E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	6	2	0	5	3	26	36	49	41	52		TCRBV20-01,TCRBV20-or09_02												CSANPSGGHSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGCTAGTGCGGGGCCTAGAAACACCATATATTTTGGAGAG	CSASAGPRNTIYF	In	VDJ	1	37	5.745430829671268E-4	8.011085610358117E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	3	7	3	5	1	4	26	37	44	38	48		TCRBV20-01,TCRBV20-or09_02												CSASAGPRNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01*01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGTGACCCCGGGGAGCTGTTTTTTGGAGAA	CASSPRDPGELFF	In	VDJ	1	37	5.745430829671268E-4	8.011085610358117E-4	39	TCRBV03						TCRBJ02	TCRBJ02-02	01	4	2	7	6	5	1	26	39	47	44	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRDPGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGACCCCCAGGGGTCGAGCAGTACTTCGGGCCG	CASRPPGVEQYF	In	VDJ	1	36	5.590148915355828E-4	7.794569783051141E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	2	6	5	1	23	34	45	39	46	TCRBV06,TCRBV10													CASRPPGVEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTAGACTAGCGGACGCACAGATACGCAGTATTTTGGCCCA	CSAR*TSGRTDTQYF	Stop	VDJ	1	36	5.590148915355828E-4		45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	2	5	1	3	2	26	37	49	40	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSAR*TSGRTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCTCTGTCGCCTCTGGAAACACCATATATTTTGGAGAG	CASSFSVASGNTIYF	In	VDJ	1	36	5.590148915355828E-4	7.794569783051141E-4	45	TCRBV12						TCRBJ01	TCRBJ01-03	01	3	10	0	0	7	0	26	40	-1	47	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSVASGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12		TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGGGGGACAGGGCGTTCAAGAGACCCAGTACTTCGGGCCA	CASSLGGQGVQETQYF	In	VDJ	1	35	5.434867001040389E-4	7.578053955744165E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	0	3	2	1	4	18	34	44	35	48	TCRBV05,TCRBV11													CASSLGGQGVQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGCGGGTCCTACGAGCAGTACTTCGGGCCG	CATSGGSYEQYF	In	VDJ	1	35	5.434867001040389E-4	7.578053955744165E-4	36	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	7	4	1	0	0	24	-1	-1	37	42		TCRBV24-01,TCRBV24-or09_02				01,02								CATSGGSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGAAGTGGCCTTCTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARRSGLLSSYNEQFF	In	VDJ	1	35	5.434867001040389E-4	7.578053955744165E-4	51	TCRBV20						TCRBJ02	TCRBJ02-01	01	2	9	0	0	6	8	26	38	47	44	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRSGLLSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCGGGATACAGGCGTTAACTATGGCTACACCTTCGGTTCG	CSATRDTGVNYGYTF	In	VDJ	1	35	5.434867001040389E-4	7.578053955744165E-4	45	TCRBV20						TCRBJ01	TCRBJ01-02	01	4	3	4	1	8	3	26	36	49	44	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATRDTGVNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGACAGGGGTGCCTCCTACGAGCAGTACTTCGGGCCG	CSAKDRGASYEQYF	In	VDJ	1	35	5.434867001040389E-4	7.578053955744165E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	2	0	1	3	26	36	46	37	49		TCRBV20-01,TCRBV20-or09_02												CSAKDRGASYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTCCATCCACCGGGACAGGGGTAGGGAACACTGAAGCTTTCTTTGGACAA	CASSPSTGTGVGNTEAFF	In	VDJ	1	35	5.434867001040389E-4	7.578053955744165E-4	54				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	2	1	9	4	24	36	55	45	59	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSPSTGTGVGNTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCACCGTGACAGGGAATGAAAAACTGTTTTTTGGCAGT	CASSTVTGNEKLFF	In	VDJ	1	35	5.434867001040389E-4	7.578053955744165E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	3	5	6	0	26	37	-1	43	50		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSTVTGNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCACCGAAGACCTAGCGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASTEDLAGGTDTQYF	In	VDJ	1	34	5.279585086724949E-4	7.361538128437189E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	10	4	2	1	11	0	24	31	-1	42	52	TCRBV12,TCRBV21													CASTEDLAGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGGGGACTCRGCYGTGTATCTCTGTGCCAGCAGCTTGGCCACTAGCGGGGTGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	34	5.279585086724949E-4		46	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	3	3	3	4	2	22	36	50	40	52	TCRBV05,TCRBV07													X+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACCCCGACGACCCTAGACACGAGCAGTACTTCGGGCCG	CAISDPDDPRHEQYF	In	VDJ	1	34	5.279585086724949E-4	7.361538128437189E-4	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	8	5	13	2	23	35	52	48	54	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03				01,02								CAISDPDDPRHEQYF+X+TCRBJ02-07		TCRBD02-01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCATCACACCCCAACCACCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	34	5.279585086724949E-4		44	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	3	6	2	2	10	26	36	41	38	51		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGCGGGAGAACACCATATATTTTGGAGAG	CASSLGRENTIYF	In	VDJ	1	34	5.279585086724949E-4	7.361538128437189E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	1	7	2	7	1	0	26	42	-1	43	50		TCRBV12-03,TCRBV12-04												CASSLGRENTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD02-01*02	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCGGACAGGGAATGGACGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	34	5.279585086724949E-4		44	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	3	7	3	6	26	37	48	40	54		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAGGTGCGGGCCAAGGGGGTAGGCTACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	33	5.12430317240951E-4		58	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	5	1	3	13	6	23	39	58	52	64		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCACCGGTGGGGACTGAAGCTTTCTTTGGACAA	CSAAPVGTEAFF	In	VDJ	1	33	5.12430317240951E-4	7.145022301130213E-4	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	6	2	5	8	0	26	35	-1	43	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAAPVGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAACTAGCGGGGGGGCCCCAGATACGCAGTATTTTGGCCCA	CASSETSGGAPDTQYF	In	VDJ	1	32	4.96902125809407E-4	6.928506473823237E-4	48	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	3	0	4	0	3	23	-1	51	38	54		TCRBV06-01,TCRBV06-08												CASSETSGGAPDTQYF+TCRBV06-X+TCRBJ02-03	TCRBV06	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTTCGACAGGGGAAAAGAGACCCAGTACTTCGGGCCA	CATSDFDRGKETQYF	In	VDJ	1	32	4.96902125809407E-4	6.928506473823237E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	2	3	4	2	24	38	50	42	52		TCRBV24-01,TCRBV24-or09_02												CATSDFDRGKETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGCTATCAGGGACAGGGGGCTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	32	4.96902125809407E-4		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	0	4	7	1	23	37	56	44	57	TCRBV01,TCRBV04													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGACGCGGGACTACCTGAGCAGTTCTTCGGGCCA	CSADAGLPEQFF	In	VDJ	1	32	4.96902125809407E-4	6.928506473823237E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	9	9	5	2	26	35	47	40	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSADAGLPEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAACCGAATCAGGGGGGCAGACTAGAAGCTTTCTTTGGACAA	CSAEPNQGGRLEAFF	In	VDJ	1	32	4.96902125809407E-4	6.928506473823237E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	8	9	8	26	35	51	44	59		TCRBV20-01,TCRBV20-or09_02												CSAEPNQGGRLEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGGGGCGACGCGCCGAGCAGTACTTCGGGCCG	CSARGRRAEQYF	In	VDJ	1	32	4.96902125809407E-4	6.928506473823237E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	0	6	0	7	26	-1	42	34	49		TCRBV20-01,TCRBV20-or09_02												CSARGRRAEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGCAGGGGGAGGAAACTGAAGCTTTCTTTGGACAA	CASSQQGEETEAFF	In	VDJ	1	32	4.96902125809407E-4	6.928506473823237E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	1	5	1	5	26	40	48	41	53		TCRBV03-01,TCRBV03-02												CASSQQGEETEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCACCGGACAGTGGCAAGAGACCCAGTACTTCGGGCCA	CASSPTGQWQETQYF	In	VDJ	1	32	4.96902125809407E-4	6.928506473823237E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	5	2	7	3	26	37	50	44	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPTGQWQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGCCCGGGACAGGGAACTGGAAACACCATATATTTTGGAGAG	CASSPGQGTGNTIYF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	3	2	3	2	26	37	49	40	51	TCRBV06,TCRBV10													CASSPGQGTGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGARGACTCRGCCCTKTATCTYTGCGCCAGCAGCCAGAGCTACGGGTCCTACGAGCAGTACTTCGGGCCG	CASSQSYGSYEQYF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	8	4	1	6	0	23	37	-1	43	47	TCRBV04,TCRBV05					01,02								CASSQSYGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCCCGCCAGGAATGTCTAACTATGGCTACACCTTCGGTTCG	CSVPPGMSNYGYTF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	4	0	6	5	26	33	43	39	48		TCRBV20-01,TCRBV20-or09_02												CSVPPGMSNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCCGGACAATTACTTATAGACGCCCAAGAGACCCAGTACTTCGGGCCA	CSAAGQLLIDAQETQYF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	6	1	3	15	26	35	43	38	58		TCRBV20-01,TCRBV20-or09_02												CSAAGQLLIDAQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCTCCCTTTGCAGGGAACACAGATACGCAGTATTTTGGCCCA	CSASSPFAGNTDTQYF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	3	2	11	2	26	37	53	48	55		TCRBV20-01,TCRBV20-or09_02												CSASSPFAGNTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGAGGGACAGCCGTCCTACGAGCAGTACTTCGGGCCG	CSASEGQPSYEQYF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	5	1	3	3	26	37	47	40	50		TCRBV20-01,TCRBV20-or09_02												CSASEGQPSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGAGGAGTATGGCTACACCTTCGGTTCG	CSASEEYGYTF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	10	2	5	3	0	26	37	-1	40	44		TCRBV20-01,TCRBV20-or09_02												CSASEEYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGAGGCCCTAAATAATTCACCCCTCCACTTTGGGAAC	CSAREEALNNSPLHF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	0	11	1	5	1	6	26	40	45	41	51		TCRBV20-01,TCRBV20-or09_02												CSAREEALNNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01*02	TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTCTGACTGGACTAGCGTAAATGAGCAGTTCTTCGGGCCA	CASSSDWTSVNEQFF	In	VDJ	1	30	4.6584574294631904E-4	6.495474819209284E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	6	7	6	2	18	31	46	37	48	TCRBV11,TCRBV23					01,02								CASSSDWTSVNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTAGTGACAGGAGCCAACAATGAGCAGTTCTTCGGGCCA	CASSLVTGANNEQFF	In	VDJ	1	30	4.6584574294631904E-4	6.495474819209284E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	4	5	4	5	23	36	46	40	51	TCRBV06,TCRBV24													CASSLVTGANNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGCCCTCGAGATACGCAGTATTTTGGCCCA	CATSGPRDTQYF	In	VDJ	1	30	4.6584574294631904E-4	6.495474819209284E-4	36	TCRBV24						TCRBJ02	TCRBJ02-03	01	5	10	0	5	0	5	24	-1	39	37	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSGPRDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGGGAGTTCAGGGGTGGAAAAACTGTTTTTTGGCAGT	CSAGGSSGVEKLFF	In	VDJ	1	30	4.6584574294631904E-4	6.495474819209284E-4	42	TCRBV20						TCRBJ01	TCRBJ01-04	01	5	4	2	8	10	2	26	35	51	45	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGGSSGVEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATAGCGGGGGGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	30	4.6584574294631904E-4		41	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	5	1	0	0	0	26	-1	-1	36	46		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACCGGGACTAGCAACGAGCAGTACTTCGGGCCG	CSTGTSNEQYF	In	VDJ	1	30	4.6584574294631904E-4	6.495474819209284E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	0	7	5	3	1	26	32	44	35	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSTGTSNEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCCGGACAGGGTTAACGGACAGCCCCAGCATTTTGGTGAT	CASSPDRVNGQPQHF	In	VDJ	1	29	4.503175515147751E-4	6.278958991902308E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	3	7	2	8	23	35	45	37	53	TCRBV06,TCRBV10													CASSPDRVNGQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCTAACACGGGAGAATTCGATGAGCAGTTCTTCGGGCCA	CATSDSNTGEFDEQFF	In	VDJ	1	29	4.503175515147751E-4	6.278958991902308E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	8	2	8	6	6	24	40	52	46	58		TCRBV24-01,TCRBV24-or09_02												CATSDSNTGEFDEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTYRGKGACTCWGCTGTGTAYTTCTGTGCCAGCAGCGTAGCAGGGGCAACTGGAAACACCATATATTTTGGAGAG	CASSVAGATGNTIYF	In	VDJ	1	29	4.503175515147751E-4	6.278958991902308E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	4	2	2	5	3	22	33	44	38	47	TCRBV03,TCRBV12													CASSVAGATGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAGCGGGTGGATGGGAGACCCAGTACTTCGGGCCA	CSARGAGGWETQYF	In	VDJ	1	29	4.503175515147751E-4	6.278958991902308E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	6	4	5	1	7	26	39	46	40	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGAGGWETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCAACGGAGGCACAGATACGCAGTATTTTGGCCCA	CSATNGGTDTQYF	In	VDJ	1	29	4.503175515147751E-4	6.278958991902308E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	10	2	1	5	0	26	36	-1	41	45		TCRBV20-01,TCRBV20-or09_02												CSATNGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATCCGGTGAAAACACCATATATTTTGGAGAG	CASSLSGENTIYF	In	VDJ	1	29	4.503175515147751E-4	6.278958991902308E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	2	8	5	6	2	3	26	41	46	43	49		TCRBV12-03,TCRBV12-04				01,02								CASSLSGENTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD02-01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCAATGGATGGGAGCCTACGAGCAGTACTTCGGGCCG	CASSQWMGAYEQYF	In	VDJ	1	28	4.347893600832311E-4	6.062443164595332E-4	42	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	9	2	2	8	0	19	31	-1	39	44		TCRBV05-06,TCRBV05-07												CASSQWMGAYEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD02-01*02	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGATTCAGGGGTGGAACACTGAAGCTTTCTTTGGACAA	CASSLAIQGWNTEAFF	In	VDJ	1	28	4.347893600832311E-4	6.062443164595332E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	2	1	4	2	18	35	45	39	47	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAIQGWNTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGGAGGACAGGGGGTCCTATAATTCACCCCTCCACTTTGGGAAC	CASREDRGSYNSPLHF	In	VDJ	1	28	4.347893600832311E-4	6.062443164595332E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	1	1	1	3	0	24	35	-1	38	48		TCRBV24-01,TCRBV24-or09_02												CASREDRGSYNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD01-01*01	TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGACATCCAAGGTAACCGCCGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	28	4.347893600832311E-4		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	6	5	0	16	26	-1	37	33	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGACAGCGTACGCTGAAGCTTTCTTTGGACAA	CSARGTAYAEAFF	In	VDJ	1	28	4.347893600832311E-4	6.062443164595332E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	6	1	6	26	37	45	38	51		TCRBV20-01,TCRBV20-or09_02												CSARGTAYAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGGATCTACTAGCGGGGGGGCATTATACGCAGTATTTTGGCCCA	CSARADLLAGGHYTQYF	In	VDJ	1	28	4.347893600832311E-4	6.062443164595332E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	3	0	7	7	4	26	39	59	46	63		TCRBV20-01,TCRBV20-or09_02												CSARADLLAGGHYTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTGGGGGACAGGGGGCATTGGAATGAGCAGTTCTTCGGGCCA	CASSQDLGDRGHWNEQFF	In	VDJ	1	28	4.347893600832311E-4	6.062443164595332E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	0	7	5	5	26	43	60	48	65		TCRBV03-01,TCRBV03-02												CASSQDLGDRGHWNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGACGGGGGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSDGGASTDTQYF	In	VDJ	1	28	4.347893600832311E-4	6.062443164595332E-4	45				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	0	0	0	2	24	-1	46	38	48	TCRBV06,TCRBV10	TCRBV06-01,TCRBV10-03												CASSDGGASTDTQYF+X+TCRBJ02-03		TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCGCAGGGGGCCCATACATCCCTCCACTTTGGGAAC	CASSSQGAHTSLHF	In	VDJ	1	27	4.1926116865168716E-4	5.845927337288356E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	4	0	14	2	8	19	32	42	34	50		TCRBV05-06,TCRBV05-07												CASSSQGAHTSLHF+TCRBV05-X+TCRBJ01-06	TCRBV05	TCRBD01-01*01	TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTACCCTGGCCCCCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	27	4.1926116865168716E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	9	0	1	5	4	24	36	44	41	48	TCRBV24,TCRBV27													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGAATGGATTCTAACTATGGCTACACCTTCGGTTCG	CASRMDSNYGYTF	In	VDJ	1	27	4.1926116865168716E-4	5.845927337288356E-4	39	TCRBV24						TCRBJ01	TCRBJ01-02	01	7	1	8	0	3	2	24	35	41	38	43		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRMDSNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGGTCTGGTGGGCAGATCAACTACGAGCAGTACTTCGGGCCG	CASRSGGQINYEQYF	In	VDJ	1	27	4.1926116865168716E-4	5.845927337288356E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	8	0	3	7	7	22	33	44	40	51		TCRBV12-03,TCRBV12-04												CASRSGGQINYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAAGGGACAGGGAAACTATGGCTACACCTTCGGTTCG	CSARKGQGNYGYTF	In	VDJ	1	27	4.1926116865168716E-4	5.845927337288356E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	2	3	1	26	37	49	40	50		TCRBV20-01,TCRBV20-or09_02												CSARKGQGNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAACTCTGGACAGCCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	27	4.1926116865168716E-4		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	5	1	6	2	26	36	48	42	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCRGCYGTGTATKTYTGTGCCAGCAGCGCCACTAGCGGCTACACAGATACGCAGTATTTTGGCCCA	CASSATSGYTDTQYF	In	VDJ	1	27	4.1926116865168716E-4	5.845927337288356E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	3	5	2	4	3	26	37	49	41	52	TCRBV11,TCRBV12					01,02								CASSATSGYTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCTAAGCCCTTCCCGGCGGGAGCTTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	26	4.0373297722014315E-4		50				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	2	4	8	3	18	35	50	43	53	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTTGCGGGGGGCAACACCGGGGAGCTGTTTTTTGGAGAA	CATSVAGGNTGELFF	In	VDJ	1	26	4.0373297722014315E-4	5.62941150998138E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	7	1	2	2	1	24	37	47	39	48		TCRBV24-01,TCRBV24-or09_02												CATSVAGGNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGACGGGACAGACTTCACAGATACGCAGTATTTTGGCCCA	CSADGTDFTDTQYF	In	VDJ	1	26	4.0373297722014315E-4	5.62941150998138E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	5	2	3	4	26	35	45	38	49		TCRBV20-01,TCRBV20-or09_02												CSADGTDFTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCAGGGGGGGGTTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	26	4.0373297722014315E-4		38	TCRBV20						TCRBJ02	TCRBJ02-07	01	5	4	1	4	2	5	26	35	44	37	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGTGGGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CSARGGSSYNSPLHF	In	VDJ	1	26	4.0373297722014315E-4	5.62941150998138E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	3	9	2	0	4	0	26	37	-1	41	46		TCRBV20-01,TCRBV20-or09_02												CSARGGSSYNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01*02	TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGCAGTTCCTATGGCTACACCTTCGGTTCG	CSARDSSSYGYTF	In	VDJ	1	26	4.0373297722014315E-4	5.62941150998138E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	5	7	4	0	5	26	-1	44	40	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDSSSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCGTAAAATCCCCCCTAGTTCCCCTCGAGCAGTACTTCGGGCCG	CASVKSPLVPLEQYF	In	VDJ	1	26	4.0373297722014315E-4	5.62941150998138E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	4	8	6	12	7	26	35	51	47	58		TCRBV03-01,TCRBV03-02				01,02								CASVKSPLVPLEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
MAGAAGACTCAGCYSYGTATCTCTGCACCAGCAGCCAAGATCCGGGACTAGCGGGGAATCATGAGCAGTTCTTCGGGCCA	CTSSQDPGLAGNHEQFF	In	VDJ	1	26	4.0373297722014315E-4	5.62941150998138E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	0	3	8	3	4	23	40	56	43	60	TCRBV01,TCRBV04													CTSSQDPGLAGNHEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTGAAGACCGGCGGGGGGGGACAGATACGCAGTATTTTGGCCCA	CASSEDRRGGTDTQYF	In	VDJ	1	26	4.0373297722014315E-4	5.62941150998138E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	0	3	8	1	26	38	55	46	56	TCRBV02,TCRBV12													CASSEDRRGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGACTCAGGGACCACTGAAGCTTTCTTTGGACAA	CASSLADSGTTEAFF	In	VDJ	1	25	3.882047857885992E-4	5.412895682674404E-4	45							TCRBJ01	TCRBJ01-01	01	0	0	7	4	7	0	18	35	-1	42	47	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLADSGTTEAFF+X+TCRBJ01-01			TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCTGGGACCAGTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	25	3.882047857885992E-4		41	TCRBV24						TCRBJ01	TCRBJ01-04	01	7	0	7	4	3	3	24	35	43	38	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCTGGACAGGCGAACTTTATCACCGGGGAGCTGTTTTTTGGAGAA	CASSPGQANFITGELFF	In	VDJ	1	25	3.882047857885992E-4	5.412895682674404E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	1	4	4	4	10	24	35	46	39	56		TCRBV24-01,TCRBV24-or09_02												CASSPGQANFITGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGTTCGTACGGTGGGAACTGAAGCTTTCTTTGGACAA	CSARGVRTVGTEAFF	In	VDJ	1	25	3.882047857885992E-4	5.412895682674404E-4	45	TCRBV20						TCRBJ01	TCRBJ01-01	01	1	0	8	5	13	0	26	39	-1	52	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGVRTVGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCACCCTTCGGGGGAGTACGGAGACCCAGTACTTCGGGCCA	CTLRGSTETQYF	In	VDJ	1	25	3.882047857885992E-4	5.412895682674404E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	10	8	2	5	5	6	26	30	41	35	47		TCRBV20-01,TCRBV20-or09_02												CTLRGSTETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGGACTCSGCCGTGTATSTCTGTGCCAGCAGCTTAGGGGGAGCCCCAGGATCTCCCAATCAGCCCCAGCATTTTGGTGAT	CASSLGGAPGSPNQPQHF	In	VDJ	1	25	3.882047857885992E-4	5.412895682674404E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	9	2	3	1	13	20	36	42	37	55	TCRBV07,TCRBV11													CASSLGGAPGSPNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGACAGGGGGCTAATAAGCAGTACTTCGGGCCG	CASSQGQGANKQYF	In	VDJ	1	25	3.882047857885992E-4	5.412895682674404E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	0	8	0	5	26	-1	52	40	57		TCRBV03-01,TCRBV03-02												CASSQGQGANKQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGGGGAGGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	25	3.882047857885992E-4		41	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	9	1	5	1	0	23	39	-1	40	46	TCRBV01,TCRBV04													X+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCACGGACGCCGGGGAGCTGTTTTTTGGAGAA	CASSPTDAGELFF	In	VDJ	1	25	3.882047857885992E-4	5.412895682674404E-4	39	TCRBV12						TCRBJ02	TCRBJ02-02	01	5	1	7	6	5	1	26	38	47	43	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTDAGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGGACTCSGCCSTSTATCTCTGTGCCAGCAGCTTAGGACGGGGGACGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLGRGTSTGELFF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	8	2	4	4	5	19	33	43	37	48	TCRBV05,TCRBV07													CASSLGRGTSTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGRGACWCRGCMSTGTATCTCTRCGCCAGCAGCGAGCCGGGACTAGGGTGGAGTGAGCAGTTCTTCGGGCCA	XASSEPGLGWSEQFF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	8	9	5	7	22	34	47	39	54	TCRBV07,TCRBV17,TCRBV23					01,02								XASSEPGLGWSEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTTAGGGCGGGGACAGGCCTCCTACGAGCAGTACTTCGGGCCG	CASSLGRGQASYEQYF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	4	0	4	1	18	34	46	38	47	TCRBV07,TCRBV11													CASSLGRGQASYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCAGGCCCGTTACGAGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	24	3.726765943570552E-4		55	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	13	5	18	30	48	43	53	TCRBV07,TCRBV11													X+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGGACTAAGACAGGGATTTACTCTGGAAACACCATATATTTTGGAGAG	CARTKTGIYSGNTIYF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	11	2	3	0	7	5	24	31	45	38	50	TCRBV06,TCRBV24													CARTKTGIYSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTAAGGACAGGTCTAAGGGGGTTGATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	24	3.726765943570552E-4		52	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	4	6	3	13	24	36	46	39	59		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCGGAACAGACGAAACGGAGCAGTACTTCGGGCCG	CSAPGTDETEQYF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	5	7	6	8	26	35	45	41	53		TCRBV20-01,TCRBV20-or09_02												CSAPGTDETEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGACAGGGGATTCACCCCTCCACTTTGGGAAC	CSAKTGDSPLHF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	2	2	8	1	0	26	36	-1	37	45		TCRBV20-01,TCRBV20-or09_02												CSAKTGDSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGTACTAGCGGGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSGTSGGQETQYF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	3	1	2	3	0	26	38	-1	41	53		TCRBV03-01,TCRBV03-02												CASSGTSGGQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGACAGCCAAAAACATTCAGTACTTCGGCGCC	CASSRTAKNIQYF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	39	TCRBV03						TCRBJ02	TCRBJ02-04	01	4	1	7	0	0	0	26	-1	-1	39	43		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTAKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03		TCRBJ02-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGATCGCCAATCGGGCTGCACGAGCAGTACTTCGGGCCG	CASSQGSPIGLHEQYF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	48	TCRBV03						TCRBJ02	TCRBJ02-07	01	1	8	0	5	11	3	26	42	57	53	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGSPIGLHEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAACAATGGCTAGCGGGAAACAATGAGCAGTTCTTCGGGCCA	CASSEQWLAGNNEQFF	In	VDJ	1	23	3.5714840292551126E-4	4.979864028060451E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	3	5	10	1	23	34	53	44	54	TCRBV02,TCRBV09													CASSEQWLAGNNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCCTTTATCACAAGGGGGCGAGAGAGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	23	3.5714840292551126E-4		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	11	5	0	8	12	6	24	31	50	43	56		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTACCCAAGGACAGGGAAACATTCAGTACTTCGGCGCC	CATSTQGQGNIQYF	In	VDJ	1	23	3.5714840292551126E-4	4.979864028060451E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	1	3	6	6	0	24	36	-1	42	50		TCRBV24-01,TCRBV24-or09_02												CATSTQGQGNIQYF+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD01-01*01	TCRBJ02-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCCAATTTTAATGACAGGGGGTTATAATTCACCCCTCCACTTTGGGAAC	CASSPILMTGGYNSPLHF	In	VDJ	1	23	3.5714840292551126E-4	4.979864028060451E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	2	1	4	11	1	23	35	55	46	56	TCRBV24,TCRBV27													CASSPILMTGGYNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGACTCGCCAGAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	23	3.5714840292551126E-4		40	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	10	5	0	7	22	-1	38	34	45		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGGAGGGGCGCGGATGGCTACACCTTCGGTTCG	CSAWRGADGYTF	In	VDJ	1	23	3.5714840292551126E-4	4.979864028060451E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	10	0	6	1	6	26	35	42	36	48		TCRBV20-01,TCRBV20-or09_02												CSAWRGADGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCAGTCAGGGCACTGAAGCTTTCTTTGGACAA	CSASSQGTEAFF	In	VDJ	1	23	3.5714840292551126E-4	4.979864028060451E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	4	6	0	26	35	-1	41	46		TCRBV20-01,TCRBV20-or09_02												CSASSQGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCATCCCGTGAACACTGAAGCTTTCTTTGGACAA	CSAHPVNTEAFF	In	VDJ	1	23	3.5714840292551126E-4	4.979864028060451E-4	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	4	6	0	0	5	26	-1	37	35	42		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAHPVNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTGGCAGGGAGACAACAATGAGCAGTTCTTCGGGCCA	CSASWQGDNNEQFF	In	VDJ	1	23	3.5714840292551126E-4	4.979864028060451E-4	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	4	3	5	4	5	26	37	46	41	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASWQGDNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCCCCCCCAGGAGCTAAACTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	23	3.5714840292551126E-4		50	TCRBV20						TCRBJ02	TCRBJ02-06	01	6	4	4	2	8	7	26	34	46	42	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-06	TCRBV20		TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTGGAACGCCCCTTCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	23	3.5714840292551126E-4		50	TCRBV03						TCRBJ01	TCRBJ01-02	01	4	1	8	4	1	17	26	39	43	40	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCCTTTCGGGACAGTTCTTTAATGAAAAACTGTTTTTTGGCAGT	CASLSGQFFNEKLFF	In	VDJ	1	22	3.416202114939673E-4	4.763348200753475E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	0	5	4	5	5	23	32	44	37	49	TCRBV06,TCRBV10													CASLSGQFFNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCGGGGGTCGTCACAGTGCTGATTATGGCTACACCTTCGGTTCG	CGGRHSADYGYTF	In	VDJ	1	22	3.416202114939673E-4	4.763348200753475E-4	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	11	6	1	5	0	16	26	-1	34	29	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CGGRHSADYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTACAGCGGAGACCCTATGGCTACACCTTCGGTTCG	CASSLQRRPYGYTF	In	VDJ	1	22	3.416202114939673E-4	4.763348200753475E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	6	5	4	3	5	26	39	47	42	52		TCRBV03-01,TCRBV03-02				01,02								CASSLQRRPYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTCTCCAGGGGGCAGGCGAGCAGTACTTCGGGCCG	CASSFLQGAGEQYF	In	VDJ	1	22	3.416202114939673E-4	4.763348200753475E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	0	6	4	3	26	40	52	44	55		TCRBV12-03,TCRBV12-04												CASSFLQGAGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTGACAGGGGCGACCCGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	3.416202114939673E-4		46	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	2	1	0	7	26	-1	47	39	54		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTTAGACCAAGGGACTACGAGGACGCAGTATTTTGGCCCA	CASSLDQGTTRTQYF	In	VDJ	1	21	3.2609202006242334E-4	4.546832373446499E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	0	9	9	5	5	22	38	50	43	55	TCRBV07,TCRBV11					01,02								CASSLDQGTTRTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CMCCARCCARACAGCTYTKTACTTCTGTGCCAGCAGTAGTCAAGGTGGTAGTTGGGAGACCCAGTACTTCGGGCCA	CASSSQGGSWETQYF	In	VDJ	1	21	3.2609202006242334E-4	4.546832373446499E-4	45	unresolved						TCRBJ02	TCRBJ02-05	01	6	5	4	5	5	10	24	36	44	41	54	TCRBV22,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSQGGSWETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCACGCGCAACGGGCAAGAGACCCAGTACTTCGGGCCA	CASTRNGQETQYF	In	VDJ	1	21	3.2609202006242334E-4	4.546832373446499E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	8	4	2	7	0	22	32	-1	39	43	TCRBV09,TCRBV12					01,02								CASTRNGQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCTCCGCGAGGGGCCTGGGGGGAATGAGCAGTTCTTCGGGCCA	CASSLREGPGGNEQFF	In	VDJ	1	21	3.2609202006242334E-4	4.546832373446499E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	9	1	7	14	0	23	36	-1	50	56	TCRBV04,TCRBV23													CASSLREGPGGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGTCGGAGGGGGTGGGGCCAACGTCCTGACTTTCGGGGCC	CSAREVGGGGANVLTF	In	VDJ	1	21	3.2609202006242334E-4	4.546832373446499E-4	48	TCRBV20						TCRBJ02	TCRBJ02-06	01	0	5	1	3	6	0	26	40	-1	46	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREVGGGGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20		TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGAGACTTCCCGACAGAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	21	3.2609202006242334E-4		38	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	2	5	4	9	1	26	31	45	40	46		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCCTAGCAGCGCAGTACTTCGGGCCG	CASSQGLAAQYF	In	VDJ	1	21	3.2609202006242334E-4	4.546832373446499E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	4	7	9	2	3	26	42	49	44	52		TCRBV03-01,TCRBV03-02				01,02								CASSQGLAAQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCRGGRGACWCAGCWSKGTATYTCTGTGCCAGCAGCGTAGACTACGGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVDYGSSYNEQFF	In	VDJ	1	20	3.105638286308794E-4	4.330316546139523E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	9	0	3	6	24	36	44	39	50	TCRBV07,TCRBV21					01,02								CASSVDYGSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGTCCTTGGCGGGGGGTTGAGACCCAGTACTTCGGGCCA	CASSPWRGVETQYF	In	VDJ	1	20	3.105638286308794E-4	4.330316546139523E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	7	1	5	6	2	19	30	44	36	46	TCRBV07,TCRBV11													CASSPWRGVETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCGATACTACTGAACCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	3.105638286308794E-4		50				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	3	9	4	4	14	22	34	42	38	56	TCRBV07,TCRBV17	TCRBV07-03,TCRBV17-01				01,02								X+X+TCRBJ01-02		TCRBD02-01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGGGACAGGGGGCGGAGAGACCCAGTACTTCGGGCCA	CASSLGTGGGETQYF	In	VDJ	1	20	3.105638286308794E-4	4.330316546139523E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	1	0	4	0	2	18	-1	45	34	47	TCRBV07,TCRBV11													CASSLGTGGGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGGGACCGACACAGATACGCAGTATTTTGGCCCA	CASSLAGTDTDTQYF	In	VDJ	1	20	3.105638286308794E-4	4.330316546139523E-4	45							TCRBJ02	TCRBJ02-03	01	0	0	7	2	1	3	18	35	41	36	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGTDTDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGGACTAGCGGGGGAGAAAGACCTGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	20	3.105638286308794E-4		61				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	0	2	1	0	10	18	-1	49	35	59	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ02-03		TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTACGGGCCTCCGAGAGTCGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	3.105638286308794E-4		46	unresolved						TCRBJ02	TCRBJ02-07	01	5	8	0	4	2	13	26	38	44	40	57	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAATTGGACAGGGCTAACTGAAGCTTTCTTTGGACAA	CSARDNWTGLTEAFF	In	VDJ	1	20	3.105638286308794E-4	4.330316546139523E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	3	5	5	3	26	40	53	45	56		TCRBV20-01,TCRBV20-or09_02												CSARDNWTGLTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGGTGGACAGGGATAAACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	20	3.105638286308794E-4		35	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	1	3	5	3	4	26	31	42	34	46		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTACCGGGACTGGCTACACCTTCGGTTCG	CASSTGTGYTF	In	VDJ	1	20	3.105638286308794E-4	4.330316546139523E-4	33	TCRBV12						TCRBJ01	TCRBJ01-02	01	5	0	7	7	3	0	26	38	-1	41	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTGTGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
RRGACWCSGCMSTGTATCTCTGYGCCAGCAGCCAAGATATTATCGCTGAAGCTTTCTTTGGACAA	CASSQDIIAEAFF	In	VDJ	1	19	2.950356371993354E-4	4.1138007188325465E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	2	2	8	6	0	8	20	-1	37	35	45	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDIIAEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAACCCCGCACAGATATGCAGTATTTTGGCCCA	CATSEPRTDMQYF	In	VDJ	1	19	2.950356371993354E-4	4.1138007188325465E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	5	11	7	4	24	38	49	45	53		TCRBV24-01,TCRBV24-or09_02												CATSEPRTDMQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGACAAGGTAATCAGCCCCAGCATTTTGGTGAT	CSAGQGNQPQHF	In	VDJ	1	19	2.950356371993354E-4	4.1138007188325465E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	6	4	1	4	26	34	40	35	44		TCRBV20-01,TCRBV20-or09_02												CSAGQGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGGRGACWCRGCWSTGTATCTCTGYGCCAGCAGCGCCGCAGGGGGCACTGAAGCTTTCTTTGGACAA	CASSAAGGTEAFF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	4	4	0	22	34	-1	38	45	TCRBV07,TCRBV23													CASSAAGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTGGAGGCGACTAGCGGGGGGGCCCGGGAGACCCAGTACTTCGGGCCA	CASSLEATSGGARETQYF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	2	0	5	4	5	19	35	53	39	58	TCRBV05,TCRBV07													CASSLEATSGGARETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCSTSTATCTCTGTGCCAGCAGCTTGCAGTACCCTCCTGAMGACTACGAGCAGTACTTCGGGCCG	CASSLQYPPXDYEQYF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	48	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	1	4	5	3	0	14	19	-1	37	34	51	TCRBV05,TCRBV07			TCRBD01,TCRBD02										CASSLQYPPXDYEQYF+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCCCCCTTCTTAGTTCCGATACGCAGTATTTTGGCCCA	CASSPLLSSDTQYF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	8	6	8	4	19	31	42	39	46	TCRBV07,TCRBV11					01,02								CASSPLLSSDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCRTGTATSKCTGTGCCAGCCGTTGGGCGCAGACTTCTCTTAGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	2.795074457677914E-4		46	unresolved						TCRBJ01	TCRBJ01-01	01	8	8	0	6	4	15	18	27	35	31	50	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCAGACGGCCTCATTCGTCTCTGAAGCTTTCTTTGGACAA	CASSQTASFVSEAFF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	45	unresolved						TCRBJ01	TCRBJ01-01	01	5	2	7	6	2	14	18	30	35	32	49	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQTASFVSEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCMTGTATCKCTGTGCCAGCAGCTCGGACCTGAGGGTCAGAGGGGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	18	2.795074457677914E-4		55	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	5	1	2	16	0	18	31	-1	47	53	TCRBV05,TCRBV07													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCGCCAAGGCCCTAACCGGGGCCAACGTCCTGACTTTCGGGGCC	CASAKALTGANVLTF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	45	unresolved						TCRBJ02	TCRBJ02-06	01	8	5	4	4	4	8	23	32	39	36	47	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASAKALTGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTAACACCGACAGTATCCCAAGAGACCCAGTACTTCGGGCCA	CASSLTPTVSQETQYF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	5	1	8	4	24	36	49	44	53		TCRBV24-01,TCRBV24-or09_02												CASSLTPTVSQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCATTGAGGTCGGCTCTACCAAGAACACCATATATTTTGGAGAG	CAIEVGSTKNTIYF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	10	11	1	7	2	14	22	29	35	31	49		TCRBV12-03,TCRBV12-04												CAIEVGSTKNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD02-01*02	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCTTTGACAGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CSARDPLTGDTGELFF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	2	2	3	6	0	26	40	-1	46	54		TCRBV20-01,TCRBV20-or09_02												CSARDPLTGDTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAATGGGATAACTATGGCTACACCTTCGGTTCG	CSAREWDNYGYTF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	0	8	1	2	0	26	40	-1	42	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREWDNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTTCCGGTTCACCCTCCGAGCAGTACTTCGGGCCG	CSATSGSPSEQYF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	8	5	6	4	9	26	36	43	40	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSATSGSPSEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAAGGAGGCCCCTCCGAGCAGTACTTCGGGCCG	CSAKGGPSEQYF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	10	1	6	2	6	26	36	43	38	49		TCRBV20-01,TCRBV20-or09_02												CSAKGGPSEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCGACAGGCCGGAGCCTGGAGACCCAGTACTTCGGGCCA	CSASTGRSLETQYF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	4	5	3	10	26	34	43	37	53		TCRBV20-01,TCRBV20-or09_02												CSASTGRSLETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCCGTGGTAGCGGGGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSRRGSGGDTGELFF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	5	0	3	7	0	26	39	-1	46	57		TCRBV03-01,TCRBV03-02												CASSRRGSGGDTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGWGACWCKGCWSTGTATYTCTGYGCCAGCACCCCTCCCCCGCGTTACCCTTAGAGCACTGAAGCTTTCTTTGGACAA	CASTPPPRYP*STEAFF	Stop	VDJ	1	18	2.795074457677914E-4		51	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	5	8	4	20	2	26	36	59	56	61	TCRBV03,TCRBV23					01,02								CASTPPPRYP*STEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAGGCCTAGCGGGGGACCCTACAATGAGCAGTTCTTCGGGCCA	CASSLRPSGGPYNEQFF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	51	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	4	2	2	4	2	26	41	55	45	57		TCRBV12-03,TCRBV12-04												CASSLRPSGGPYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTAGCAGGGTCCGGAAACACCATATATTTTGGAGAG	CASSLAGSGNTIYF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	42							TCRBJ01	TCRBJ01-03	01	0	5	3	4	0	3	18	-1	39	35	42	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGSGNTIYF+X+TCRBJ01-03			TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
MAGAAGACTCAGCYSYGTATCTCTGCACCAGCAGCCACTAGAAGGACCAGGGGTTAGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	2.6397925433624744E-4		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	4	10	5	23	37	53	47	58	TCRBV01,TCRBV04													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCAACCCTCCGCGATATACGCAGTATTTTGGCCCA	CSAPNPPRYTQYF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	7	6	7	11	2	26	35	49	46	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPNPPRYTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACTAACTAGCGGGGAGACCTCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	17	2.6397925433624744E-4		50	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	3	3	2	4	6	26	38	52	42	58		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAAGGACGGAAACTACGAGCAGTACTTCGGGCCG	CSAKDGNYEQYF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	1	7	3	3	5	26	34	41	37	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKDGNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCAGCGGGGGGCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	17	2.6397925433624744E-4		47	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	1	0	2	2	26	39	50	41	52		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGTTGCGCAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVAQGNTGELFF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	1	5	0	24	37	-1	42	47	TCRBV06,TCRBV10	TCRBV06-01,TCRBV10-03												CASSVAQGNTGELFF+X+TCRBJ02-02		TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTCCTTACAGGGAGTGGAGACCCAGTACTTCGGGCCA	CASSSLQGVETQYF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	3	5	4	4	26	39	49	43	53	TCRBV12,TCRBV21													CASSSLQGVETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCAGCGTCCGGCAGCCCCAGCATTTTGGTGAT	CASSSSVRQPQHF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	6	6	7	2	5	26	39	45	41	50		TCRBV12-03,TCRBV12-04				01,02								CASSSSVRQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD02-01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTCGGGACAGAACTTTACGAGCAGTACTTCGGGCCG	CASSLGTELYEQYF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	5	4	4	5	26	37	48	41	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLGTELYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTGGCCGGGGGGTCAACGAGCAGTACTTCGGGCCG	CASSGRGVNEQYF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	1	5	4	3	24	35	46	39	49	TCRBV12,TCRBV21													CASSGRGVNEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCRGCCMTGTATCKCTGTGCCAGCAGCTTGGAAACAGGGGGATCTCTGTACGACTATGGCTACACCTTCGGTTCG	CASSLETGGSLYDYGYTF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	1	3	2	11	19	35	45	37	56	TCRBV05,TCRBV07													CASSLETGGSLYDYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGACTCGGCYGTGTATCTCTGTGCCAGCAGCCAAGAAGCGGGGGGGCCAGATACGCAGTATTTTGGCCCA	CASSQEAGGPDTQYF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	6	0	4	0	1	19	-1	46	36	47	TCRBV03,TCRBV07													CASSQEAGGPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCTTTCCGGGACAGGGAGTAGATACGCAGTATTTTGGCCCA	CASSSFPGQGVDTQYF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	3	5	8	3	24	36	53	44	56		TCRBV24-01,TCRBV24-or09_02												CASSSFPGQGVDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCCTATCCCTGACCGCTTATACGCAGTATTTTGGCCCA	CASSSLSLTAYTQYF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	45	TCRBV24						TCRBJ02	TCRBJ02-03	01	6	2	7	7	11	5	24	36	50	47	55		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSLSLTAYTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTACGGGGCGGGGGGAGGCGTGAACACTGAAGCTTTCTTTGGACAA	CASSYGAGGGVNTEAFF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	51	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	7	1	0	6	5	24	36	50	42	55		TCRBV24-01,TCRBV24-or09_02												CASSYGAGGGVNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAACGCGGGCGGCGGGATGGCTACACCTTCGGTTCG	CASSERGRRDGYTF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	7	4	6	4	7	22	34	43	38	50		TCRBV12-03,TCRBV12-04				01,02								CASSERGRRDGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGTGACAGGAGCTTAGGTCAGCCCCAGCATTTTGGTGAT	CSASGDRSLGQPQHF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	4	6	4	8	26	37	47	41	55		TCRBV20-01,TCRBV20-or09_02												CSASGDRSLGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACGGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSQRGGTDTQYF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	8	1	1	0	0	26	-1	-1	41	48		TCRBV03-01,TCRBV03-02												CASSQRGGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTACTCACAGGTTATCTATGGCTACACCTTCGGTTCG	CASSYSQVIYGYTF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	4	4	4	4	26	39	48	43	52		TCRBV12-03,TCRBV12-04												CASSYSQVIYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCAAACCGGACCTCTTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQTGPLNTGELFF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	48	TCRBV12						TCRBJ02	TCRBJ02-02	01	5	1	7	2	6	5	26	38	48	44	53		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQTGPLNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCAGGGGGCTACTATGGCTACACCTTCGGTTCG	CASSSGGYYGYTF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	0	3	2	1	26	37	47	39	48		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSSGGYYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGTCAGTCCCGGGGCGGCGGGGGGAGAGACCCAGTACTTCGGGCCA	CVSPGAAGGETQYF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	14	7	1	4	14	0	24	28	-1	42	50		TCRBV24-01,TCRBV24-or09_02												CVSPGAAGGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCGTACAGGGGAAGCTTTCTTTGGACAA	CATSDRTGEAFF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	8	4	0	24	38	-1	42	48		TCRBV24-01,TCRBV24-or09_02												CATSDRTGEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGGGCTGACAGGGGGTATGACGAAAAACTGTTTTTTGGCAGT	CSGADRGYDEKLFF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	2	1	8	5	6	26	33	47	38	53		TCRBV20-01,TCRBV20-or09_02												CSGADRGYDEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTTGGGGGGGTCTTACTTGAAGCTTTCTTTGGACAA	CSAVGGVLLEAFF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	0	7	3	7	26	35	45	38	52		TCRBV20-01,TCRBV20-or09_02												CSAVGGVLLEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGTCCGCAATAATTCACCCCTCCACTTTGGGAAC	CSASVRNNSPLHF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	39	TCRBV20						TCRBJ01	TCRBJ01-06	01	3	4	6	5	6	0	26	37	-1	43	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASVRNNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGGACAGGACTTAACTATGGCTACACCTTCGGTTCG	CSAGTGLNYGYTF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	4	1	1	3	26	34	43	35	46		TCRBV20-01,TCRBV20-or09_02												CSAGTGLNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCCTTAACTTGAACACTGAAGCTTTCTTTGGACAA	CSAPLNLNTEAFF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	3	10	0	8	0	26	34	-1	42	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPLNLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAATGCTAGAGAGTGGCGGAACCGGGGGCTACACCTTCGGTTCG		Out	VDJ	1	15	2.3292287147315952E-4		40	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	7	5	8	3	7	26	40	47	43	54		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCCACAGGACGGGTGAAGCTTTCTTTGGACAA	CASSQAHRTGEAFF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	4	7	3	5	26	42	50	45	55		TCRBV03-01,TCRBV03-02												CASSQAHRTGEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAACGGGGGCGGGGACCCAGTACTTCGGGCCA	CASRTGAGTQYF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	36	TCRBV12						TCRBJ02	TCRBJ02-05	01	6	6	0	7	3	3	26	37	46	40	49		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRTGAGTQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGTAMSCTCYCAGACATCTGTGTACTTCTGTGCCAGCAGTGACTCTTGTCCCGGGACAGGGCCGAGCAGTACTTCGGGCCG		Out	VDJ	1	14	2.1739468004161556E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	3	6	7	1	28	45	61	52	62	TCRBV06,TCRBV10													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTTTGGGGACTGGGACTGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	14	2.1739468004161556E-4		49	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	0	10	1	4	9	24	35	45	39	54	TCRBV12,TCRBV21					01,02								X+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCAGGAGACWCRGCMSKGTATKTCTGTGCCAGCAGCTTAGATCGGGCCAGGGTATGCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	2.1739468004161556E-4		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	4	11	5	24	36	52	47	57	TCRBV11,TCRBV21													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTCCCGGGACAGGCAACCCTACGAGCAGTACTTCGGGCCG	CASSSRDRQPYEQYF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	4	2	2	4	22	36	46	38	50	TCRBV07,TCRBV11													CASSSRDRQPYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGGRGACWYGGCWSTGTATCTCTGYGCCAGCAGCGTACAGGGCTCCCGTGGCTACACCTTCGGTTCG	CASSVQGSRGYTF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	3	7	2	6	22	34	42	36	48	TCRBV07,TCRBV23													CASSVQGSRGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCCAAGATAGGCAGGAGGGGTCCGCTTTCTTTGGACAA	CASSQDRQEGSAFF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	10	0	11	6	4	19	36	48	42	52	TCRBV04,TCRBV11													CASSQDRQEGSAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTGGCGGGAAACTACAATGAGCAGTTCTTCGGGCCA	CASSLAGNYNEQFF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	8	3	3	0	2	19	-1	40	35	42	TCRBV05,TCRBV07													CASSLAGNYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTGGCCGGGACAGGCCTGAACACTGAAGCTTTCTTTGGACAA	CASSLAGTGLNTEAFF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	4	0	2	2	19	35	45	37	47	TCRBV05,TCRBV07													CASSLAGTGLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCTCCGGCAGGGGAAAGGGAGCTATGGCTACACCTTCGGTTCG	CASSLRQGKGSYGYTF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	4	6	8	19	31	43	37	51	TCRBV05,TCRBV11													CASSLRQGKGSYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCGGACGGAACAATGAGCAGTTCTTCGGGCCA	CASSLAGRNNEQFF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	42							TCRBJ02	TCRBJ02-01	01	0	1	7	5	1	3	18	35	40	36	43	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGRNNEQFF+X+TCRBJ02-01			TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCAAGAGCGGGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSQERGGQETQYF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	45				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	7	0	1	0	0	18	-1	-1	35	44	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQERGGQETQYF+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCATCCCCAGAAACCCTCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	14	2.1739468004161556E-4		46	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	11	4	5	3	7	7	24	31	41	38	48		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD01-01*01	TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGGCCGGGACGGGCGCGGAAAACTGTTTTTTGGCAGT	CATSDGRDGRGKLFF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	45	TCRBV24						TCRBJ01	TCRBJ01-04	01	4	0	7	10	5	8	24	38	48	43	56		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDGRDGRGKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCAGACTAGCTTCTACAATGAGCAGTTCTTCGGGCCA	CATSDQTSFYNEQFF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	7	3	3	2	24	38	48	41	50		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDQTSFYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAACTGGGAACCGAGGGATGGCTACACCTTCGGTTCG	CASNWEPRDGYTF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	11	0	6	10	0	22	32	-1	42	47	TCRBV09,TCRBV12													CASNWEPRDGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGTGGGCCAGGAAACACCATATATTTTGGAGAG	CSASGGPGNTIYF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	8	0	4	4	2	26	37	45	41	47		TCRBV20-01,TCRBV20-or09_02												CSASGGPGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGCAAGCATGATCAGCCCCAGCATTTTGGTGAT	CSASGKHDQPQHF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	39	TCRBV20						TCRBJ01	TCRBJ01-05	01	3	9	0	5	1	7	26	37	41	38	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGKHDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGCTCGGGGACTTAGATCTCCAAGAGACCCAGTACTTCGGGCCA	CSARALGDLDLQETQYF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	0	10	1	6	7	26	39	51	45	58		TCRBV20-01,TCRBV20-or09_02				01,02								CSARALGDLDLQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGTGGACAGGGATGGACACTGAAGCTTTCTTTGGACAA	CSAWTGMDTEAFF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	3	2	4	26	34	44	36	48		TCRBV20-01,TCRBV20-or09_02												CSAWTGMDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCACCCCGGACAGGGTTGGCTATGGCTACACCTTCGGTTCG	CSAPTPDRVGYGYTF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	3	4	9	4	26	34	51	43	55		TCRBV20-01,TCRBV20-or09_02												CSAPTPDRVGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCGGCTATAGGGGTCTAAGTATATATTTTGGAGAG	CASGYRGLSIYF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	36	unresolved			unresolved			TCRBJ01	TCRBJ01-03	01	8	5	2	13	6	7	26	35	46	41	53	TCRBV03,TCRBV12			TCRBD01,TCRBD02										CASGYRGLSIYF+X+TCRBJ01-03	unresolved	unresolved	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCTTATATGAGGACGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	14	2.1739468004161556E-4		46	unresolved						TCRBJ01	TCRBJ01-01	01	5	1	7	0	8	2	26	38	50	46	52	TCRBV03,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGAGATACGGGGACAGATACGCAGTATTTTGGCCCA	CASRDTGTDTQYF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	3	3	5	0	26	37	-1	42	47		TCRBV03-01,TCRBV03-02												CASRDTGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGGGAGTTTGGCTAATGAAAAACTGTTTTTTGGCAGT	CASSVGSLANEKLFF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	6	9	2	3	4	5	26	37	46	41	51	TCRBV09,TCRBV12													CASSVGSLANEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGCGTAGCTGGGAGGAATCCGGTGGGTGAGCAGTTCTTCGGGCCA	CASSVAGRNPVGEQFF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	1	9	6	11	24	36	48	42	59	TCRBV02,TCRBV21													CASSVAGRNPVGEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGCACAGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSLAQGAYEQYF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	1	2	3	0	19	33	-1	36	44		TCRBV05-06,TCRBV05-07												CASSLAQGAYEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCACCGGGACAGAGCGAACGAGCAGTACTTCGGGCCG	CASSHRDRANEQYF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	5	4	5	19	31	42	35	47		TCRBV05-06,TCRBV05-07												CASSHRDRANEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGGCAGGGACGACTACAATGAGCAGTTCTTCGGGCCA	CASSLGRDDYNEQFF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	45	unresolved						TCRBJ02	TCRBJ02-01	01	1	0	7	3	3	2	18	34	42	37	44	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGRDDYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CAGAAGACTCRGCCMTGTATCKCTGYGCCAGCAGCCAAGCAACAGGGTCTGGAAACACCATATATTTTGGAGAG	CASSQATGSGNTIYF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	3	1	6	0	18	30	-1	36	42	TCRBV04,TCRBV07													CASSQATGSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCAGTCGAGACAGGACCCTTTACCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	13	2.0186648861007157E-4		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	4	0	3	9	23	35	44	38	53	TCRBV06,TCRBV27													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCTGGACTGGGTGGGACCCAAGCACAGATACGCAGTATTTTGGCCCA	CASWTGWDPSTDTQYF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	48	TCRBV24						TCRBJ02	TCRBJ02-03	01	11	0	7	0	12	3	24	31	48	43	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASWTGWDPSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCGAAGGGGGCGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSSEGGGTGELFF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	5	0	5	5	3	24	36	48	41	51		TCRBV24-01,TCRBV24-or09_02												CASSSEGGGTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CMCCAACCAGACAKCTMTKTACYTCTGTGCCAGCAGTTACAGCGGGGGGGTATTGTCAGATACGCAGTATTTTGGCCCA	CASSYSGGVLSDTQYF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	0	4	2	6	25	38	50	40	56	TCRBV24,TCRBV28													CASSYSGGVLSDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTACCGGGACAGTCCCCTACGAGCAGTACTTCGGGCCG	CSARVTGTVPYEQYF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	5	2	5	3	26	39	51	44	54		TCRBV20-01,TCRBV20-or09_02												CSARVTGTVPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCCCAGGGTATACTAGAGACCCAGTACTTCGGGCCA	CSARDSQGILETQYF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	3	4	4	6	26	40	49	44	55		TCRBV20-01,TCRBV20-or09_02												CSARDSQGILETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGGTAGCAACTACAATGAGCAGTTCTTCGGGCCA	CSAREGSNYNEQFF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	5	7	3	3	2	26	40	47	43	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSAREGSNYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGAAGCGGGACTAGCGGGTTACAATGAGCAGTTCTTCGGGCCA	CASSQEAGLAGYNEQFF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	51	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	4	4	6	1	26	40	58	46	59		TCRBV03-01,TCRBV03-02				01,02								CASSQEAGLAGYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGAATCTTGGCGAGCAGTACTTCGGGCCG	CASSLNLGEQYF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	36	TCRBV12						TCRBJ02	TCRBJ02-07	01	3	0	10	6	7	0	26	40	-1	47	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNLGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGGGGACTYRGCTKTGTATYTCTGTGCCAGCAGCTTATTGGACAGCGGAATAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	12	1.863382971785276E-4		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	5	0	5	6	23	35	46	40	52	TCRBV07,TCRBV09													X+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCCTACTAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLLANTGELFF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	3	8	0	2	0	23	35	-1	37	42	TCRBV02,TCRBV09					01,02								CASSLLANTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGCTTGGKGACTCWGCYSTGTAYTTCTGTGCCAGCAGTGAAAAGTCGGATAACACTGAAGCTTTCTTTGGACAA	CASSEKSDNTEAFF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	6	1	8	2	9	1	20	31	43	40	44	TCRBV03,TCRBV13			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEKSDNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GRGACWCGGCMCTGTATCTCTGYGCCAGCAGCCTTAGACAGGCCGTCTATGGCTACACCTTCGGTTCG	CASSLRQAVYGYTF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	4	4	4	4	19	31	41	35	45	TCRBV05,TCRBV23													CASSLRQAVYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCACCTGGGAAAAAAAGGACAGGAAGGGCGAGCAGTACTTCGGGCCG	CASTWEKKDRKGEQYF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	4	6	13	5	19	29	49	42	54	TCRBV07,TCRBV11													CASTWEKKDRKGEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
RRGACWCGGCMCTGTATCTCTGYGCCAGCAGCCAAGGGGAGGATAGCGGGGGGGTGGCAGATACGCAGTATTTTGGCCCA	CASSQGEDSGGVADTQYF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	5	0	4	8	3	20	35	54	43	57	TCRBV05,TCRBV23													CASSQGEDSGGVADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTTATCCGGGACTTTGACCAATGAGCAGTTCTTCGGGCCA	CASSLSGTLTNEQFF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	10	6	3	5	18	33	42	36	47	TCRBV11,TCRBV23					01,02								CASSLSGTLTNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTATCCCGGGACAGGGTACGATACGCAGTATTTTGGCCCA	CASSYPGTGYDTQYF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	3	6	4	3	23	37	50	41	53	TCRBV06,TCRBV24													CASSYPGTGYDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATACAGGGGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	1.863382971785276E-4		37	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	1	6	4	0	24	36	-1	40	48		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGAGATAGCGGGTACAATTGAGCAGTTCTTCGGGCCA	CATSDEIAGTIEQFF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	5	4	9	5	6	24	38	50	43	56		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDEIAGTIEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTGGCTAGCGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	12	1.863382971785276E-4		38	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	4	6	4	4	0	26	38	-1	42	48		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATGTCCAGCACCGGACCCGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSANVQHRTRSGANVLTF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	54	TCRBV20						TCRBJ02	TCRBJ02-06	01	4	1	7	0	12	3	26	36	52	48	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSANVQHRTRSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20		TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ASGACTCSGCCSTGTATCTCTGTGCCAGCAGCACCCGGAGCGGAACCTACGAGCAGTACTTCGGGCCG	CASSTRSGTYEQYF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	6	5	2	6	2	20	32	43	38	45	TCRBV05,TCRBV07					01,02								CASSTRSGTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCAGTCAGGGGGTTACCAGCGGAATCAGCCCCAGCATTTTGGTGAT	CATSRDQSGGYQRNQPQHF	In	VDJ	6	255	0.003959688815043712	0.005521153596327892	57	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	1	4	5	10	18	35	47	40	57														CATSRDQSGGYQRNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGGGCCCTGTGAGGGACAGCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	4	144	0.0022360595661423312		61	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	0	5	0	11	1	18	35	53	46	54														X+TCRBV15-01+TCRBJ02-06	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAAATAGCGGGATGGGGCTCAATGAGCAGTTCTTCGGGCCA	CATSRNSGMGLNEQFF	In	VDJ	3	141	0.0021894749918476993	0.0030528731650283636	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	5	3	6	2	7	18	33	43	35	50														CATSRNSGMGLNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGCGACAGGGCGGTGGGAGACCCAGTACTTCGGGCCA	CATSATGRWETQYF	In	VDJ	3	127	0.0019720803118060837	0.0027497510067985968	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	3	5	2	6	18	30	39	32	45														CATSATGRWETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAGCCCGTTTTAAGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	116	0.0018012702060591003		47	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	5	7	4	0	10	18	-1	39	35	49						01,02								X+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTCTGGGCTACTTTATGGCTACACCTTCGGTTCG	CATSRDSGLLYGYTF	In	VDJ	2	73	0.0011335579745027097	0.0015805655393409258	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	8	0	5	4	5	18	35	43	39	48														CATSRDSGLLYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACTAGCGGGGGGGCCACAGATACGCAGTATTTTGGCCCA	CATSTSGGATDTQYF	In	VDJ	2	72	0.0011180297830711656	0.0015589139566102282	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	4	0	2	0	1	18	-1	43	31	44														CATSTSGGATDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCTAGGGGTGGAGACCCAGTACTTCGGGCCA	CATSRDLGVETQYF	In	VDJ	2	69	0.001071445208776534	0.0014939592084181354	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	5	2	5	3	2	18	35	43	38	45														CATSRDLGVETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACCGGGACAGGGGACTACGAGCAGTACTTCGGGCCG	CATSTGTGDYEQYF	In	VDJ	2	64	9.93804251618814E-4	0.0013857012947646474	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	3	2	1	18	31	43	33	44														CATSTGTGDYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGACCTACGGGGGGCGCGGGAAAAACTGTTTTTTGGCAGT	CATSRDLRGAREKLFF	In	VDJ	1	49	7.608813801456545E-4	0.001060927553804183	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	1	8	7	5	18	32	46	39	51														CATSRDLRGAREKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD02-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGACCCTACTCCTCGCAGGGGTTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	40	6.211276572617588E-4		55	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	2	1	12	1	18	33	51	45	52														X+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGCTGGATATCGGGGGCATTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	28	4.347893600832311E-4		47	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-07	01	5	6	0	1	8	3	18	30	44	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACGCAGCCATGTACCTGTGTGCCATCAGCAGGACGGGACGATGGGAGACCCAGTACTTCGGGCCA	CAISRTGRWETQYF	In	VDJ	1	21	3.2609202006242334E-4	4.546832373446499E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-05	01	3	0	7	5	3	5	18	32	40	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISRTGRWETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01		TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAAAGCCCGACAGAATGGCCTTTTGGGAGGGCCG		Out	VDJ	1	17	2.6397925433624744E-4		41	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	5	19	6	15	18	33	44	39	59														X+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGGACTATTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQDYYSNQPQHF	In	VDJ	111	4495	0.06979922048479013	0.09732386437448577	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	1	9	0	2	3	18	30	38	32	41						01,02								CASSQDYYSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATACTACGGGGCAGGGGCCCAGTACTTCGGGCCA	CASSLYYGAGAQYF	In	VDJ	11	459	0.007127439867078682	0.009938076473390204	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	2	9	10	0	18	33	-1	43	49														CASSLYYGAGAQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACGGGGTGACGCCGGGGAGCTGTTTTTTGGAGAA	CASSLRGDAGELFF	In	VDJ	11	441	0.00684793242131089	0.009548347984237648	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	8	3	6	0	5	18	-1	38	33	43														CASSLRGDAGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTACGGGTCTATGAACACTGAAGCTTTCTTTGGACAA	CASSFYGSMNTEAFF	In	VDJ	8	314	0.004875852109504806	0.006798596977439051	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	8	4	0	3	4	18	32	39	35	43						01,02								CASSFYGSMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGACACCACAGATACGCAGTATTTTGGCCCA	CASSLGDTTDTQYF	In	VDJ	6	261	0.0040528579636329755	0.005651063092712077	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	6	2	0	1	18	-1	40	34	41														CASSLGDTTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCACAGGGGGCACATTCACCCCTCCACTTTGGGAAC	CASSAQGAHSPLHF	In	VDJ	6	241	0.0037422941350020965	0.005218031438098125	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	0	8	2	2	18	30	41	32	43														CASSAQGAHSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCCCGATTCATGGGGCAATGAGCAGTTCTTCGGGCCA	CASSLPDSWGNEQFF	In	VDJ	3	124	0.001925495737511452	0.002684796258606504	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	3	6	2	6	11	0	18	32	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLPDSWGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGGTGCCCTCAATGAGCAGTTCTTCGGGCCA	CASSLGGALNEQFF	In	VDJ	3	118	0.0018323265889221881	0.0025548867622223184	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	1	6	2	6	0	6	18	-1	38	34	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGALNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGGGGACTAGCGGGAACTGGAGATACGCAGTATTTTGGCCCA	CASSLRGLAGTGDTQYF	In	VDJ	2	99	0.0015372909517228528	0.0021435066903390636	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	0	3	5	2	5	18	33	48	35	53														CASSLRGLAGTGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTAGACAGCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLDSANTGELFF	In	VDJ	2	98	0.001521762760291309	0.002121855107608366	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	6	6	0	1	0	18	35	-1	36	40						01,02								CASSLDSANTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACCTTGGCATTTTGGGCCCGTACGAGCAGTACTTCGGGCCG	CASSLDLGILGPYEQYF	In	VDJ	2	80	0.0012422553145235175	0.0017321266184558092	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	8	0	4	12	3	18	35	51	47	54														CASSLDLGILGPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAATTCGGGACAAGAGACCCAGTACTTCGGGCCA	CASSLNSGQETQYF	In	VDJ	2	78	0.0012111989316604295	0.0016888234529944138	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	8	3	2	4	0	18	33	-1	37	42														CASSLNSGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCAGGACAGGGGTCAATGAGCAGTTCTTCGGGCCA	CASSSRTGVNEQFF	In	VDJ	2	67	0.0010403888259134459	0.0014506560429567402	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	2	6	3	1	18	31	43	34	44														CASSSRTGVNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGAAACTACCGGGACTAGCGGGGGTCAAGAGACCCAGTACTTCGGGCCA	CASSETTGTSGGQETQYF	In	VDJ	2	66	0.001024860634481902	0.0014290044602260426	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	0	2	2	9	1	18	30	53	39	54														CASSETTGTSGGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTAGCGGGTTTAACACAGATACGCAGTATTTTGGCCCA	CASSLSGFNTDTQYF	In	VDJ	2	66	0.001024860634481902	0.0014290044602260426	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	4	2	2	5	18	30	39	32	44						01,02								CASSLSGFNTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGATGGACTAGCGGGGGAACAGATACGCAGTATTTTGGCCCA	CASRWTSGGTDTQYF	In	VDJ	2	64	9.93804251618814E-4	0.0013857012947646474	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	1	2	3	2	1	18	29	44	31	45														CASRWTSGGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACCGAGCGGATCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSHRADLAKNIQYF	In	VDJ	2	62	9.62747868755726E-4	0.001342398129303252	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	6	5	0	5	4	18	30	40	35	44						01,02								CASSHRADLAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01	TCRBJ02-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCGGAAGGGCGGGGTCGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	59	9.161632944610941E-4		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	7	3	2	8	2	18	32	46	40	48														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCAAATCGGGCGGCATGAAAGAGACCCAGTACTTCGGGCCA	CASTKSGGMKETQYF	In	VDJ	1	59	9.161632944610941E-4	0.0012774433811111592	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	7	8	0	3	7	7	18	28	39	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTKSGGMKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGGACACAGGGTCGGAAACCTTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	50	7.764095715771984E-4		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	3	3	0	4	11	18	27	37	31	48														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTTTTGACACAAATTAACTATGGCTACACCTTCGGTTCG	CASSLVLTQINYGYTF	In	VDJ	1	47	7.298249972825665E-4	0.0010176243883427878	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	6	1	6	5	18	32	42	38	47														CASSLVLTQINYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTACTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSSTSGSTDTQYF	In	VDJ	1	47	7.298249972825665E-4	0.0010176243883427878	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	3	4	0	2	0	18	31	-1	33	42						01,02								CASSSTSGSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGYCCAGGGACAGGGGGTTACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGTGGYSYNEQFF	In	VDJ	1	42	6.521840401248467E-4	9.093664746892998E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	1	0	3	3	18	30	44	33	47														CASSPGTGGYSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGGGGTTTTCCCGGGCCCCAACACGAACACTGAAGCTTTCTTTGGACAA	CASSLGVFPGPNTNTEAFF	In	VDJ	1	39	6.055994658302147E-4	8.444117264972069E-4	57	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	1	8	0	1	10	8	18	34	48	44	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGVFPGPNTNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGACTAGCGGGAAACACAGATACGCAGTATTTTGGCCCA	CASSSGLAGNTDTQYF	In	VDJ	1	39	6.055994658302147E-4	8.444117264972069E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	0	3	2	1	2	18	31	45	32	47														CASSSGLAGNTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAACAGCCGACCACCACAGGGGTTAGCCAAAAACATTCAGTACTTCGGCGCC	CANSRPPQGLAKNIQYF	In	VDJ	1	39	6.055994658302147E-4	8.444117264972069E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	3	2	0	8	2	18	30	45	38	47														CANSRPPQGLAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAACCGTCGACCGGGATCCCATGCAAGAGACCCAGTACTTCGGGCCA	CASSQTVDRDPMQETQYF	In	VDJ	1	35	5.434867001040389E-4	7.578053955744165E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	8	3	2	12	7	18	30	47	42	54														CASSQTVDRDPMQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGGACTAGCGGGGGCGTTACGCAGTATTTTGGCCCA	CASSPGTSGGVTQYF	In	VDJ	1	34	5.279585086724949E-4	7.361538128437189E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	0	2	8	3	3	18	30	47	33	50														CASSPGTSGGVTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCGAGGGGGCTATGCAGATACGCAGTATTTTGGCCCA	CASSLRGGYADTQYF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	5	0	4	3	4	18	32	42	35	46														CASSLRGGYADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGCTTTACGGGGACGGAGACCCAGTACTTCGGGCCA	CASSLSFTGTETQYF	In	VDJ	1	29	4.503175515147751E-4	6.278958991902308E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	3	0	7	5	10	1	18	32	47	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSFTGTETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAACAGGGGGAGTTTGGGAAAAATTGTTTTTTGGCAGT	CASSSTGGVWEKLFF	In	VDJ	1	29	4.503175515147751E-4	6.278958991902308E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	1	15	2	14	18	31	41	33	55														CASSSTGGVWEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACCTCTTTGCGGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	28	4.347893600832311E-4		49	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	7	4	0	7	0	18	35	-1	42	47						01,02								X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAATACAGTCGACCAGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	27	4.1926116865168716E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	5	4	2	15	18	28	34	30	49														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGGGAGCCCCATCACGTTACAAGAGACCCAGTACTTCGGGCCA	CASSPGSPITLQETQYF	In	VDJ	1	25	3.882047857885992E-4	5.412895682674404E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	4	3	2	1	15	18	30	36	31	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGSPITLQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACAGGGATTTGAAGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLGQGFEGSGANVLTF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	57	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	0	3	0	0	9	18	-1	41	32	50														CASSLGQGFEGSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTTATTACCCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	23	3.5714840292551126E-4		52	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	3	6	5	10	5	18	32	45	42	50														X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATACGGGACAGTCACTGAAGCTTTCTTTGGACAA	CASSLYGTVTEAFF	In	VDJ	1	23	3.5714840292551126E-4	4.979864028060451E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	5	4	3	1	18	33	43	36	44														CASSLYGTVTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCGATCCGGGACGGGAAAAGAGACCCAGTACTTCGGGCCA	CASSFRSGTGKETQYF	In	VDJ	1	22	3.416202114939673E-4	4.763348200753475E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	3	0	7	3	7	5	18	32	44	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRSGTGKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTGGAGGGGCGAGGAGATACGCAGTATTTTGGCCCA	CASSLLEGRGDTQYF	In	VDJ	1	22	3.416202114939673E-4	4.763348200753475E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	10	0	5	2	6	18	33	41	35	47														CASSLLEGRGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTGAGAGTAGCGGGAGGAGAAGTCTCACAGATACGCAGTATTTTGGCCCA	CASSESSGRRSLTDTQYF	In	VDJ	1	21	3.2609202006242334E-4	4.546832373446499E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	5	1	2	6	8	18	29	45	35	53														CASSESSGRRSLTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAAGCGGGGGGGCCTCTACAATGAGCAGTTCTTCGGGCCA	CASSLKRGGLYNEQFF	In	VDJ	1	21	3.2609202006242334E-4	4.546832373446499E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	6	0	3	1	3	18	33	44	34	47														CASSLKRGGLYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGACCCTTGGGGGAAGTCCACAGATACGCAGTATTTTGGCCCA	CASSSDPWGKSTDTQYF	In	VDJ	1	21	3.2609202006242334E-4	4.546832373446499E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	0	6	1	2	5	5	18	35	45	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSDPWGKSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTAATCGGTGTTAATGAGCAGTTCTTCGGGCCA	CASSLVIGVNEQFF	In	VDJ	1	20	3.105638286308794E-4	4.330316546139523E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	8	5	7	4	4	18	34	41	38	45						01,02								CASSLVIGVNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTACTAGCAGCTTGGGGACTAGCGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CTSSLGTSGGQETQYF	In	VDJ	1	20	3.105638286308794E-4	4.330316546139523E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	0	2	1	1	0	18	32	-1	33	47														CTSSLGTSGGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCCTAGACAGGGGGAATTACGAGCAGTACTTCGGGCCG	CASSLDRGNYEQYF	In	VDJ	1	19	2.950356371993354E-4	4.1138007188325465E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	1	4	0	3	18	-1	42	35	45														CASSLDRGNYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGTTGGGGCCCAGAGGCCATTCAGTACTTCGGCGCC	CASSLGWGPEAIQYF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	7	0	9	5	8	18	32	42	37	50														CASSLGWGPEAIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGATGGTGGGGCCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	2.6397925433624744E-4		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	7	0	3	6	2	18	32	43	38	45														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGAAGTGGGACAGGGGGCGAAGGCTACACCTTCGGTTCG	CASSSRSGTGGEGYTF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	0	8	8	3	18	31	51	39	54														CASSSRSGTGGEGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAACGCGACCCGGGACAGGGTGGCGGCTACACCTTCGGTTCG	CASSKRDPGQGGGYTF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	8	11	4	18	30	50	41	54														CASSKRDPGQGGGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGGAAGGCCTCCCTTCCTACGAGCAGTACTTCGGGCCG	CASREGLPSYEQYF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	6	1	8	1	0	10	18	-1	32	29	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASREGLPSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGCTTGGGGGCGGCGGAACTGAAGCTTTCTTTGGACAA	CASSLELGGGGTEAFF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	6	0	5	4	6	18	35	45	39	51														CASSLELGGGGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTATCGACAGGGTATGACACTGAAGCTTTCTTTGGACAA	CASSLSTGYDTEAFF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	3	5	4	18	30	42	35	46														CASSLSTGYDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCACGGGAGGGGGCAACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	2.3292287147315952E-4		46	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	0	2	4	5	18	30	42	34	47														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGAGGACAGGGGGCTGGGCCCAAAAGCTTTCTTTGGACAA		Out	VDJ	1	15	2.3292287147315952E-4		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	0	9	1	9	18	29	41	30	50														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACCCCGAACACTGAAGCTTTCTTTGGACAA	CASSLGTPNTEAFF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	1	1	7	1	0	3	18	-1	38	34	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGTPNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTCCGAGGCAGAAGCTAACTATGGCTACACCTTCGGTTCG	CASSSEAEANYGYTF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	11	1	0	2	6	18	31	37	33	43														CASSSEAEANYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCAGGGGGCTCATTCACCCCTCCACTTTGGGAAC	CASSFQGAHSPLHF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	4	0	8	1	2	18	32	41	33	43														CASSFQGAHSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGCTGCTAATGGGACAGGGGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	13	2.0186648861007157E-4		53	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	1	4	10	0	18	31	-1	41	52														X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGAGGTGCAGGGGGATTGGGGCGAGCAGTACTTCGGGCCG	CASSPEVQGDWGEQYF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	1	6	9	7	18	30	46	39	53														CASSPEVQGDWGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACAATTGGGGGGCGGGTCAGCCCCAGCATTTTGGTGAT	CASSHNWGAGQPQHF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	5	6	0	6	8	3	18	30	44	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHNWGAGQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCYTAGTATCGCGACGGCAAGAGACCCAGTACTTCGGGCCA	CASSLVSRRQETQYF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	1	2	7	2	6	2	18	34	43	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVSRRQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCGAACCCGGGACCGCGTATGGCTACACCTTCGGTTCG		Out	VDJ	1	12	1.863382971785276E-4		43	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	5	0	7	5	7	4	18	30	42	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCGGGACTTACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGLTNTGELFF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	10	0	2	2	18	30	38	32	40						01,02								CASSPGLTNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCCGGGACAGGGGCCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	26	1060	0.016459882917436604		47	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	2	3	2	26	38	51	41	53														X+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTCGTTGACGGGGGTGGGACGGTCTATATGGCTACACCTTCGGTTCG		Out	VDJ	7	301	0.004673985620894734		52	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	8	2	5	6	12	26	39	51	45	63														X+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD02-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTGGCCCCCTACAGGGGGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	5	186	0.002888243606267178		47	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	1	3	8	2	26	39	55	47	57														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTTCCTGGCGTGCCCTGAAGCTTTCTTTGGACAA	CASGLFLACPEAFF	In	VDJ	4	148	0.0022981723318685073	0.0032044342441432468	42	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-01	01	2	9	0	6	5	5	26	41	49	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLFLACPEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGACCCGACAGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	78	0.0012111989316604295		37	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	4	3	4	0	26	37	-1	41	47														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCACGAGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	36	5.590148915355828E-4		35	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	11	2	1	3	0	26	37	-1	40	43														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACATGGACCTTTAATATCGATGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	24	3.726765943570552E-4		44	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	12	1	7	9	8	14	26	31	43	39	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGAGCCAAGAGACCCAGTACTTCGGGCCA	CASGLSQETQYF	In	VDJ	1	22	3.416202114939673E-4	4.763348200753475E-4	36	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-05	01	2	5	5	1	0	0	26	-1	-1	41	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLSQETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01		TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCCGGCCCTTAAAGGACAGGGTGGGTGGCCTAGCAGTTCTTCGGGCCA		Out	VDJ	1	18	2.795074457677914E-4		49	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	12	1	3	11	15	10	26	31	54	46	64														X+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGCCACCGGGACAGGGAACAATGAGCAGTTCTTCGGGCCA	CASGLATGTGNNEQFF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	48	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	0	3	5	5	1	26	42	56	47	57														CASGLATGTGNNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCAGTTGAGCCCCAGGGCGGAAGAGACCCAGTACTTCGGGCCA	CASGQLSPRAEETQYF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	48	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	3	3	11	3	26	38	54	49	57														CASGQLSPRAEETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAGCAGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	41	6.366558486933027E-4		41	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-02	01	2	2	7	4	7	0	20	35	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGAGGGTACAAGAGACCCAGTACTTCGGGCCA	CASSQSRVQETQYF	In	VDJ	1	36	5.590148915355828E-4	7.794569783051141E-4	42	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	11	0	2	0	2	20	-1	42	37	44														CASSQSRVQETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGACAGGGACAGGGCGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	26	4.0373297722014315E-4		49	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	3	4	4	3	20	37	50	41	53														X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCACAAAGATAGGGGGGGAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	24	3.726765943570552E-4		47	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	3	9	0	7	8	0	20	34	-1	42	49														X+TCRBV23-01+TCRBJ01-06	TCRBV23-01*01	TCRBD02-01*01	TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTCGACAATCAAGAGACCCAGTACTTCGGGCCA	CASSFDNQETQYF	In	VDJ	1	20	3.105638286308794E-4	4.330316546139523E-4	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	6	2	4	2	20	31	39	35	41														CASSFDNQETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAAGGGGTCCGGGCGGTTCCACAGATACGCAGTATTTTGGCCCA	CASSQRGPGGSTDTQYF	In	VDJ	1	19	2.950356371993354E-4	4.1138007188325465E-4	51	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	5	2	2	0	12	20	-1	40	35	52														CASSQRGPGGSTDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGTAGAGACAGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	18	2.795074457677914E-4		46	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	2	5	1	5	0	20	37	-1	42	47														X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGACACGGCACTGTATCTCTGCGCCAGCCCCCTAAGGACAGGGAAGTACGAGCAGTACTTCGGGCCG	CASPLRTGKYEQYF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	1	3	4	7	3	20	29	44	36	47														CASPLRTGKYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTTCGTGTGGGGGGGCGTTTAAATGAGCAGTTCTTCGGGCCA	CASSFRVGGRLNEQFF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	9	0	7	9	6	20	31	47	40	53														CASSFRVGGRLNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGAGGCGGAAGGTCCCTCTGGAAACACCATATATTTTGGAGAG	CASSQEAEGPSGNTIYF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	51	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	2	7	5	0	3	7	20	35	42	38	49						01,02								CASSQEAEGPSGNTIYF+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01	TCRBD02-01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTGGAGCAGGGGGCCCGCACAGATACGCAGTATTTTGGCCCA	CASSLEQGARTDTQYF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	48	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	0	1	7	2	20	31	46	38	48														CASSLEQGARTDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTTATGCCGGGGCCCACAGATACGCAGTATTTTGGCCCA	CASSFMPGPTDTQYF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	45	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-03	01	6	7	0	2	9	1	20	31	45	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFMPGPTDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATATATCCAGGGGTATGGCTACACCTTCGGTTCG	CASSQYIQGYGYTF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	2	5	5	0	20	36	-1	41	47														CASSQYIQGYGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGGGGATGAGCAGTTCTTCGGGCCA	CASSYSGDEQFF	In	VDJ	61	2469	0.03833910464448206	0.05345775776209241	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	3	8	0	0	23	-1	-1	40	45														CASSYSGDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGTCGGGGGGAGGCGTGAACACTGAAGCTTTCTTTGGACAA	CASSYGSGGGVNTEAFF	In	VDJ	39	1573	0.02442584512181866	0.03405793963538735	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	1	0	4	5	23	38	49	42	54														CASSYGSGGGVNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTACCGGGACGGCCTCTGAAGCTTTCTTTGGACAA	CASSYSTGTASEAFF	In	VDJ	28	1131	0.01756238450907623	0.024487940068419003	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	0	7	6	4	5	23	40	49	44	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSTGTASEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCATTTAAGGGGCTAGCTTCGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	8	330	0.00512430317240951		47	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	5	2	3	6	9	23	34	45	40	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACTGGTACAGGGGACAGCAATCAGCCCCAGCATTTTGGTGAT	CATGTGDSNQPQHF	In	VDJ	7	278	0.004316837217969223	0.006019139999133937	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	3	2	1	5	2	23	30	42	35	44														CATGTGDSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGAATATCAAATGAAAAACTGTTTTTTGGCAGT	CASSYGISNEKLFF	In	VDJ	4	174	0.0027019053090886506	0.0037673753951413848	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	2	1	8	5	0	6	23	-1	41	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGISNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTATCCGGGGGGTAGGGATACGCAGTATTTTGGCCCA	CASSYYPGGRDTQYF	In	VDJ	3	138	0.002142890417553068	0.002987918416836271	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	8	1	6	3	4	23	39	49	42	53														CASSYYPGGRDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAGACCCGGGGGACTACAATGAGCAGTTCTTCGGGCCA	CASSYSDPGDYNEQFF	In	VDJ	3	134	0.0020807776518268917	0.0029013120859134804	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	2	3	5	1	23	40	51	45	52														CASSYSDPGDYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTTCCCAGGGGGTTAACTATGGCTACACCTTCGGTTCG	CASSFSQGVNYGYTF	In	VDJ	3	120	0.0018633829717852762	0.0025981899276837136	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	1	1	5	1	23	36	48	41	49														CASSFSQGVNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGCTCCACTGAAGCTTTCTTTGGACAA	CASSYGSTEAFF	In	VDJ	2	95	0.001475178185996677	0.002056900359416273	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	9	0	4	0	2	23	-1	41	38	43														CASSYGSTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGTGGCCCCATGGAGACCCAGTACTTCGGGCCA	CASSRGPMETQYF	In	VDJ	2	85	0.0013198962716812373	0.0018403845321092972	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	9	0	5	4	6	23	34	41	38	47														CASSRGPMETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGACACCACCTGGAGAGAAAAACTGTTTTTTGGCAGT	CASSDTTWREKLFF	In	VDJ	2	66	0.001024860634481902	0.0014290044602260426	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	6	2	6	8	1	11	23	34	39	35	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDTTWREKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGGAGGGTTGGCTAACTATGGCTACACCTTCGGTTCG	CASSEGGLANYGYTF	In	VDJ	1	59	9.161632944610941E-4	0.0012774433811111592	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	9	0	0	2	4	23	35	44	37	48														CASSEGGLANYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCGAACCTACACAGATACGCAGTATTTTGGCCCA	CASSYSRTYTDTQYF	In	VDJ	1	51	7.919377630087424E-4	0.0011042307192655784	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	9	2	6	0	23	40	-1	46	49						01,02								CASSYSRTYTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCTAACCCCCTTAACGAGCAGTACTTCGGGCCG	CASSYPNPLNEQYF	In	VDJ	1	49	7.608813801456545E-4	0.001060927553804183	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	9	5	1	9	23	38	42	39	51						01,02								CASSYPNPLNEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATAAAGTGGGGGGGATGACGGATGAAAAACTGTTTTTTGGCAGT	CASSDKVGGMTDEKLFF	In	VDJ	1	49	7.608813801456545E-4	0.001060927553804183	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	9	0	6	8	7	23	35	50	43	57														CASSDKVGGMTDEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATTCGGGGCGGGGCGGTACGCAGTATTTTGGCCCA	CASNSGRGGTQYF	In	VDJ	1	48	7.453531887141105E-4	0.0010392759710734854	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	7	3	8	7	3	23	33	46	40	49														CASNSGRGGTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGGGGGACATTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	47	7.298249972825665E-4		44	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	0	6	1	3	2	23	38	47	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCAGGGGGAACCGCCGGGGCCAACGTCCTGACTTTCGGGGCC	CASRPGGTAGANVLTF	In	VDJ	1	45	6.987686144194785E-4	9.743212228813926E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	4	1	4	2	7	23	34	43	36	50														CASRPGGTAGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACAGGCGGGCAGCCCCAGCATTTTGGTGAT	CASSYSTGGQPQHF	In	VDJ	1	43	6.677122315563906E-4	9.310180574199974E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	2	4	7	0	4	23	-1	46	40	50														CASSYSTGGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAATTCCACCGGGACAGGTAGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	41	6.366558486933027E-4		53	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	4	3	8	3	23	37	53	45	56														X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGCGGGGCCAGATACGCAGTATTTTGGCCCA	CASRAGPDTQYF	In	VDJ	1	41	6.366558486933027E-4	8.877148919586022E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	7	3	4	1	1	23	34	41	35	42														CASRAGPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGACTGGGACAACTAACTATGGCTACACCTTCGGTTCG	CASSETGTTNYGYTF	In	VDJ	1	40	6.211276572617588E-4	8.660633092279046E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	6	0	6	1	23	35	47	41	48														CASSETGTTNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTTCAACCGGGACAGTAAATATGGCTACACCTTCGGTTCG	CASRFNRDSKYGYTF	In	VDJ	1	40	6.211276572617588E-4	8.660633092279046E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	5	8	4	23	34	49	42	53														CASRFNRDSKYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGCCGTCGGGGGGGGCTACACCTTCGGTTCG	CASSYSAVGGGYTF	In	VDJ	1	37	5.745430829671268E-4	8.011085610358117E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	8	1	8	6	0	23	40	-1	46	53														CASSYSAVGGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGGGACATAGGCCCTTCGTCCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	37	5.745430829671268E-4		52	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	6	4	1	14	23	38	45	39	59														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGCCACCGGGCAGGGGAAGGCTACACCTTCGGTTCG	CASRHRAGEGYTF	In	VDJ	1	36	5.590148915355828E-4	7.794569783051141E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	4	2	8	10	2	23	32	48	42	50														CASRHRAGEGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCGGTGGGACAGGGGTTTTTGGCTACACCTTCGGTTCG	CASSTGGTGVFGYTF	In	VDJ	1	36	5.590148915355828E-4	7.794569783051141E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	2	7	6	4	23	35	51	41	55														CASSTGGTGVFGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATTGTCAGGGGGCGTGTGAGCAGTACTTCGGGCCG	CASSYCQGACEQYF	In	VDJ	1	35	5.434867001040389E-4	7.578053955744165E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	0	7	4	4	23	37	49	41	53														CASSYCQGACEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGATTAGCGGGGGGGTCGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	34	5.279585086724949E-4		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	5	0	5	6	2	23	35	52	41	54														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACAGGGAATTCACCCCTCCACTTTGGGAAC	CASSYTGNSPLHF	In	VDJ	1	33	5.12430317240951E-4	7.145022301130213E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	3	3	7	0	0	23	-1	-1	38	44														CASSYTGNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTAGAAGGACAGGGGGTACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	33	5.12430317240951E-4		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	1	5	4	1	23	39	53	43	54														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCAGGGTCCGGCTACACCTTCGGTTCG	CASSYAGSGYTF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	8	1	3	23	38	44	39	47														CASSYAGSGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCCTCCCTCCGGGAGGGGCACTGAAGCTTTCTTTGGACAA	CASSDPPSGRGTEAFF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	0	4	11	1	23	35	54	46	55														CASSDPPSGRGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTCCAGCCGGGACTAGCTTTCATTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	31	4.81373934377863E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	7	9	8	6	23	34	51	42	57						01,02								X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGGCTTTGCCGGGCCCAAAGGGACCTGGGGAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	30	4.6584574294631904E-4		55	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	9	0	7	2	17	7	23	31	53	48	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTGAGACTCAATACGCAGTATTTTGGCCCA	CASSVRLNTQYF	In	VDJ	1	27	4.1926116865168716E-4	5.845927337288356E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	10	7	4	2	23	35	43	39	45						01,02								CASSVRLNTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCCATATCAGGGGGCCGATGAGCAGTTCTTCGGGCCA	CASSSPYQGADEQFF	In	VDJ	1	26	4.0373297722014315E-4	5.62941150998138E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	0	8	8	2	23	36	52	44	54														CASSSPYQGADEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGACAGGGGGGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLTGGDSNQPQHF	In	VDJ	1	25	3.882047857885992E-4	5.412895682674404E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	1	0	1	3	23	36	46	37	49														CASSLTGGDSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCTTAGCGGGGGGGCCTCGGGAGACCCAGTACTTCGGGCCA	CASTLAGGPRETQYF	In	VDJ	1	25	3.882047857885992E-4	5.412895682674404E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	5	0	5	3	6	23	33	47	36	53														CASTLAGGPRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATACAGGGGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAIQGAGANVLTF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	10	3	1	2	1	0	23	30	-1	31	39														CAIQGAGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGGTTATGGCTACACCTTCGGTTCG	CASSYSGYGYTF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	8	5	5	0	1	23	-1	43	40	44						01,02								CASSYSGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGACAGGGGGCTTCGAGCAGTACTTCGGGCCG	CASSYGTGGFEQYF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	0	6	0	2	23	-1	50	38	52														CASSYGTGGFEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACTACAGGGTGATGAAGCTTTCTTTGGACAA	CASRLQGDEAFF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	7	3	3	23	34	43	37	46														CASRLQGDEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCTTTCCGCGGCCGGGGAGCTGTTTTTTGGAGAA	CASTLSAAGELFF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	7	5	6	8	0	23	33	-1	41	45						01,02								CASTLSAAGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCACAGGGGGCGGCTATGGCTACACCTTCGGTTCG	CASTTGGGYGYTF	In	VDJ	1	24	3.726765943570552E-4	5.196379855367427E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	0	4	2	2	23	33	44	35	46														CASTTGGGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTTACCGGGACGGCCTCTGAAGCTTTTTTTGGACAA	CASSYFTGTASEAFF	In	VDJ	1	23	3.5714840292551126E-4	4.979864028060451E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	1	0	7	17	5	16	23	39	49	44	65				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYFTGTASEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTGGATCCCCGACTCAGTGAGCAGTTCTTCGGGCCA	CASSYLDPRLSEQFF	In	VDJ	1	23	3.5714840292551126E-4	4.979864028060451E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	2	10	9	10	3	23	38	52	48	55						01,02								CASSYLDPRLSEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAACTGAAAACGCCGGGACAGGGGTCTAATGAGCAGTTCTTCGGGCCA	CASS*LKTPGQGSNEQFF	Stop	VDJ	1	23	3.5714840292551126E-4		54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	2	7	12	3	23	37	59	49	62														CASS*LKTPGQGSNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTATAGGAAAGGGCGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	22	3.416202114939673E-4		44	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	5	5	3	1	7	2	23	35	46	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGAATGCGGAAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSENAESSYNEQFF	In	VDJ	1	20	3.105638286308794E-4	4.330316546139523E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	7	5	0	6	4	23	35	45	41	49						01,02								CASSENAESSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGGGGGGGACAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	3.105638286308794E-4		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	0	0	0	5	23	-1	43	35	48														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCAGGGACGGCCTCGTTAATTCACCCCTCCACTTTGGGAAC	CASTRDGLVNSPLHF	In	VDJ	1	20	3.105638286308794E-4	4.330316546139523E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	7	0	7	6	3	8	23	33	41	36	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTRDGLVNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGTCTAGGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	19	2.950356371993354E-4		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	4	8	1	3	1	23	40	47	43	48						01,02								X+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01	TCRBJ02-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCGACTCCGGGACAGGGGAACTATGGCTACACCTTCGGTTCG	CASRPTPGQGNYGYTF	In	VDJ	1	19	2.950356371993354E-4	4.1138007188325465E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	2	2	9	0	23	34	-1	43	53														CASRPTPGQGNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTTGGACTAGCGGGGGATACAATGAGCAGTTCTTCGGGCCA	CASSSWTSGGYNEQFF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	1	2	4	3	1	23	36	52	39	53														CASSSWTSGGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACTCAATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	18	2.795074457677914E-4		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	2	10	0	0	3	23	-1	44	40	47						01,02								X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTATTCTAGCGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASYSSGGQETQYF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	8	4	2	1	4	0	23	32	-1	36	46														CASYSSGGQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAGGTTAATGAAAAACTGTTTTTTGGCAGT	CASSYQVNEKLFF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	4	4	0	1	23	-1	42	38	43														CASSYQVNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSYRDTGELFF	In	VDJ	1	16	2.484510629047035E-4	3.4642532369116185E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	11	2	3	1	0	23	38	-1	39	42														CASSYRDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGAGACCACAAGAGACCCAGTACTTCGGGCCA	CASGRPQETQYF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	8	9	2	2	0	4	23	-1	37	32	41														CASGRPQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCCGGACTAGCGGGGGGGCTGGATCCTACGAGCAGTACTTCGGGCCG	CASSFRTSGGAGSYEQYF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	1	0	1	3	5	23	36	54	39	59														CASSFRTSGGAGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGGAGCCTTTACTAACTATGGCTACACCTTCGGTTCG	CASSYSGAFTNYGYTF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	10	2	0	1	6	23	40	45	41	51														CASSYSGAFTNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGTTGGGCTGGGAAACTATGGCTACACCTTCGGTTCG	CASRVGLGNYGYTF	In	VDJ	1	14	2.1739468004161556E-4	3.031221582297666E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	6	0	8	2	9	0	23	34	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRVGLGNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGACGACAGGGTCGGAGACCCAGTACTTCGGGCCA	CASRTTGSETQYF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	3	5	3	3	23	34	44	37	47														CASRTTGSETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGGACGGATTATAAATGGCTACACCTTCGGTTCG	CASSGRIINGYTF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	6	1	7	6	1	9	23	34	39	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGRIINGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGAATTAAGGACAGGGAATTCACCCCTCCACTTTGGGAAC	CASTELRTGNSPLHF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	1	3	7	9	0	23	33	-1	42	50														CASTELRTGNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGAACAGGGGCCGCCACTGAAGCTTTCTTTGGACAA	CAIRTGAATEAFF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	4	1	4	23	34	42	35	46														CAIRTGAATEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACACTGGGGTAGGGTACGATACGCAGTATTTTGGCCCA		Out	VDJ	1	12	1.863382971785276E-4		38	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	10	5	3	6	9	3	23	30	43	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGATACAGGGAGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	5	215	0.003338561157781953		43	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	9	0	7	6	0	24	39	-1	45	52													Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGGCACAGGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSGTGGSTDTQYF	In	VDJ	3	109	0.0016925728660382926	0.00236002251764604	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	1	0	3	1	24	36	47	39	48													Vb 18	CASSGTGGSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGGACGACGGGGGGATCTACAATGAGCAGTTCTTCGGGCCA	CASSDDGGIYNEQFF	In	VDJ	3	107	0.0016615164831752045	0.002316719352184645	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	1	3	6	2	24	35	48	41	50													Vb 18	CASSDDGGIYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCCTAAGGACAGGAACGTCCAGTGAGCAGTTCTTCGGGCCA	CASSPPLRTGTSSEQFF	In	VDJ	2	77	0.0011956707402288856	0.0016671718702637162	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	4	9	5	9	24	41	53	46	62													Vb 18	CASSPPLRTGTSSEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGACCATCAGGGGCATATACCCTAACAAGAGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	70	0.0010869734002080778		61	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	2	7	8	18	20	34	48	42	66													Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCACCCCCCAGGGGGAACTATGGTTACACCTTCGGTTCG	CASSSPPRGNYGYTF	In	VDJ	2	65	0.0010093324430503578	0.001407352877495345	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	1	11	3	9	24	41	51	44	60													Vb 18	CASSSPPRGNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCGTAGGATCGGGGGAAAAACTGTTTTTTGGCAGT	CASSVGSGEKLFF	In	VDJ	1	55	8.540505287349182E-4	0.0011908370501883688	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	8	3	8	8	0	24	35	-1	43	48													Vb 18	CASSVGSGEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTTCCCTGCCAATGAGCAGTTCTTCGGGCCA	CASSPFPANEQFF	In	VDJ	1	53	8.229941458718303E-4	0.0011475338847269736	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	3	10	0	6	7	0	24	38	-1	45	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPFPANEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGTCAACAGGGTTAATGAAAAACTGTTTTTTGGCAGT	CASSPVNRVNEKLFF	In	VDJ	1	53	8.229941458718303E-4	0.0011475338847269736	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	3	3	4	4	1	24	39	49	43	50													Vb 18	CASSPVNRVNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGTGGACAGAGCCTACGAGCAGTACTTCGGGCCG	CASSPVDRAYEQYF	In	VDJ	1	52	8.074659544402863E-4	0.001125882301996276	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	5	2	3	2	24	38	47	41	49													Vb 18	CASSPVDRAYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGGGGAGTCATGAACACTGAAGCTTTCTTTGGACAA	CASSPRGVMNTEAFF	In	VDJ	1	49	7.608813801456545E-4	0.001060927553804183	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	2	5	2	0	0	5	24	-1	44	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRGVMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGAACCTTCAGGGGGTCGACGAGCAGTACTTCGGGCCG	CASSNLQGVDEQYF	In	VDJ	1	48	7.453531887141105E-4	0.0010392759710734854	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	1	5	7	3	24	35	49	42	52													Vb 18	CASSNLQGVDEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGGGGGCCGGCGAGCAGTACTTCGGGCCG	CASSRGAGEQYF	In	VDJ	1	48	7.453531887141105E-4	0.0010392759710734854	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	4	6	0	6	1	3	24	37	44	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSRGAGEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCTCGACCTATGGAGATACGCAGTATTTTGGCCCA	CASSPSTYGDTQYF	In	VDJ	1	47	7.298249972825665E-4	0.0010176243883427878	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	3	2	7	5	3	6	24	38	44	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPSTYGDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCTCGGTTAATACCGGGGAGCTGTTTTTTGGAGAA	CASSPPSVNTGELFF	In	VDJ	1	40	6.211276572617588E-4	8.660633092279046E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	8	5	5	2	5	24	41	46	43	51						01,02							Vb 18	CASSPPSVNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCGGGACAGTTATCAGCCCCAGCATTTTGGTGAT	CASSRDSYQPQHF	In	VDJ	1	39	6.055994658302147E-4	8.444117264972069E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	5	5	2	2	24	35	44	37	46													Vb 18	CASSRDSYQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGGGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSRGANTEAFF	In	VDJ	1	38	5.900712743986708E-4	8.227601437665093E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	4	6	0	1	1	0	24	37	-1	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSRGANTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGCCTCTACAGGGCAACAAGAGACCCAGTACTTCGGGCCA	CASSASTGQQETQYF	In	VDJ	1	33	5.12430317240951E-4	7.145022301130213E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	3	2	6	3	24	36	48	42	51													Vb 18	CASSASTGQQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCGGACAGGGGTAGACGAGCAGTACTTCGGGCCG	CASSRTGVDEQYF	In	VDJ	1	31	4.81373934377863E-4	6.71199064651626E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	2	5	2	3	24	35	46	37	49													Vb 18	CASSRTGVDEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGGCGACAGGGGTCGACGAGCAGTACTTCGGGCCG	CASSATGVDEQYF	In	VDJ	1	30	4.6584574294631904E-4	6.495474819209284E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	2	5	3	3	24	35	46	38	49													Vb 18	CASSATGVDEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGCACAGGGGCCTATGGCTACACCTTCGGTTCG	CASSPGTGAYGYTF	In	VDJ	1	29	4.503175515147751E-4	6.278958991902308E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	2	4	4	1	24	38	49	42	50													Vb 18	CASSPGTGAYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACATCCTGACAGGGGGCGAAGACACGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	4.1926116865168716E-4		49	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	0	5	7	6	24	36	53	43	59													Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTGGGACAGAATGCCCGGGGAGCTGTTTTTTGGAGAA	CASWDRMPGELFF	In	VDJ	1	23	3.5714840292551126E-4	4.979864028060451E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	0	5	6	0	5	24	-1	41	34	46													Vb 18	CASWDRMPGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCCCCGCGGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSPAPRGAYEQYF	In	VDJ	1	23	3.5714840292551126E-4	4.979864028060451E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	7	1	2	5	0	24	39	-1	44	52													Vb 18	CASSPAPRGAYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTGGGACAGGGGTTTCCGAGCAGTACTTCGGGCCG	CASSGTGVSEQYF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	2	6	1	4	24	35	46	36	50													Vb 18	CASSGTGVSEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCACAGGGACCGCCTGGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	2.795074457677914E-4		35	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	3	3	7	0	8	24	-1	39	33	47													Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGAACAGCTCTGGAAACACCATATATTTTGGAGAG	CASSPNSSGNTIYF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	3	5	0	2	0	24	38	-1	40	44													Vb 18	CASSPNSSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCATCAAGCTCTGGAAACACCATATATTTTGGAGAG	CASSPSSSSGNTIYF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	2	4	6	0	1	5	24	39	42	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPSSSSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGAGCCCTAGGGGAGACCCAGTACTTCGGGCCA	CASSPGALGETQYF	In	VDJ	1	15	2.3292287147315952E-4	3.247737409604642E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	2	5	3	5	8	0	24	39	-1	47	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGALGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGAGGAGGAGCGGGGTACTACGAGCAGTACTTCGGGCCG	CASSEGGGAGYYEQYF	In	VDJ	16	644	0.010000155281914315	0.013943619278569264	48	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	6	3	3	7	2	23	39	53	46	55														CASSEGGGAGYYEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01	TCRBD02-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAAGGCCGGGGATACACGCAGTATTTTGGCCCA	CASSEGRGYTQYF	In	VDJ	2	61	9.472196773241821E-4	0.0013207465465725544	39	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	8	3	9	2	4	23	39	46	41	50														CASSEGRGYTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGGACAGCTCCTACGAGCAGTACTTCGGGCCG	CASSEGDSSYEQYF	In	VDJ	1	30	4.6584574294631904E-4	6.495474819209284E-4	42	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	5	0	0	0	23	-1	-1	39	46														CASSEGDSSYEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGGTTAATGAAAAACTGTTTTTTGGCAGT	CASSEGVNEKLFF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	39	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-04	01	1	0	9	4	0	1	23	-1	42	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGVNEKLFF+TCRBV06-01+TCRBJ01-04	TCRBV06-01*01		TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGCAGGGGAAATGGAAATACCATATATTTTGGAGAG	CASSEGRGNGNTIYF	In	VDJ	1	17	2.6397925433624744E-4	3.6807690642185945E-4	45	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	4	2	10	1	10	23	39	46	40	56														CASSEGRGNGNTIYF+TCRBV06-01+TCRBJ01-03	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTCCGCCACAGGGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSATGSNTGELFF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	48	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	3	0	5	1	22	35	46	40	47														CASSSATGSNTGELFF+TCRBV07-04+TCRBJ02-02	TCRBV07-04*01	TCRBD01-01*01	TCRBJ02-02*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTTCTTGAACACTGAAGCTTTCTTTGGACAA	CAWFLNTEAFF	In	VDJ	5	204	0.0031677510520349695	0.004416922877062314	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	4	10	0	2	0	26	35	-1	37	39			unresolved			01,02							Vb 20	CAWFLNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGAGCGTTTGGAAAACTGTTTTTTGGCAGT	CAWSGAFGKLFF	In	VDJ	2	78	0.0012111989316604295	0.0016888234529944138	36	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	6	6	10	1	5	26	39	44	40	49						01,02							Vb 20	CAWSGAFGKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02	TCRBD02-01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCGGGATCAATCAGCCCCAGCATTTTGGTGAT	CAWSVGINQPQHF	In	VDJ	1	59	9.161632944610941E-4	0.0012774433811111592	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	8	3	3	0	1	26	-1	45	40	46			unresolved										Vb 20	CAWSVGINQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGACTAGCAGACTACGAGCAGTACTTCGGGCCG	CAWGLADYEQYF	In	VDJ	1	53	8.229941458718303E-4	0.0011475338847269736	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	7	3	0	3	26	-1	43	35	46			unresolved			01,02							Vb 20	CAWGLADYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCACCGATCCTAGGGGGCCCAAGCAGTACTTCGGGCCG	CATDPRGPKQYF	In	VDJ	1	48	7.453531887141105E-4	0.0010392759710734854	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	5	0	8	9	3	26	32	48	41	51													Vb 20	CATDPRGPKQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGAGGCCGGTCGGGACTCCAGCATTTTGGTGAT	CAWSGGRSGLQHF	In	VDJ	1	46	7.142968058510225E-4	9.959728056120902E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	0	10	12	10	0	26	39	-1	49	55			unresolved			01,02							Vb 20	CAWSGGRSGLQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD02-01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCAGGGGGCGTCTAATGAAAAACTGTTTTTTGGCAGT	CAWSQGASNEKLFF	In	VDJ	1	34	5.279585086724949E-4	7.361538128437189E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	0	3	1	2	26	37	46	38	48													Vb 20	CAWSQGASNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCCCGGGGGAGTAACATTCAGTACTTCGGCGCC	CAWSARGSNIQYF	In	VDJ	1	32	4.96902125809407E-4	6.928506473823237E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	1	8	2	7	2	3	26	39	47	41	50													Vb 20	CAWSARGSNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
CCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGCCGGGACTAGCGGCGGGGCTTTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	32	4.96902125809407E-4		56	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	0	5	3	4	9	25	38	53	42	62						01,02							Vb 20	X+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGACTTTGGGTCACGATCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	30	4.6584574294631904E-4		49	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	2	10	0	0	12	26	-1	41	37	53						01,02							Vb 20	X+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGACTCTAGCGGGGGGGCAACAGATACGCAGTATTTTGGCCCA	CAWDSSGGATDTQYF	In	VDJ	1	29	4.503175515147751E-4	6.278958991902308E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	0	3	4	2	26	35	51	39	53													Vb 20	CAWDSSGGATDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACAGGAAACAATCAGCCCCAGCATTTTGGTGAT	CAWSTGNNQPQHF	In	VDJ	1	29	4.503175515147751E-4	6.278958991902308E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	4	3	0	3	26	-1	43	38	46													Vb 20	CAWSTGNNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCGGACATTCACATTCAGTACTTCGGCGCC	CAWSPDIHIQYF	In	VDJ	1	28	4.347893600832311E-4	6.062443164595332E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	1	6	8	2	3	26	38	45	40	48													Vb 20	CAWSPDIHIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-04*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATCGTGAACACTGAAGCTTTCTTTGGACAA	CAWIVNTEAFF	In	VDJ	1	27	4.1926116865168716E-4	5.845927337288356E-4	33	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	8	6	0	1	0	26	36	-1	37	39						01,02							Vb 20	CAWIVNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGACATCCGAGGGAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	26	4.0373297722014315E-4		47	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	11	0	0	7	1	26	39	51	46	52			unresolved										Vb 20	X+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGCGGACAGGGAGGAGAGACCCAGTACTTCGGGCCA	CACGQGGETQYF	In	VDJ	1	26	4.0373297722014315E-4	5.62941150998138E-4	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	3	4	1	3	26	34	43	35	46													Vb 20	CACGQGGETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGTCTGGAGTAAAGGCCAGGGCAATCAGCCCCAGCATTTTGGTGAT	CVWSKGQGNQPQHF	In	VDJ	1	23	3.5714840292551126E-4	4.979864028060451E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	4	2	6	0	26	38	-1	44	48													Vb 20	CVWSKGQGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCTAGCGACAGATACGCAGTATTTTGGCCCA	CAWSLATDTQYF	In	VDJ	1	22	3.416202114939673E-4	4.763348200753475E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	6	3	1	0	26	37	-1	38	44			unresolved			01,02							Vb 20	CAWSLATDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01	TCRBJ02-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCTCGGACGGAGGGCCTACGAGCAGTACTTCGGGCCG	CAWSLGRRAYEQYF	In	VDJ	1	21	3.2609202006242334E-4	4.546832373446499E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	0	2	8	0	26	37	-1	45	51			unresolved										Vb 20	CAWSLGRRAYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGTGGGGCGCTAATCCAAGAGACCCAGTACTTCGGGCCA	CAWSSGALIQETQYF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	7	0	1	3	6	26	38	46	41	52													Vb 20	CAWSSGALIQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTGGGGAGGACAGGGCCCCTTTAGCAATCAGCCCCAGCATTTTGGTGAT	CAWSWGGQGPFSNQPQHF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	54	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	1	3	0	6	6	26	38	52	44	58			unresolved										Vb 20	CAWSWGGQGPFSNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGAGGAGGGGGGGAAGAACGAGCAGTACTTCGGGCCG	CTSSQEEGGKNEQYF	In	VDJ	13	534	0.008292054224444479	0.011561945178192526	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	9	0	5	3	4	23	40	50	43	54														CTSSQEEGGKNEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAACTAGCGGGGGGGGATGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	137	0.0021273622261215237		47	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	4	0	7	0	5	23	-1	50	38	55														X+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCTCTTACCTGGGCACTGAAGCTTTCTTTGGACAA	CASSSYLGTEAFF	In	VDJ	2	99	0.0015372909517228528	0.0021435066903390636	39	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-01	01	5	0	9	4	8	0	23	35	-1	43	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSYLGTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01		TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAAGGGGCCCAGAACACTGAAGCTTTCTTTGGACAA	CASSQEGAQNTEAFF	In	VDJ	1	54	8.385223373033743E-4	0.0011691854674576712	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	2	1	0	4	23	-1	45	40	49														CASSQEGAQNTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAAACCCGGGGGCCGGAGTACTTCGGGCCA	CASSQETRGPEYF	In	VDJ	1	30	4.6584574294631904E-4	6.495474819209284E-4	39	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-05	01	0	6	0	12	5	3	23	40	51	45	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQETRGPEYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01		TCRBJ02-05*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AGACTCAGCTGCGTATCTCTGCGCCAGCAGCTTCCGACCCCTAAAGGACAGGTCAAGGGGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	29	4.503175515147751E-4		62	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	4	1	14	10	19	31	52	45	62														X+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAGAGCCCCTCGCGGGGGGGTTACGAGCAGTACTTCGGGCCG	CTSSQSPSRGGYEQYF	In	VDJ	1	18	2.795074457677914E-4	3.8972848915255705E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	7	0	4	9	1	23	37	55	46	56														CTSSQSPSRGGYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-07*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCGGTCGGGGTCTGAAGCTTTCTTTGGACAA	CASSQDRSGSEAFF	In	VDJ	1	13	2.0186648861007157E-4	2.81470575499069E-4	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	3	6	5	1	23	40	50	45	51														CASSQDRSGSEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ01-01*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTCGGACAGCTCGACATATATTTTGGAGAG	CASSQVGQLDIYF	In	VDJ	1	12	1.863382971785276E-4	2.5981899276837135E-4	39	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	1	5	12	2	5	23	39	47	41	52														CASSQVGQLDIYF+TCRBV01-01+TCRBJ01-03	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-03*01	1545B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1848	1325	514	7	0	876	702	164	10	0	64399	46186	17942	271	0	0.175205797	7.7986989	0.218602225	7.63799667				51621	0.0294291228	0.0973238647	0.143697888	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:16	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7169913513186079	MSKCC- Snyder- P01-02		1519.0	
